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ABSTRACT 
 Homologous recombination (HR) serves critical roles in DNA repair to maintain 
genome stability, and the malfunction of HR contributes to carcinogenesis and cancer 
development. Current research focuses on the regulation against deleterious 
recombination between imperfectly matching sequences, which has been documented in 
certain myeloid leukemias, hereditary nonpolyposis colorectal cancers and other genetic 
diseases. Homology dependency of recombination was examined in cultured thymidine 
kinase-deficient mouse fibroblasts. Cells have chromosomal integration of DNA 
constructs harboring a herpes tk gene (the “recipient”) and a closely linked truncated 
“donor” tk sequence. The recipient was rendered non-functional by insertion of the 
recognition site for endonuclease I-SceI, and the donor sequence could restore the 
function of the recipient through spontaneous gene conversion or via recombinational 
repair provoked by a double-strand break (DSB) at the I-SceI site. Recombination events 
were recoverable by HAT selection for tk-positive clones. Three different donor 
sequences contained 16, 25, or 33 mismatches relative to the recipient, and these 
mismatches were clustered within these “homeologous” sequences surrounded by region 
of high homology. Previous work indicated that mammalian cells fastidiously avoid 
recombination between homeologous sequences, while our results revealed that when 
homeologous sequences are surrounded by high homology, mismatches are frequently 
included in gene conversion events. Knock-down of DNA mismatch repair provided 
evidence that incorporation of mismatches into gene conversion tracts involved repair
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of mismatched heteroduplex intermediates. Our results demonstrate that mismatch repair 
of multiple mispaired bases does not function to impede exchange between homeologous 
sequences. Moreover, gene conversion tracts from spontaneous recombination showed 
that either all or none of the mismatches were transferred from donor to recipient, 
suggesting that recombination must begin and end in high homology. But this 
requirement was somewhat relaxed in DSB-induced events with recombination ending in 
homeology. Further experiments with a rearranged construct were attempted to 
investigate the relaxed homology requirement during DSB repair. In addition to the study 
on homology requirement of recombination, research works were also carried out to 
characterize the roles of RecQ4 helicases in DSB repair. It is the first demonstration that 
RecQ4 deficiency reduces the fraction of crossover events in DSB-induced 
recombination. Moreover, BLM deficiency failed to boost crossover events in RecQ4 
deficient cells. It is postulated that these two helicases act agonistically to determine the 
generation of crossover events. 
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CHAPTER 1 INTRODUCTION TO HOMOLOGOUS RECOMBINATION 
AND DNA DOUBLE STRAND BREAK REPAIR IN MAMMALIAN 
CELLS 
Cells are facing numerous attacks on chromosomal DNA throughout their life 
cycles, such as reactive oxygen species, genotoxic chemicals or radiations. These attacks 
from endogenous or exogenous sources may damage nitrogenous base, break 
deoxyribose, introduce single-strand nick, interstrand crosslink or even double-strand 
break into the genomic DNA. To counteract these DNA lesions, cells maintain several 
repair pathways to protect genome integrity (1, 2). Base excision repair (BER) and 
nucleotide excision repair (NER) recognize the damaged nucleotides on one strand of 
DNA, cleave and resynthesize them according to the remaining, complementary DNA 
strand. But when DNA damages affect both strands of a DNA sequence, for example, 
DNA double-strand break (DSB) or interstrand crosslink (ICL), homologous 
recombination (HR) is needed for faithful repair (3, 4). HR relies on RecA helicase to 
perform homology search and strand invasion in bacteria while in eukaryotes, Rad51 
(homolog of E.coli RecA) serves the same function of RecA (5–7). Besides HR, there are 
other homology independent, error prone pathways to repair DSB, for example, 
nonhomologous end joining (NHEJ), single strand annealing (SSA) and alternative NHEJ 
(8, 9).  
The pivotal roles of HR in maintaining genome stability are well demonstrated in 
several rare genetic diseases characterized with genome instability and cancer 
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predispositions. Patients with Fanconi anemia may have congenital birth defects, short 
stature, high incidence of acute myeloid leukemia, and bone marrow failure at an early 
age (10). These syndromes are caused by mutants within a group of genes, the Fanconi 
anemia complementation group (FANC) gene family. Cells deficient in FANC genes 
barely respond to replication stress caused by DNA ICLs and fail to repair them through 
HR, therefore these cells are not able to maintain the genome stability especially when 
facing crosslinking agents like cisplatin and mitomycin C. RecQ helicase BLM 
participates in HR and inhibits Holliday junction resolution toward crossover (CO) 
events. BLM deficient cells have high rate of sister chromatid exchange (SCE) as well as 
elevated recombination between homologous chromosomes (11–13). As a result, the 
patients with BLM deficiency (Bloom syndrome) are characterized with genome 
instability, short stature and predisposition to cancer within multiple tissues. Genetic 
studies also revealed that deficiencies of other HR mediators, such as BRCA1, BRCA2, 
RAD54B, RAD51B, RAD51C and RAD51D, endanger the genome stability and 
contribute to the susceptibility to several cancers including breast cancer, ovarian cancer 
and colon cancer (14). Specifically, mutations in BRCA1 and BRCA2 significantly 
increase the carrier’s risk in breast cancer and ovarian cancer, and also contribute to other 
types of cancer. These two genes mainly assist in RAD51 nucleoprotein filament 
formation, homology search and strand invasion during HR (4). As described above, HR 
pathway is so tightly connected to genome stability that discoveries of remaining HR 
components, functions of these participating proteins, and regulation within this 
complicate process would broaden our knowledge of the genome maintenance in somatic 
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cells, and help elucidating the genomic alterations in carcinogenesis and cancer 
development. 
 Two working models of HR are briefly illustrated in Figure 1.1. The 
recombination starts from a DNA damage event breaking both strands of a DNA 
molecule. Then, 5' exonuclease resects the broken DNA ends to produce 3’ single-strand 
overhangs for homologous pairing (4, 15). Rad51 coats the single-strand overhang, 
directs it to invade a DNA sequence with high homology, and pairs it with the 
complementary strand (4). Following the strand invasion, DNA synthesis elongates the 
invading strand under the guide of the homologous template, therefore restoring the 
broken region as well as nearby nucleotide sequences. After strand invasion and DNA 
synthesis, HR may diverge into two ways. 
 In synthesis dependent strand annealing (SDSA) pathway, the nascent DNA 
strand aborts DNA synthesis, detaches from the homologous template and anneals to the 
other resected broken end. Through cooperation of DNA polymerase, exonuclease and 
DNA ligase, the broken DNA molecule is finally rejoined through base pairing of the 
complementary DNA ends. SDSA will repair the DSB-damaged DNA sequence 
according to the chosen homologous template, and leave gene conversion tract in the 
restored DNA molecule (16–19) .  
 In the double strand break repair (DSBR) model, the initial strand invasion and 
DNA synthesis peels off  the non-template strand of the template to form a bubble shaped 
D-loop, and then the extended D-loop anneals to the other resected broken end starting 
the DNA synthesis of the second strand (7, 20). Later on, the temporary “synaptonemal” 
intermediate matures into two stable Holliday junctions (double Holliday junctions,   
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Figure 1.1 Double strand break repair model (DSBR) and synthesis dependent strand 
annealing model (SDSA). 
Two models describing the procedure to repair DNA DSB through HR are demonstrated 
in above Figure. Black lines represent the strands of the broken DNA molecule while the 
gray lines represent the strands of the template DNA molecule. The grey arrowheads 
show the 3’ end of the DNA strand and the direction of DNA synthesis. The dashed lines 
indicate they are the newly synthesized DNA strands. Black or white arrowheads point to 
the sites for cleavage and re-ligation in Holliday junction resolution. Adapted from San 
Filippo et al. 2008 (4).   
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dHJs) bridging these two participating DNA molecules. Finally, the Holliday junctions 
(HJs) are resolved by coordinated endonuclease cleavage and strand ligation. Holliday 
junction resolution has two competing outcomes: gene conversion (GC), which restores 
the broken DNA molecule using genetic information from its homologous template, or 
crossover (CO), which not only restores the broken DNA molecule, but also splices these 
two DNA molecules around the repair region. 
 Supplementary to the DSBR model, Holliday junction dissolution describes a sub-
pathway to separate the dHJs connected DNA molecules. RecQ helicase BLM, 
Topoisomerase IIIα and RMI1 (RecQ mediated genome instability 1 or BLAP75)-RMI2 
(BLAP18) propel the convergent branch migration of dHJs to form hemicatenated DNA 
molecules, then cut and re-ligate one DNA strand to eliminate the topological link 
between these two molecules (21, 22). The Holliday junction dissolution only restores the 
broken DNA molecule with gene conversion product indistinguishable from that of 
SDSA pathway. 
 Without exogenous stress or disturbance, HR happens at an extremely low rate 
during cell proliferation, and it is called spontaneous recombination. The origin of 
spontaneous recombination is debatable and probably different causes mentioned below 
all contribute to the spontaneous recombination events. HR may start from a 
spontaneously occurring DSB, and generate gene conversion or crossover events as 
described above (Figure 1.1). Secondly, a stalled replication fork may cause spontaneous 
recombination as well (23). When a replication fork meets obstacle, and pauses, it may 
regress, unwinding the newly synthesized DNA strands from the parental DNA (Figure 
1.2, right panel). These two complementary strands then anneal and turn the replication 
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fork into a chicken foot structure. The newly synthesized leading strand within the 
structure would invade the parental DNA to reestablish the replication fork. DNA 
recombination restoring stalled replication fork usually does not cause strand splicing 
between sister chromatids. Thirdly, collapsed replication forks spark spontaneous 
recombination (24). When leading strand encounters a nick on its complementary, 
parental DNA strand, it will run off the ongoing replication fork as a one-ended DSB. The 
broken end would invade the parental DNA molecule and reconstruct a new replication 
fork with the help of RAD51 (Figure 1.2, left panel). Unlike stalled replication fork, 
restoration of the collapsed replication fork tends to generate SCE. Spontaneous 
recombination is needed to resolve other DNA lesions during replication as well, which 
involves HJs and associated resolution, similar to previous two described pathways (25). 
Lastly, the newly synthesized DNA strand may simply unwind from the original parental 
strand, and anneal to a nearby homologous strand to continue DNA replication (4). The 
template switching allows daughter DNA molecule to copy from a homologous partner 
and overcome the lesions on its parental DNA molecule.  
 In recombination studies, fluctuation test has been used to collect spontaneous 
recombination events as well as to estimate the rate of the recombination events (26). The 
fluctuation test was first introduced to delineate the origin of the bacteria’s immunity 
against virus, from spontaneous mutation or acquired immunity (27). Proportion of 
resistant bacteria were monitored in a growing culture and subsequent cultures, and the 
great variation across the subcultures confirmed the mutation hypothesis. The occurrence 
of HR events fits the mathematical description in aforementioned paper, which implies   
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Figure 1.2 DNA recombination restores problematic replication forks. 
The collapsed and stalled replication fork are rescued by HR, as shown above. Parental 
DNA strands are drawn with black line while the daughter strands are drawn with gray 
line. Newly synthesized DNA strands are drawn with dash line and the arrowheads 
indicate the 3’ end of the DNA strand. Adapted from Helleday 2003 (28).  
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that the recombination events arise during cell proliferation similar to the spontaneous 
mutations.  
 HR participates in DSB repair to maintain genome stability, as stated earlier in 
this chapter and the recombination frequency is dramatically boosted by DNA DSB. 
Ionizing radiation, reactive oxygen species, and other chemicals produce DNA DSBs 
directly or indirectly (29). Approximately 50 endogenous DNA DSBs happen per cell 
cycle, and the number will double if the cells are facing 1 Gyt ionizing radiation (9). 
Timely repair of DSBs is vital for cells to overcome these intracellular or extracellular 
stresses, while the failure would lead to cell cycle arrest and even cell death (8). As 
illustrated in Figure 1.1, during HR, broken DNA ends are resected to generate 3’ single-
strand overhangs and then directed to a homologous template for restorative DNA 
synthesis. HR faithfully repairs the broken DNA molecule, while sometimes produces 
crossover events splicing the broken DNA molecule and the template DNA molecule. HR 
is also critical to repair other DNA lesions. DNA ICLs may be cleaved to produce DSB, 
and then HR takes the turn to complete the late stage of repair (10). Conceivably HR can 
fix DSBs generated by other repair pathways, and accurately restore the broken sequence 
based on a homologous template.  
 HR provides faithful repair even if the broken DNA molecule loses a significant 
amount of DNA sequence after DNA damage. The benefits of the HR are obvious unless 
the chosen homologous template has a mutation within region needed for repair. In this 
rare circumstance, loss of heterozygosity (LOH) will severely affect the normal gene 
function in the host cell (9, 13).  
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 Cells also utilize other pathways to repair DSBs, especially non-dividing cells 
lacking in HR activity. Non-homologous end joining (NHEJ), single strand annealing 
(SSA), precise ligation (PL) and other alternative pathways can repair DNA DSBs 
(Figure 1.3). NHEJ is a prominent pathway to repair DSB, especially when the damaged 
DNA does not have homologous sequence available nearby. NHEJ shares protein 
components with HR initially: MRN (MRE11-RAD50-NBS1) complex trims broken 
DNA ends and cleaves obstructive adducts for both pathways. NHEJ employs Ku70 
(XRCC6, Lupus Ku autoantigen protein p70 or X-ray repair cross complementing 6), 
Ku80 to tether the broken ends and uses DNA ligase IV to reestablish the linkage (30–
32).  
 NHEJ events keep the structure and continuity of the damaged chromosome, 
though produce sequence deletions ranging from several base pairs to thousands of base 
pairs. These events would affect normal gene function if the coding sequence or 
regulatory element get changed after repair. Available evidence also shows that NHEJ 
events are capable of efficient and accurate DSB repair when compatible DNA ends exist 
for direct ligation, which was called PL previously.  
 When the two-ended DSBs somehow still have complementary ends, PL directly 
ligates them, and preserves the original DNA sequence without any alteration (33, 34). 
Limited number of studies in DNA repair addressed PL since most recombination 
systems are designed to select events with sequence changes after repair. However, PL is 
likely the most time-and energy-efficient way of accurate repair if compatible ends 
remain after DSB. Using mutant I-SceI sites to recover re-ligation events, a recent study 
revealed that PL is the predominant way to repair DSBs with complementary ends, while  
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Figure 1.3 NHEJ and SSA pathways to fix DNA DSBs. 
Overview of NHEJ and SSA pathway. Critical proteins in NHEJ are drawn on the left, 
while re-ligation procedure of SSA is drawn on the right. Adapted from Lazzerini-Denchi 
et al. 2016 (35) and Schubert et al. 2011 (36). 
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only 5% of the repair events are NHEJ with nucleotide deletions (37). Moreover, PL 
relies on NHEJ components, for example, Ku70, XRCC3 and ligase IV. It is conceivable 
that before the generation of NHEJ events with sequence deletion, the compatible ends 
were tethered together, and PL ligated them successfully multiple times (37, 38). 
NHEJ efficiently repairs DSB without using a DNA template across cell cycles, 
and it may bring minor or moderate deletions to the DNA sequence. When NHEJ is 
delayed or damaged, cells may take an alternative pathway: alternative NHEJ (A-NHEJ) 
(31, 34, 38, 39). For example, NHEJ relies on ligase IV, Ku70 and DNA-PKcs. If cells 
have deficiency in these proteins, the broken ends may get extensive resection before 
ligation, therefore, repair events with long deletions become commonly observed. 
Sometimes, the broken end may be ligated with a broken ends from other breakages, 
producing chromosomal translocation or fusion (31, 40). In A-NHEJ, re-ligation of the 
broken ends relies more on microhomology, and utilizes a set of protein components 
including PARP1, CtBP-interacting protein (CtIP), ligase I and ligase III. Some of these 
protein components are also used by HR during strand resection (40, 41). Also, 
monitoring of the DNA repair process shows that A-NHEJ happens late in the DSB 
repair, and serves as a backup pathway when NHEJ failed in initial attempts.  
If DNA DSB happens in one of the tandem repeats on a chromosome, the 
complementary sequences on either side of the breakage could be revealed though 
extensive unwinding or end resection (34, 42, 43). After strand annealing between these 
two tandem repeat sequences, the single strand overhangs/flaps are cleaved off, and then 
the strand ligation mediates the fusion of the two tandem repeats. SSA also uses 
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homology to repair DSB, but unlike HR, SSA mediated repair and sequence deletion are 
independent of Rad51. 
 Break induced repair (BIR) rescues a DSB event even when one side of a broken 
DNA molecule is lost after DNA damage, which is not cued by aforementioned pathways 
(44). BIR may use a nearby sister chromatid as template to accurately restore the broken 
chromosome: RAD51 directs the DNA single strand overhang to invade and establish a 
replication fork on the sister chromatid (Figure 1.4). Unlike semi-conservative DNA 
replication, BIR moves the replication fork through sliding of the D-loop, while the 
synthesis of lagging strand is carried out using the newly synthesized leading strand as 
template (45).Though BIR saves cells from deleterious loss of chromosome, it will 
produce chromosomal fusion or translocation if an improper template was chosen. 
 SSA, A-NHEJ and BIR are error prone pathways bringing profound changes to 
local DNA sequence and chromosomal structure. LOH, sequence deletion, chromosomal 
fusion and translocation are known outcomes if cells adapt these pathways. Since 
aforementioned repair pathways bring different risks to the genome, choice of pathway to 
counteract DSB is critical to the benefits of the host cells. These pathways are likely 
attempted in an order for the best of the cells, which may differ because of different cell 
lines, cell cycle or genetic background.  
 NHEJ is a prominent pathway to repair DSBs in all phases of cell cycle, and 
usually acts swiftly to fix the lethal DNA lesion. NHEJ does not need extensive resection 
and prolonged DNA synthesis; nucleotide cleavage and/or addition is sufficient to rejoin 
the broken DNA. If complementary ends still exist after DSBs, precise ligation of the 
broken fragments would dominate the ligation events. When the cells failed in this  
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Figure 1.4 Break induced replication model (BIR). 
BIR fixes DSB by re-synthesizing the lost DNA fragment. The DNA sequence of broken 
molecule is in black while sequence of template DNA is in gray. Newly synthesized DNA 
strand is drawn with dashed line, while the grey or black color represents the identity of 
the sequence. The arrowheads indicate the 3’ end and the direction of DNA synthesis. 
Adapted from Donnianni et al. 2013 (45). 
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particular attempt, they would turn to error-prone NHEJ, HR or other alternative events 
for repair (32).  
 HR in somatic cells relies on recombinase Rad51, which is only detectable in 
G2/S phase, due to cell cycle dependent transcription (46, 47). In the meantime, sister 
chromatids provide the nearby homologous template for efficient recombination (19). 
Apparently, without the critical recombinase Rad51 for strand invasion and exchange, 
and without a nearby template, homologous paring and exchange between two sequences 
are not the preferred pathway for repair. When both NHEJ and HR are available to 
compete, the CtIP, recruited by MRE11, stimulates end resection and channels the repair 
toward HR. CtIP’s activity relies on CDK-dependent phosphorylation (48, 49), and 
interestingly, RecQ4, one of the RecQ helicase facilitates CtIP’s recruitment at the DSB 
site (15) while another RecQ helicase, WRN, suppresses the recruitment of CtIP and 
MRE11, propelling DSB repair through NHEJ without extensive end resection (41).  
 If initial attempts through NHEJ or HR failed, extensive resection and degradation 
may reveal remote homology or microhomology for re-ligation, so SSA or A-NHEJ 
would follow afterward. In NHEJ deficient cells, the repair pathway turns to A-NHEJ, 
which uses microhomology and ligase III to mediate the end rejoining (50, 51). 
 As stated in previous paragraphs, recombination mediators and interacting 
partners not only participate in DSB repair but also shift the repair toward different 
pathways and recombination products. RecQ4, one of the RecQ helicase, has been 
associated with DSB repair. Patients with defective RecQ4 have Rothmund Thomson 
syndrome, which was characterized with poikiloderma, cataracts, predisposition to 
osteosarcoma, and accelerated aging. It is of great importance to explore RecQ4’s 
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function in DSB repair since the RecQ4 deficient cells show several typical signs of 
genome instability. Experiments were conducted on RecQ4 helicases by analyzing DSB-
induced recombinants after siRNA knockdown in human fibroblast cells. Increase of gene 
conversion events was observed in RecQ4 deficient cells, opposite to the impact BLM 
deficiency brought. Moreover, BLM deficiency failed to increase crossover events in 
RecQ4 deficient cells while it dramatically boosted crossover events in wild type cells. 
Our results showed that RecQ4 and BLM shift the final products of HR toward opposite 
directions, indicating agonistic roles they may play in HR. Since crossover is potentially 
deleterious outcome in DSB repair, current genetic study provides preliminary data and 
evidence to understand RecQ4’s impact on the genome stability, and these results warrant 
further mechanistic studies.  
 Another potential risk of HR lies in template selection. HR maintains the genome 
stability in somatic cells by cuing DNA breakage from radiation, genome toxic chemicals 
or endogenous cell stress (8, 29). However, if the Rad51 coated DNA overhang invades a 
non-allelic template sequence, and retrieves the incorrect DNA sequence, mutation and 
malfunction are imaginable (52). Sporadically, recombination between non-allelic 
sequences causes genetic diseases and contributes to cancer development (30, 52). When 
DNA recombination happens between imperfectly matching sequences (synonymous 
with diverged sequences and homeologous sequences), the restored DNA molecule would 
have certain DNA sequence replaced by that of the DNA template. These recombination 
events with a homeologous conversion tract are thus called homeologous recombination 
events (HeR events) (53–56). Due to HeR’s deleterious consequences to gene function 
and genome stability, a lot of research have been done to address the mechanism how 
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cells avoid DNA recombination between diverged sequences. It has been confirmed in 
multiple model organisms that functional DNA mismatch repair (MMR) is needed to 
prevent recombination events between diverged sequence, however, at which stage the 
MMR intervenes the homeologous recombination and the detailed mechanism is not well 
known and still in debate (54, 57–59).  
 Pursuing the previous findings in our laboratory (53, 55), a systematic research 
has been done to explore the mechanism how mammalian cells exclude highly diverged 
sequences from DNA recombination, and the results are presented in current dissertation. 
New substrates were constructed to have different lengths of diverged sequences 
surrounded by perfect homology. Both spontaneous recombinants and DSB recombinants 
from new substrates were collected and analyzed. The obtained data clearly demonstrates 
that HeR events are common when sufficient homology for recombination locates on 
both sides of the homeologous sequences. Additionally, strand exchange between 
homeologous sequences is supported by evidence of heteroduplex DNA intermediate 
after MSH2 knockdown. These results argue that DNA recombination does not target and 
reject genetic exchange between highly diverged sequences in these new substrates. 
Though MMR prevents recombination from happening between imperfectly matching 
sequences, our results added to current paradigm that in certain circumstances, MMR 
does not impede the exchange between diverged sequences, but facilitates it by 
converting mismatched nucleotides to the recombination template. Moreover, our results 
revealed the relaxed homology requirement of DSB-induced recombination, which 
demonstrates the higher risk of HeR events during DNA damage and repair.  
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CHAPTER 2 RECOVERY AND ANALYSIS OF SPONTANEOUS AND 
DSB-INDUCED RECOMBINANTS IN MOUSE LTK- CELLS 
 HR is able to faithfully repair a damaged DNA molecule. It directs the DSB ends 
of the broken DNA to its homologous template, synthesizes the lost DNA sequence and 
restores the broken region seamlessly. However, improper choice of recombination 
template may bring HeR events: If the broken DNA sequence pairs with another non-
allelic DNA sequence and gets synthesized depending on a wrong template, it will likely 
bring mutations and malfunction to the involved genes. 
 Our research focuses on the risk of homologous recombination between non-
allelic, evolutionarily related fragments with high sequence divergence. These events 
may convert the DNA sequence of one fragment to the other, and sometimes they even 
recombine these two DNA molecules within the diverged sequence creating reciprocal 
crossovers. These events are collectively called homeologous recombination (HeR), since 
the HR took diverged sequences (homeologous sequences) as substrates. Many reports 
confirmed HeR events between non-allelic sequences in germ-line cells or somatic cells 
(52, 60). HeR events did happen between members of a gene family since they both share 
substantial homology and reside in nearby locations. HeR events also happened between 
highly diverged and physically separated repeat sequences like Alu sequences. One type 
of hereditary nonpolyposis colorectal cancer (HNPCC) was caused by chromosomal 
rearrangement between two Alu sequences (60). In addition, tens of thousands of 
degenerative pseudogenes in mammalian cells still have adequate homology to
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recombine with their parent genes (61–63). All these HeR events between non-allelic 
substrates may bring fatal mutations to functional genes, produce chromosomal deletions 
or duplications, or even generate severe gross rearrangement by splicing non-homologous 
chromosomes. Studying the HeR events between these substrates allows us to understand 
the tight regulation cells maintain to achieve reparation rather than impairment. 
 Previous studies demonstrated that HR scrutinizes potential templates and only 
allows efficient exchange between perfectly matching sequences (64). The strict 
exclusion of diverged sequences during HR relies on DNA mismatch repair (MMR). 
Horizontal gene transfer (HGT) between closely related bacteria species elevates 
significantly when the recipient cells are deficient in MMR (54, 65). In yeast, active 
MMR prevents HR from happening between diverged sequences as well (59, 66–68). 
Systematic studies have been carried out in Saccharomyces cerevisiae comparing HeR 
events in wild type and MMR deficient cells: MMR reduces HeR events up to 30-fold as 
the sequence divergence increases from 0% to 9%, while beyond 9%, the rarity of HeR 
events is likely a combination of  the 30-fold reduction enforced by MMR and weak 
interaction between highly diverged sequences (66). In mouse cells, a single nucleotide 
mismatching could reduce the spontaneous recombination 30-fold (26). In mammalian 
cells, HeR events between 1% to 1.5% diverged sequences increase 7 to 10-fold after 
ablation of MSH2 (3, 69). Beside MMR, other protein factors also contribute to the 
prevention of HeR events, probably by unwinding the potential mismatched heteroduplex 
DNA (hDNA) intermediate in the HeR process. Yeast Sgs1 helicase is vital to the 
rejection of HeR events (68), and recent results in our laboratory show that RecQ helicase 
BLM, the mammalian homolog of Sgs1, suppresses HeR events in human cells as well 
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(70). In vitro experiments show that BLM and MSH2 cooperate in detecting strand 
annealing between diverged DNA sequences and peeling them apart, therefore, aborting 
the strand invasion (56). The end resection and strand invasion toward homeologous 
sequence may be attempted multiple times before the DNA repair is redirected to 
alternative pathways. 
A series of research projects have been carried out in our laboratory to investigate 
HeR events between highly diverged sequences in mammalian cells, and some 
representative substrates are illustrated in Figure 2.1. These recombination substrates 
were designed to collect recombination events involving diverged DNA sequences 
originally from herpes simplex virus: the DNA sequences of type 1 and type 2 herpes 
simplex virus thymidine kinase (HSV-1 TK and HSV-2 TK) share 80% homology, similar 
to that between highly diverged Alu sequences or other repetitive elements (53, 55). 
Spontaneous recombination between HSV-1 TK and HSV-2 TK sequences was not 
recovered in our previous experiments using the pHOME substrate, and the 
recombination frequency was estimated to be lower than 10-9 (event per cell division) 
(26, 55). When it comes to the recombination between HSV-1 TK recipient sequence and 
hybrid donor sequence of HSV-1 TK and HSV-2 TK (pHYB21A or pHYB12-8), the 
spontaneous recombination frequencies are at 10-8, similar that with HSV-1 TK region of 
aforementioned donors (53). In these experiments on pHYB21A and pHYB12-8, only 1 
out of 81 recombinant clones shows a conversion tract in the HSV-1 TK recipient toward 
HSV-2 TK sequence, a signature of HeR events. Exchange between homeologous 
sequence became common only in recombination substrate pHYB121, which carries 
HSV-1 TK recipient and hybrid donor composed of HSV-1 TK, HSV-2 TK and HSV-1   
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Figure 2.1 Alignment of recipients and donors from selected recombination substrates. 
The structures of donors and recipients used in previous experiments are shown above, 
and the alignment reveals the position of endonuclease recognition sites (XhoI or I-SceI) 
within recipients relative to the donor’s sequence.  
The white rectangles represent DNA sequences of HSV-1 TK and the striped rectangles 
represent HSV-2 TK sequences. The I-SceI or XhoI site in recipient is marked by a tilted 
partial circle and solid line. And the dash line runs across these donors to show the 
nucleotide position where recipients hold the oligonucleotides insertion harboring the 
recognition site of either XhoI or I-SceI. Arrangement of recipient and donor after 
chromosomal integration is shown below the alignment. 
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TK sequence. In this case, 11 out of 39 recombination events have gene conversions in 
HSV1-TK recipient, and the conversion tracts always include all the nucleotide 
mismatches between HSV-1 TK recipient and hybrid donor.  
 Considering the recombination events from pHYB21A and pHYB12-8, the 
spontaneous recombination events preferentially occur between perfectly matching 
sequences and avoid nearby homeologous sequences. The exchange between 
homeologous sequence during spontaneous recombination is barely allowed unless 
homology lies on both sides of the homeologous sequence, as shown by pHYB121. 
Therefore, apparently perfect homology is required at both the initiation and resolution 
site during HR. To further evaluate the supervision against homeologous sequences 
during HR, increasing lengths of homeologous sequence were engineered in new 
substrates to reveal how exchange between homeologous sequences is processed during 
spontaneous recombination. If the “homology” rule is enforced at both initiation and 
resolution, the recombination events in new substrates would be similar to that of 
pHYB121, even though they have different lengths of homeologous sequence inside the 
donor. Moreover, the proposed experiments help to clarify whether the homeologous 
sequences in the hybrid donors impede HR to achieve the genetic exchange between 
them, and whether they are actually targeted by aforementioned mechanism for rejection 
or destruction. 
 All three new substrates carry a full length HSV-1 TK recipient and a hybrid 
donor composed of HSV-1 TK, HSV-2 TK and HSV-1 TK sequences. Donors of these 
substrates differ in the length of the HSV-2 TK sequence, and their upstream and 
downstream HSV-1 TK sequences exceed the minimal efficient processing segment 
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(MEPS, approximate 200 bp in mouse cells) required for efficient recombination (26, 71, 
72). Spontaneous recombination between donor and recipient may remove the I-SceI 
insertion from HSV-1 TK recipient, thus restore the function of the viral thymidine 
kinase. These recombination events enable host cells to survive and form resistant clones 
in culture medium containing HAT.  
 Analysis of these recombinants will reveal how clusters of mismatches affect 
strand exchange between DNA molecules during spontaneous recombination. If HR 
vigorously rejects homeologous sequences, the HeR recombination frequency or the 
proportion of HeR recombinants would decrease when the substrate has a longer 
homeologous region. Meanwhile, nucleotide mismatches between the donor and recipient 
allow us to examine the border of recombination events, so it is possible to see whether 
spontaneous recombination starts and ends exclusively in the homologous region, 
converting all mismatched nucleotides.  
 Ionizing radiation, reactive oxygen species, and other genome toxic chemicals 
cause DNA double-strand breaks (DSBs) directly or indirectly (9, 29). In proliferating 
cells, HR is a vital pathway to repair DNA DSBs and saves cells from cell cycle stalling. 
However, if not harnessed, HR may conduct genetic exchange between non-allelic DNA 
sequences, and some even generate chromosomal translocation or fusion. DNA 
recombination between highly diverged sequences, so called homeologous recombination 
(HeR), was also observed in mouse Ltk- cells during DSB repair (55). These HeR events 
happened between thymidine kinase sequences of type 1 and type 2 herpes simplex virus, 
and their frequencies are 600-fold less than HR events (53). The sequence exchange 
between homeologous region during DSB repair occurs more if DSBs provoked HR in a 
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nearby homology: The HeR frequency between HSV-1 TK recipient and hybrid donor 
composed of HSV-1 TK and HSV-2 TK sequences is 3 times more than HeR events 
between pure homeologous sequences. 
  As described in previous paragraphs and in Figure 2.1, HeR event between 
homeologous sequences was not recovered during spontaneous recombination (55, 73). 
Even half of the homeologous donor was replaced with homologous sequence to boost 
initiation of HR (pHYB21A or pHYB12-8), exchange between homeologous sequences 
is still a rare event (53). Spontaneous recombination prefers perfect homology to start and 
end, thus it either manages to incorporates all mismatched nucleotides in conversion tract 
once encountering homeologous sequence, or simply return to the initiation site for 
resolution without converting any nucleotide if homology is not available on the other 
side of the homeologous sequence (53). However, in DSB induced HR between HSV-1 
TK and hybrid donor composed of HSV-1 TK and HSV-2 TK sequences, genetic 
exchange frequently propagates into nearby homeologous region, converting some 
mismatched nucleotides (55). Therefore, the homology requirement for resolution 
appeared to be somewhat relaxed in proximity to a DSB during DSB repair. To test this 
hypothesis, experiments were designed to examine whether DSB induced HR events 
frequently get resolved in the middle of the homeologous region when homologous 
region is available on both sides. Transferring of mismatched nucleotides from donor to 
recipient will reveal the range of homeologous exchange. After comparing the choices of 
resolution site, difference in homology requirement between DSBs induced HR and 
spontaneous recombination could be obtained.  
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 To learn how HR processes homeologous sequences during DSB repair, 
endonuclease I-SceI was transiently expressed in selected cell lines. After the I-SceI 
introduced DSB gets repaired through HR, NHEJ or other alternative pathways, the host 
cell may gain a functional thymidine kinase and form a recombinant clone in HAT 
selection. Experiments were carried out on the same selected cell lines examined for 
spontaneous recombination, which have different lengths of homeology in the donor (55). 
Therefore, the comparison between DSB repair recombinants and spontaneous 
recombinants may reveal whether exchange between homeologous sequences might be 
processed differently during DSB repair. The HeR events and conversion tracts in these 
cell lines may answer the following questions: whether the homology requirement in 
resolution is indeed relaxed during DSB induced recombination, whether the 
homeologous region poses an obstacle to HR in conducting sequence exchange between 
them, and whether strand exchange with substantial mismatches is targeted for rejection 
or destruction. For example, if there is vigorous rejection of the homeologous sequence, 
clone frequency or proportion of HeR recombinants should decrease in cell lines carrying 
a longer homeologous region in their substrates.  
Materials and Methods: 
 Construction of substrate: The backbones of new substrates are from vector 
pJS-1(72). Three substrates, pLD1, pHYB121, pJSBam8 were developed from pJS-1 in 
previous experiments (53, 55), and they are used directly to build new pBWW substrates 
(Figure 2.2 to Figure 2.5). pJSBam8 has a 2.5 Kb HSV1-TK gene inserted at the unique 
BamHI site of pJS-1, and the gene sequence has been rendered nonfunctional by 8bp 
oligonucleotides insertion containing XhoI I site at nucleotide position 1215. The   
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Figure 2.2 Workflow to construct substrate pBWW1. 
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white 
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are 
HSV-2 TK sequences. pBWW1 has 33 mismatches between donor and recipient, and it 
was used to build 3 other recombination substrates examined in current studies.  
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Figure 2.3 Workflow to construct substrate pBWW33. 
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white 
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are 
HSV-2 TK sequences. pBWW33 has 33 mismatches between donor and I-SceI site 
containing recipient, and it was used in subsequent recombination experiments.  
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Figure 2.4 Workflow to construct substrate pBWW25. 
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white 
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are 
HSV-2 TK sequences. pBWW25 has 25 mismatches between donor and recipient, and it 
was used in subsequent recombination experiments. 
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Figure 2.5 Workflow to construct substrate pBWW16. 
Plasmids, primers and restriction sites in use are drawn and labeled in figure. The white 
bars in donors and recipient are HSV-1 TK sequences, while the solid bars in donors are 
HSV-2 TK sequences. pBWW16 has 16 mismatches between donor and recipient, and it 
was used in subsequent recombination experiments.  
 29 
nucleotides in HSV1-TK are numbered the same as in the Wagner’s paper hereafter (74). 
pHYB121 has the same nonfunctional HSV-1 TK recipient inserted at BamHI site as 
substrate pJSBam8, but it also has a hybrid donor inserted at the unique HindIII site. The 
hybrid donor of pHYB121 is composed of continuous HSV-1 TK, HSV-2 TK and HSV-1 
TK sequences: nucleotides 848-1096 of HSV-1 TK sequence followed by nucleotides 
1097-1167 of HSV-2 TK sequence followed by nucleotides 1168-1459 of HSV-1 TK 
sequence. pLD1 also has a 2.5 Kb HSV-1 TK sequence at the same BamHI site, but 
unlike pHYB121 and pJSBam8, a 30bp oligonucleotide was inserted at position 1215 of 
the tk gene introducing an I-SceI site. pLD1 has a hybrid donor of HSV-1 TK and HSV-2 
TK sequence inserted at the unique HindIII site, which was excised and discarded during 
substrate construction. pTK1 has the original full length HSV-1 TK sequence at its 
unique BamHI site and it was used as a PCR template. One recombinant from substrate 
pLD1, pLD1-3-6-3-5, has a recombined HSV-1 TK recipient with nucleotides 968-1167 
replaced by HSV-2 Tk sequence, so its recipient has 33 different nucleotides compared 
with the original HSV-1 TK sequence.   
At the beginning, the hybrid donor of pBWW33 was amplified from cell line 
pLD1-3-6-3-5’s genomic DNA using AW130 (5’ATT ATC TAA GCT TAG CCA CGG 
AAG TCC GCC TGG 3’ which contains HindIII recognition site and matches HSV1-TK 
nucleotides 623-642) and AW93 (5’TGA TCA TAA GCT TAA GAC GTC CAA GGC 
CCA GG 3’which contains HindIII recognition site and matches HSV1-TK nucleotides 
1459-1441). The 0.8 Kb PCR product was cut by HindIII, purified using a MinElute Gel 
Purification Kit (Qiagen) and ligated with the HindIII linearized pJSBam8 to produce 
substrate pBWW1. Therefore, the pBWW1 has the hybrid donor, 0.8 Kb HSV1-TK 
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sequence with 33 nucleotides changed to HSV-2 TK sequence, in addition to a XhoI site 
disrupted HSV-1 TK recipient. The donor in pBWW1 was then excised and ligated into 
the HindIII site of pLD1 to generate pBWW33. 
 The hybrid donor of pBWW25 was amplified from cell line pLD1-3-6-3-5‘s 
genomic DNA and substrate pTK1 through three steps of PCR. Firstly, AW130 and 
AW131(5’ GGC GAT AGG GTG CCG GTC GAA GAT GAG GG3’ which matches 
HSV1-TK nucleotides 1016-988) were used to amplify HSV1-TK nucleotides 623 to 
1016 from pTK1. Secondly, AW132 (5’CCC TCA TCT TCG ACC GGC ACC CTA TCG 
CC3’ which matches HSV1-TK nucleotides 988-1016) and AW93 were used to amplify 
HSV1-TK nucleotides 988-1459 from pLD1-3-6-3-5. Lastly, these two PCR fragments 
were annealed using the overlapping HSV-1 TK nucleotides 988-1016 sequence, and then 
extended before the last PCR amplification by AW130 and AW93. After final PCR 
amplification, the complete donor fragment was cut by HindIII and purified as described 
above. The donor of pBWW16 was excised from pHYB121 using HindIII, and it was 
purified the same way as done to other donors. The previously made pBWW33 has the I-
SceI disrupted HSV-1 TK recipient and hybrid donor carrying 33 nucleotides from HSV-
2 TK sequence. The donor of pBWW33 was cut out by HindIII, and then the plasmid 
backbone was ligated with these two newly prepared donor fragments to generate 
pBWW25 and pBWW16 respectively.   
 Digested DNA fragments were separated on agarose gel, and then the target bands 
were excised and purified using a MinElute Gel Purification Kit (Qiagen). Or, the 
digested DNA fragments were separated by low melting point agarose gels and harvested 
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through phenol extractions. PCR products were subjected to additional gel purification 
before HindIII digestion if there were additional, nonspecific bands. 
 For each ligation reaction, 15ng donor fragment and 45 ng vector backbone were 
mixed with 1 uL T4 ligase (NEB) in 20 uL 1X ligation buffer (NEB), and the ligation 
reaction was kept at 16 ºC overnight. On the second day, 5 uL ligation solution was 
introduced into alpha-Select chemically competent bacteria (Bioline) as instructed by the 
supplier. Transformants were plated at different dilutions on LB media containing 40 
ug/mL neomycin, and they were kept overnight at 37 ºC in incubator. Viable clones were 
picked and cultured overnight in 5 mL LB medium, and 4 to 5 mL bacterial culture was 
extracted for plasmid using Qiaprep Spin Miniprep Kit (Qiagen). 
 The donor insertion of pBWW33 was identified by HindIII digestion, and the size 
of insertion was confirmed by PCR amplification of the whole insertion using AW53 
(5’TTA GCT CCT TCG GTC CTC CG 3’ which matches vector pJS1 5094-5113) and 
AW58 (5’CCA ACT TAC TTC TGA CAA CG 3’ which matches pJS1 5147-5128). 
Sequencing of substrate pBWW33 using primers AW94 (5’TAA TAC GAC TCA CTA 
TAG GGG GCT TCA TTC AGC TCC GGT TCC 3’ which matches pJS1 5023-5044) 
confirmed the orientation of the donor insertion. For substrate pBWW16, AW94 and 
AW93 will amplify the correct donor insertion, while AW94 and AW92 (5’ ATT ATC 
TAA GCT TGA TAT CGG CCG GGG ACG CGG 3’ which matches HSV1-TK 848-867) 
amplify the reversed donor insertion. The donor of pBWW16 was amplified using AW94 
and AW58 (5’CCA ACT TAC TTC TGA CAA CG 3’ which matches pJS1 5147-5128) 
and sequenced before use. Finally, I-SceI digested substrates were checked on agarose gel 
to make sure they have intact recognition site of I-SceI within HSV1-TK recipient. 
 32 
 Cell culture: Mouse Ltk- cell line and its derivative cell lines were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS), minimal essential medium nonessential amino acids and 50 ug of 
gentamicin. All cells were incubated at 37 ºC with 5% CO2.  
  Cell line establishment: Mouse Ltk- cells were transfected with each substrate 
through electroporation, and the cells with chromosomal integration of the substrate were 
selected using G418. Five million cells were pelleted in a 15 mL conical tube, washed 
one time by 5 mL PBS and then suspended in 775 uL PBS. The ClaI linearized substrate 
(2.5 ug in 25 uL digestion buffer) was added into the cell suspension to make it 800 uL 
before electroporation. The electroporation was carried out in a cuvette with 0.4 cm gap 
width at 1000 volts and 25 microfarads, and then the time constant was always 0.4 
milliseconds. Right after electroporation, all the cells were transferred into a T175 flask 
and they were cultured for 2 days before G418 selection. Two days later, the cells were 
trypsinized, and 100,000 cells were plated in each T75 flask with 200 ug/mL G418.  
Syringe transfection (75) was attempted one time on pBWW33. Linearized pBWW33 
(1.25 ug) was mixed with 0.5 million cells in 1mL culture medium, and then the cell 
suspension was taken into a 1ml syringe. All cells were forced through 30-gauge needle 4 
times (8 strokes including the first transfer) to allow plasmid penetrating cell membrane. 
After the procedure, all cells were plated into 10 T75 flasks. On the next day, G418 was 
added into the culture medium at 200 ug/ml. The G418 selection usually took 11 to 14 
days before resistant clones grew up.  
 G418 resistant clones were picked and cultured separately in a 24 well plate. After 
2 weeks, all cells in a well were trypsinized and transferred in one T25 flask. Upon 
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confluence, cells of each flask were separated into two T25 flasks: cells in one flask were 
frozen and stored at -80ºC, while the cells in second flask were used to prepare genomic 
DNA.  
 Genomic DNA of these clones were extracted as described before (73), and their 
concentrations were measured by spectrophotometer. For Southern blot, 8 ug genomic 
DNA was digested by HindIII or BamHI, separated on agarose gel and transferred onto 
nitrocellulose. Meanwhile, 10 pg digested substrate was loaded aside to display the intact 
donor or recipient, and their signals are equivalent to a single copy integration in mice 
genome. Full length HSV-1 TK sequence was used to synthesize probe, which hybridizes 
with recipient and donors (76). Cell lines were chosen for further experiments if they 
have intact donor and recipient, and their signal indicate a single copy integration of the 
substrate. 
 Collect spontaneous homeologous and homologous recombinants: Fluctuation 
test was carried out on each cell line to collect spontaneous recombinants as described 
before (77). In fluctuation test, 10 subclones were grown up in parallel. Initially, 100 cells 
were seeded per well in 24 well plate to start a subclone. Once confluent, the cells from 
each well were trypsinized and transferred into T25 flask. They were subsequently 
transferred into T75 flask, and then two T175 flasks, where the cells grew up to 
approximate 40 million. Finally, for each subclone, cells from the 2 T175 flasks were 
trypsinized and plated in HAT selection. Maximal 10 million cells were plated in a T175 
flask with 30 mL 1 X HAT medium to achieve effective selection as well as proper clone 
density. HAT resistant clones usually became visible 2 to 3 weeks afterward, and then  
they were picked and cultured for sequence analysis as described before.  
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 Calculation of clone frequency, homologous recombination frequency and 
homeologous recombination frequency: In fluctuation test, the clone frequency was 
calculated for each subclone by dividing the number of HAT resistant clones by the 
number of cells subjected to HAT selection. Then, the clone frequencies of 10 subclones 
were averaged to generate the clone frequency of the cell line. Similarly, the HR 
frequencies of the 10 subclones were calculated separately, and then they were averaged 
for the cell line. For each subclone, the HR frequency was calculated by multiplying 
clone frequency of the subclone with the proportion of HR clones in analyzed clones. 
HeR frequencies were calculated for each subclone separately the same as HR events, 
and they were averaged to generate HeR frequency of the cell line. If there were other 
events, like the reactivation of mouse thymidine kinase pseudogene, these events were 
still counted in clone frequency, therefore, the spontaneous recombination frequency 
would be different from the clone frequency and calculated separately case by case.  
 PCR amplification and sequencing: All PCR amplifications were performed 
using GE’s illustra Puretaq Ready-To-Go PCR Beads as instructed by the supplier. The 
dried PCR bead was dissolved in 25 uL reaction solution containing DNA template and 
50 ng of each primer. And this 25 uL reconstituted PCR mixture was overlaid with 
mineral oil to prevent evaporation in following thermal-cycling.  
 PCR amplification of HSV-1 TK sequence used following “Touchdown” protocol: 
The initial denaturation starts at 95ºC for 5 minutes. In the first 12 cycles, the 1 minute 
annealing step starts at 72ºC and then the temperature drops 2ºC after every two cycles 
until it reaches 62ºC; the elongation takes 3 minutes at 72ºC, and the denaturation takes 1 
minute at 95ºC. In next 24 cycles, annealing takes 1 minute at 60ºC, elongation takes 3 
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minutes at 72ºC and denaturation takes 1 minute at 95ºC. Final elongation step takes 10 
minutes at 72ºC.  
 To analyze collected recombinants, the HSV-1 TK recipient sequence was 
amplified by primer pair AW85 and AW133 or primer pair AW100 and AW133 from 500 
ng genomic DNA using touchdown protocol. These two primer pairs amplify 1.4Kb or 
1.1Kb sequences from the HSV1-TK recipient, and both products include the nucleotides 
968-1126 of HSV-1 TK sequence, which would be altered by these recombination events. 
To prepare these PCR products for sequencing, 10 uL PCR solution was treated by EXOI 
and SAP (NEB) for 15 minutes at 37ºC, and then the mixture was incubated at 80ºC for 
15 minutes to deactivate the added enzymes. Samples were sequenced using T7 promoter 
primer at the core facility in University of South Carolina or at ETON Bioscience Inc.  
 Analysis of spontaneous homeologous and homologous recombinants: All 
alignments were carried out using SciEdCentral software to compare recombinant DNA 
sequences with reference sequences (HSV-2 TK sequence and HSV-1 TK recipient 
sequence).  
 Transfection by electroporation: To collect DSB repair recombinants, the 
plasmid pSce was electroporated into cells to introduce a DSB in the recipient at the I-
SceI site. Before electroporation, cells were cultured in T75 flasks until their number 
exceeded 5X106. On the day of transfection, cells in T75 flasks were trypsinized, re-
suspended in culture medium and counted on a hemocytometer. For each transfection, 5 
X106 cells were transferred into a 15 mL conical tube, and centrifuged at 300 x g for 3 
minutes. The cells pellet was washed using 5 mL phosphate buffered saline (PBS), and 
then centrifuged again as described above. The newly pelleted cells were re-suspended in 
 36 
800 uL PBS before electroporation. For each electroporation, 20 ug pSce plasmid was 
first added to the cuvette, and then 800 uL cells suspension. The DNA and cells were 
mixed in the cuvette by pipetting several times. All electroporation experiments were 
performed using a Bio-Rad Gene Pulser set to 750 volts and 25 uF. The actual time 
constant of these electroporation experiments was always 0.4 ms.  
 Immediately after electroporation, cells were transferred into a 15 mL conical 
tube containing 4.2 mL culture medium to obtain a final concentration of 1X106 
cells/mL. A small portion of the electroporated cells was removed to measure plating 
efficiency as described in next paragraph, while the rest cells were plated into 3 T75 
flasks for subsequent HAT selection. 
 Measurement of plating efficiency: To obtain plating efficiency, 100 
electroporated cells were transferred into each one of the two T25 flasks and cultured for 
two weeks. The clone numbers in these two flasks were averaged and then divided by 
100 to give plating efficiency of the experiment.  
 Selection and culture of recombinant clone: The electroporated cells were 
separated into three T75 flasks. The cells were cultured in 15 mL media for 2 days before 
being fed with HAT selection media. About 2 weeks after selection, discrete clones 
formed in T75 flasks, and they were randomly picked for further analysis (55). The HAT 
resistant clones in T75 flasks were counted to calculate clone frequency. The total clone 
number in three flasks was divided by 5X106, and then divided by plating efficiency to 
generate clone frequency. 
 Southern blot: The genomic DNA of selected recombinants was digested by 
BamHI and HindIII, and then separated through electrophoresis for Southern blot. 
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Moreover, HindIII digestion was used to check the junction fragment in some 
recombinants that were suspected to carry more than one copy of substrate. 
 Subcloning of cells: To obtain subclones of an existing cell line, the cells were 
diluted to 100 cells/mL Then, 0.5 mL diluted cell suspension was transferred into a T75 
flask together with 15mL media and incubated for 2 weeks. Discrete cell clones formed 
in the T75 were picked and cultured separately for later analysis.  
Results: 
Structure of substrates: Three new substrates all have a full length HSV-1 TK 
recipient and a hybrid donor made of HSV1-TK and HSV2-TK sequences. The HSV-1 
TK recipient in three substrates is the same and it has 30bp insertion at position 1215: the 
nucleotides are numbered the same as in the Wagner’s paper (74). This 30 bp nucleotide 
insertion contains the recognition site of endonuclease I-SceI, and destroys the thymidine 
kinase’s function encoded by the recipient. Donors in these substrates range from 612 bp 
to 837 bp, and they are hybrid donors composed of continuous HSV-1 TK, HSV-2 TK 
and HSV-1 TK sequences. All the donors have upstream HSV-1 TK sequences between 
250 bp and 380 bp, then HSV-2 TK sequences between 60 bp and 200 bp, and finally the 
same downstream HSV-1 TK sequence of around 300 bp. When the HSV-1 TK recipient 
is aligned to these three hybrid donors (Figure 2.6), the I-SceI insertion site always 
locates against the downstream HSV-1 TK sequences of these donors, and about 50 bp 
away from the border of HSV-2 TK sequences. The HSV-2 TK sequences in these 
substrates are 60 bp, 153 bp and 199 bp respectively, and they carry 16, 25 and 33 
nucleotide mismatches compared with the HSV-1 TK recipient (Figure 2.7). These 
substrates are named pBWW16, pBWW25 and pBWW33 after the number of  
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Figure 2.6 Alignment of donors and recipients from pBWW plasmids. 
The structures of donors and recipients used in current experiments are shown above, and 
the alignment reveals the location of recipient’s I-SceI recognition site, relative to the 
donor’s sequence. The white rectangles represent HSV-1 TK sequences and the striped 
rectangles represent HSV-2 TK sequences. Previously constructed substrate pHR99 has 
similar structure, while it carries a HSV1-TK donor slightly longer than the rest donors. 
  
 39 
 
Figure 2.7 Alignment of recipient and donor sequences in substrate pBWW33 to show 
mismatched nucleotides. 
Compared with donor, the recipient has 30 bp oligonucleotide insertion including an 18 
bp recognition site of I-SceI (underlined). Totally 33 mismatched nucleotides (indicated 
by the *) exist between donor and recipient, and they are numbered from M1 to M33 
depending on their closeness to the I-SceI site. The labeling of mismatched nucleotides is 
opposite to the nucleotide sequence of tk: the first mismatched nucleotide is the remotest 
from I-SceI, thus labeled as M33 while the last mismatched nucleotide is labeled as M1. 
Mismatched nucleotides M16 and M25 are labeled here since they are first mismatched 
nucleotides in substrate pBWW16 and pBWW25. Below the DNA sequence, the 
nucleotides are numbered with “^” the same as in the Wagner’s (74). 
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mismatched nucleotides in their hybrid donors. These substrates were linearized by 
endonuclease ClaI before transfection, and Figure 2.8 shows the restriction map of these 
substrates. To check the completeness of these tandem repeats after genome integration, 
endonuclease BamHI and HindIII were used separately to digest genomic DNA for 
Southern blot. 
 Construction of plasmids: pBWW1 and pBWW33 were constructed by Bryan 
Wehrenberg and Barbara Waldman. pBWW1 plasmid with correct insertion and sequence 
were confirmed through PCR (Figure 2.9) and DNA sequencing. AW53 and AW58 
amplified the whole insertion at HindIII site of the substrate, and these 0.9 Kb PCR 
products indicate one copy of donor insertion. Plasmids of 7 bacterial clones pBWW1-6 
to pBWW1-12 were checked by PCR and DNA sequencing. Donor in pBWW1-8 has the 
correct direction and sequence, so the plasmid was renamed as pBWW1 and used in 
following experiments. 
 Substrate pBWW33 and pBWW25 were constructed by Bryan Wehrenberg and 
Barbara Waldman, and their donors were examined and sequenced as described above. 
 To make substrate pBWW16, donor fragment and plasmid backbone were excised 
by HindIII from pHYB121 and pBWW33, respectively. They were gel purified and 
checked before ligation (Figure 2.10). 
 Correct pBWW16 plasmids were found through enzyme digestion (Figure 2.11) 
and PCR amplification using primer pair AW53 and AW58 or AW53 and AW39 (Figure 
2.12). The direction and sequence of donors were further examined through DNA 
sequencing. Donor of pBWW16-2 has correct direction and sequence, so the plasmid was 
renamed as pBWW16 and used in following experiments.  
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Figure 2.8 Structure and restriction map of pBWW substrates. 
Restriction map of pBWW substrates shows their structure after chromosomal 
integration, and it also demonstrates the size of DNA fragments after HindIII or BamHI 
digestion. The linearized substrate is about 9.1 Kb. They have a 0.6 Kb or a 0.8 Kb 
hybrid donor flanked by HindIII sites, and a 2.5 Kb HSV-1 TK recipient flanked by 
BamHI sites. The Neo cassette between donor and recipient is used for selection in 
prokaryotic or eukaryotic cells. 
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Figure 2.9 Identification of plasmid pBWW1 with 0.9 Kb donor insertion using primers 
AW53 and AW58. 
Lane 1 to 7, PCR product of pBWW1-6, 7, 8, 9, 10, 11 and 12.  
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Figure 2.10 Fragments of donor and backbone were examined before ligation for plasmid 
pBWW16. 
Lane 1, 0.6 Kb donor. Lane 2, 8.2 Kb plasmid backbone of pBWW33. 
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Figure 2.11 Identification of plasmid pBWW16 with 0.6 Kb donor insertion. 
Lane 1 to 8, HindIII digestion of plasmids from clone pBWW16-1 to pBWW16-8. 
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Figure 2.12 Direction of donor insertions in plasmid pBWW16 was confirmed by PCR. 
Top: Lane 1 and 10, PCR product of negative control; lane 2-9, PCR product from clones 
pBWW16-1 to pBWW16-8 using primer pair AW53 and AW58; Lane 11 to 18, PCR 
product from clones pBWW16-1 to pBWW16-8 using AW53 and AW39. Bottom: 
schema of the PCR strategy. Plasmids of pBWW16-1,2,3,4,8 have the insertion in correct 
direction and they were further sequenced for accuracy.   
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 Substrates pBWW33, pBWW25 and pBWW16 were cut by I-SceI and examined 
on gel. The digestion of pBWW16 shows it is linearized by endonuclease I-SceI (Figure 
2.13).   
 Establishing cell lines: Substrates pBWW33, pBWW25 and pBWW16 were 
linearized by digestion with ClaI (Figure 2.2 to 2.5) before transfection. The mouse Ltk- 
cells were transfected with each substrate separately through electroporation, and then the 
treated cells were selected by G418 for stable integration of the substrate. Syringe 
transfection was only carried out on substrate pBWW33 once, and the treated cells were 
subjected to the same G418 selection. G418 resistant clones from both methods were 
screened by Southern blot to find cell lines with a single copy integration of each 
substrate. 
 Screening cell lines with single copy integration of substrate: Genomic DNA 
from each clone was digested using HindIII or BamHI, and loaded together with the 
corresponding digestion of the substrate for Southern blotting. In HindIII digestion, the 
cell line with intact substrate should show a DNA fragment lining up with the donor of 
the substrate, and a junction fragment larger than the non-donor fragment of the digested 
substrate. Similarly, in BamHI digestion, the cell line should have a 2.5Kb fragment 
lining up with the recipient of the substrate, and a junction fragment larger than the non-
recipient fragment of the digested substrate. All cell lines in use were checked by both 
digestions to make sure they have intact donor and recipient as well as only one junction  
fragment. The copy number in cell lines was also estimated by comparing signals of 
genomic DNA and the plasmid control. 
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Figure 2.13 I-SceI successfully linearized pBWW16. 
Lane 1, pBWW16 plasmid. Lane 2, I-SceI digested pBWW16 plasmid 
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 Southern blotting was carried out on pBWW25 stably transfected cell lines by 
Bryan Wehrenberg and Barbara Waldman, and the results were recorded in Bryan 
Wehrenberg’s undergraduate Honors thesis entitled “Homeologous Recombination in 
Mammalian Cells”. Southern blot results of pBWW33 and pBWW16 were described in 
this chapter, and the selected Southern blot images of pBWW33 and pBWW16 stably 
transfected cell lines are shown in Figure 2.14, Figure 2.15, Figure 2.16 and Figure 2.17. 
The HSV-1 TK probe recognizes the HSV-1 TK sequence in the recipient as well as that 
in the hybrid donors. Cell lines were chosen for future experiments only when they had 
intact donor and recipient bands, and one junction fragment of proper size. These donor 
or recipient bands in selected cell lines are generally lighter than peers, so they have 
better chance to have single copy integration of the substrate.   
 For each substrate, more than 2 cell lines with single copy integration were found. 
The Southern blot results of selected cell lines pBWW33-48, pBWW33-67, pBWW16-2 
and pBWW16-6 were labeled in these figures (Figure 2.14 to Figure 2.17).  
 Spontaneous recombination frequency and HeR frequency of examined cell 
lines: Fluctuation tests were performed on selected cell lines, and the statistics and clone 
frequencies are shown in Table 2.1 to Table 2.5. One additional fluctuation test was 
carried out on cell lines pBWW33-67 and pBWW33-48, which have 33 mismatched 
nucleotides between donor and recipient sequences.  
 The obtained spontaneous recombination frequencies from examined cell lines 
range from 2.33X10-8 to 5.38X10-7, while their HeR frequency ranges from 1.54X10-8 to 
1.83X10-7. In contrast, the homologous substrate pHR99 has recombination frequency at 
5.72X10-7 with no HeR events.  
 49 
 
Figure 2.14 Identification of pBWW33 cell lines with correct plasmid integration through 
BamHI digestion. 
The size and copy number of recipient were screened as described above. Lane 1, BamHI 
digested plasmid pBWW33. Lane 2 to 13, BamHI digested genomic DNA from 
pBWW33 stably integrated cell lines. pBWW33-67 (lane 3) and pBWW33-48 (lane 9) 
were chosen for following experiments. The sizes of selected DNA fragments are labeled 
on the right side: 6.6 Kb lines up with one fragment from HindIII digested lambda DNA, 
while 2.5 Kb lines up with the fragment of recipient.    
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Figure 2.15 Identification of pBWW33 cell lines with correct plasmid integration through 
HindIII digestion. 
The size and copy number of donor were examined as described above. Lane 1, HindIII 
digested plasmid pBWW33. Lane 2 to 13, HindIII digested genomic DNA from 
pBWW33 stably integrated cell lines. pBWW33-67 (lane 2) and pBWW33-48 (lane 4) 
were chosen for recombination experiments. The sizes of selected DNA fragments are 
labeled on the right side: 8.3 Kb and 0.9 Kb line up with these two fragments from 
HindIII digested pBWW33 plasmid. In lane 1, 8.3 Kb fragment is visible and pointed by 
a tiny black arrowhead, while the 0.9 Kb fragment is not visible with its location marked 
on the right side.   
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Figure 2.16 Identification of pBWW16 cell lines with correct plasmid integration through 
BamHI digestion. 
The size and copy number of recipient were examined. Lane 2, BamHI digested plasmid 
pBWW16. Lane 1, 3 to 13, BamHI digested genomic DNA from pBWW16 stably 
integrated cell lines. pBWW16-2 (lane 3) and pBWW16-6 (lane 5) were chosen for 
recombination experiments. The sizes of selected DNA fragments are labeled on the right 
side: 6.6 Kb lines up with one fragment from HindIII digested lambda DNA, while 2.5 
Kb lines up with the fragment of recipient.  
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Figure 2.17 Identification of pBWW16 cell lines with correct plasmid integration through 
HindIII digestion. 
The size and copy number of donor were examined for integration of intact substrate. 
Lane 1, HindIII digested plasmid pBWW16. Lane 2 to 13, HindIII digested genomic 
DNA from pBWW16 stably integrated cell lines. pBWW16-2 (lane 2) and pBWW16-6 
(lane 4) were chosen for further experiments. The sizes of selected DNA fragments are 
labeled on the right side: 8.3 Kb and 0.6 Kb line up with these two fragments from 
HindIII digested pBWW16 plasmid 
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Table 2.1 Spontaneous recombination frequencies and HeR frequencies in cell line 
pBWW16-2 and pBWW16-6. 
 
Cell line Subclone 
clone 
frequency 
(10-8) 
# of colonies 
analyzed 
# of Homeologous 
recombinants 
Homeologous 
recombination 
frequency 
 (10-8) 
pBWW16-2 1 0 0 0 0 
 2 0 0 0 0 
 3 6.62 3 0 0 
 4 3.64 2 0 0 
 5 5.00 1 0 0 
 6 0 0 0 0 
 7 3.33 1 1 3.33  
 8 0 0 0 0 
 9 46.22 10 0 0 
 10 18.07 6 4 12.05  
      
 Total  23 5  
  Avg. = 8.29   Avg. = 1.54 
            
pBWW16-6 1 0 0 0 0 
 2 0 0 0 0 
 3 26.67 6 4 17.78  
 4 2.78 1 1 2.78  
 5 6.67 2 2 6.67  
 6 46.67 12 9 35.00  
 7 0 0 0 0 
 8 3.33 1 1 3.33  
 9 0 0 0 0 
 10 0 1* 0 0 
      
 Total  23 17  
  Avg. = 8.61   Avg. = 6.56 
 
Substrate pBWW16 has 16 mismatched nucleotides between donor and recipient. 
The clone frequency was calculated for each subclone by dividing the number of HAT 
resistant clones by the number of cells subjected to HAT selection. Then, the clone 
frequencies of 10 subclones were averaged to generate the clone frequency of the cell 
line. Similarly, for each subclone, the HeR frequency was calculated by multiplying clone 
frequency of the subclone with the proportion of HeR clones in analyzed clones, and then 
they were averaged to generate HeR frequency of the cell line  
* one HAT resistant clone of pBWW16-6 is not spontaneous recombinant as mentioned in 
following discussion, and excluded from calculation of recombination frequency.  
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Table 2.2 Spontaneous recombination frequencies and HeR frequencies in cell line 
pBWW25-13 and pBWW25-16. 
 
Cell line Subclone 
clone 
frequency 
(10-8) 
# of 
colonies 
analyzed 
# of Homeologous 
recombinants 
Homeologous 
recombination 
frequency 
(10-8) 
pBWW25-13 1 3.75 1 0 0 
 2 0 0 0 0 
 3 0 0 0 0 
 4 3.21 1 1 3.21 
 5 3.14 1 0 0 
 6 317 10 0 0 
 7 24 7 7 24 
 8 0 0 0 0 
 9 0 0 0 0 
 10 0 0 0 0  
      
 Total  20 8  
  Avg. = 35.11   Avg. = 2.72 
            
pBWW25-16 1 127.91 1 0 0 
 2 62.07 3 1 20.69  
 3 7.19 1 1 7.19  
 4 11.49 2 0 0 
 5 17.01 3 0 0 
 6 117.12 1 1 117.12  
 7 27.59 2* 0 0 
 8 43.86 3 0 0 
 9 43.35 4 1 10.84  
 10 80.60 3 1 26.87  
      
 Total  23 5  
  Avg. = 53.82   Avg.  = 18.27 
 
Substrate pBWW25 has 25 mismatched nucleotides between donor and recipient.  
The clone frequency and HeR frequency were calculated as stated in Table 2.1. 
* One HAT resistant clone of pBWW25-16 is not spontaneous recombinant as mentioned 
in following discussion, and excluded from calculation of recombination frequency. 
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Table 2.3 Spontaneous recombination frequencies and HeR frequencies in cell line 
pBWW33-48. 
 
Cell line 
# of 
Exp 
 
Subclone 
Clone 
frequency 
(10-8) 
# of Colonies 
analyzed 
# of 
Homeologous 
recombinants 
Homeologous 
recombination 
frequency 
 (10-8) 
pBWW33-48 1 1 0 0 0 0 
  2 8.00 0 0 0 
  3 0 0 0 0 
  4 0 0 0 0 
  5 7.81 1 1 7.81 
  6 7.52 1 1 7.52 
  7 0 0 0 0 
  8 0 0 0 0 
  9 0 0 0 0 
  10 0 0 0 0 
  11 0 0 0 0 
       
 2 1 0 0 0 0 
  2 0 0 0 0 
  3 0 0 0 0 
  4 0 0 0 0 
  5 0 0 0 0 
  6 4.67 1 0 0 
  7 7.69 0 0 0 
  8 0 0 0 0 
  9 31.25 4 4 31.25 
  10 66.27 10 1 6.63 
       
  Total  17 7  
   Avg. = 6.66   Avg. = 2.66 
 
Substrate pBWW33 has 33 mismatched nucleotides between donor and recipient. The 
clone frequency and HeR frequency were calculated as stated in Table 2.1. Two 
fluctuation tests were carried out on pBWW33-48, and the clone frequency or HeR 
frequency were calculated by averaging that of every subclone. 
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Table 2.4 Spontaneous recombination frequencies and HeR frequencies in cell line 
pBWW33-67. 
 
Cell line 
# of 
Exp 
Subclone 
Clone 
frequency 
(10-8) 
# of Colonies 
analyzed 
# of 
Homeologous 
recombinants 
Homeologous 
recombination 
frequency 
(10-8) 
pBWW33-67 1 1 0 0 0 0 
  2 0 0 0 0 
  3 0 0 0 0 
  4 0 0 0 0 
  5 0 0 0 0 
  6 3.66 0 0 3.66 
  7 0 0 0 0 
  8 0 0 0 0 
  9 26.55 7 7 26.55 
  10 0 0 0 0 
       
 2 1 3.45 1 0 0 
  2 0.00 0 0 0 
  3 0.00 0 0 0 
  4 9.62 3** 3 9.62 
  5 0 0 0 0 
  6 0 0 0 0 
  7 4.12 5* 0 0 
  8 7.25 1 0 0 
  9 3.68 1 1 3.68 
  10 3.40 1 1 3.40 
       
  Total  19 12  
   Avg. = 3.09   Avg.  = 2.35 
 
Substrate pBWW33 has 33 mismatched nucleotides between donor and recipient. The 
clone frequency and HeR frequency were calculated as stated in Table 2.1. Two 
fluctuation tests were carried out on pBWW33-67, and the clone frequency or HeR 
frequency were calculated by averaging that of each subclone.  
* In subclone 7 of pBWW33-67 Experiment 2, 4 out of 5 HATR clones are not 
spontaneous recombinants, so the recombination frequency is obtained through the 
multiplying raw clone frequency and proportion of spontaneous recombinants.  
** In subclone 4 of pBWW33-67 Experiment 2, all three analyzed recombinants have 
original recipient as well as HeR recipient, which indicates one recombination event 
happened in cells with substrate duplication (confirmed later in Chapter 3). Thus, for this 
particular subclone, the clone frequency or homeologous recombination frequency 
occurring to a single copy substrate should be half of the raw clone frequency.  
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Table 2.5 Clone frequencies and spontaneous recombination frequencies in cell line 
pHR99-4. 
 
Cell line Subclones 
 
Clone 
frequency  
(10-8) 
# of 
Colonies 
analyzed 
# of Homologous 
recombinants 
Homologous 
recombination 
frequency 
(10-8) 
pHR99-4 1  285.71 2* 0 0 
 2  125.79 2* 1 62.89 
 3  59.32 2 2 59.32 
 4  196.36 0 0 0 
 5  107.62 2* 1 53.81 
 6  140.22 0 0 0 
 7  157.89 1* 0 0 
 8  204.78 0 0 0 
 9  144.74 0 0 0 
 10  401.22 1 1 401.22 
       
 Total   10 5  
  
 
Avg. = 182.37  Avg.  = 57.72 
 
Cell line pHR99-4 has homologous substrate pHR99, which does not have mismatched 
nucleotides between its donor and recipient.  
Clone frequency was calculated for each subclone by dividing the number of HAT 
resistant clones by the number of cells subjected to HAT selection. Then, the clone 
frequencies of 10 subclones were averaged to generate the clone frequency of the cell 
line. Similarly, for each subclone, the HR frequency was calculated by multiplying clone 
frequency of the subclone with the proportion of HR clones in analyzed clones and they 
were averaged to generate HR frequency of the cell line. 
* In cell line pHR99-4, approximately half of clones are non-recombinant, therefore, the 
spontaneous recombination frequency would be much different from the clone frequency 
and calculated separately case by case. 
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HeR recombination events and conversion tracts during spontaneous 
recombination: For each cell line, 10 to 23 clones from fluctuation tests were analyzed, 
and they were categorized based on their recipient sequences (Table 2.6). The vast 
majority of these collected clones removed the I-SceI insertion and restored the recipient 
to a continuous tk sequence, so they belong to spontaneous recombination events. If the 
recipient does not have mismatched nucleotides converted to HSV-2 TK, the 
recombination event is HR event, and listed in “recipient with no mismatch” in Table 2.6. 
A recombination event is recognized as HeR event only when its recipient does have 
mismatched nucleotides converted to HSV-2 TK sequence. 
 Among these HeR events, the restored recipients always acquired the mismatched 
nucleotides at position 1167, the closest mismatched nucleotide to the I-SceI site. Starting 
from there, the conversion tract extended continuously to the distal end regardless where 
it ended. These HeR events are thus further categorized based on whether the recipient 
acquired all the mismatched nucleotides from donor, and listed in “recipient with all 
mismatches” or “recipient with fewer than all mismatches” in Table 2.6. The proportion 
of HeR events was calculated as the percentile of HeR events within spontaneous 
recombination events.  In examined cell lines, it is common to see the conversion of 
HSV-1 TK sequence to HSV-2 TK sequence, and proportion of the HeR events ranges 
from 22% to 75%. Cell line with the least mismatched nucleotides between donor and 
recipient does not have the highest proportion of HeR events. There were sporadic clones 
survived HAT selection via reactivation of mice thymidine kinase pseudogene rather than 
recombination within substrate (described later in Chapter 3), and these non-
recombinants were listed in “other events” for cell lines where they arose.  
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Table 2.6 Recovered recombinant clones and their conversion tracts from spontaneous 
recombination. 
 
Cell Lines 
Analyzed
 clones 
Recipient 
with all  
mismatches 
Recipient with 
mismatches 
(fewer than all) 
Recipient with 
no mismatch 
Other 
events 
Fraction of 
HeR 
pBWW16-2 23 5 0 18 0 22% 
pBWW16-6 23 17 0 5 1 77% 
pBWW25-13 20 8 0 12 0 40% 
pBWW25-16 23 4 1 17 1 23% 
pBWW33-48 17 7 0 10 0 41% 
pBWW33-67 19 9 0 3 7 75% 
       
Total  
or  
Average 
125 50 1 65 9 44% 
 
If the conversion tract includes all mismatches and fewer mismatches, the event is 
categorized as HeR. 
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 All recipients in HeR events acquired all mismatched nucleotides from donor 
except one obtained in cell line pBWW25-16: the recipient of clone pBWW25-16-4-27 
only acquired the first 17 mismatched nucleotides out of total 25. The collected 
recombinants in current research were given a name, which is a combination of cell line, 
experiment and clone number, linked by dashes. 
 Clone frequency and HeR frequency in examined cell lines during DSB 
repair: Transfection was carried out on cell line pBWW16-2, pBWW16-6, pBWW25-
13, pBWW25-16, pBWW33-48, pBWW33-67 and pHR99-4. pBWW16-2 and 
pBWW16-6 are cell lines of substrate pBWW16, which has 16 mismatched nucleotides 
between donor and recipient within the homeologous region. pBWW25-13 and 
pBWW25-16 are cell lines carrying 25 mismatched nucleotides, while pBWW33-48 and 
pBWW33-67 are cell lines carrying 33 mismatched nucleotides. To collect DSB-induced 
recombinants of these cell lines, pSce was transiently expressed in these cell lines. After 
I-SceI introduced a DSB into the recipient, the broken recipient sequence may be repaired 
and regain functional thymidine kinase. If so, colonies would form in HAT selection. 
 Table 2.7 lists clone frequencies and HeR frequencies of pBWW cell lines during 
DSB repair and Table 2.8 lists the clone frequency and HR frequency of pHR99-4 during 
DSB repair. The clone frequency was calculated for every cell lines as described in 
Materials and Methods, while the HeR frequency in pBWW cell lines is the product of 
clone frequency and the proportion of HeR events. 
 In DSB repair, the clone frequency of pBWW cell lines ranges from 1.01X10-5 to 
8.53X10-5. Since almost all the HAT resistant clones in these cell lines are recombinants 
precisely removing the 30 bp insertion, the clone frequency is equivalent to the   
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Table 2.7 Clone frequencies and HeR frequencies of pBWW cell lines in DSB repair. 
 
Cell line 
Expt. 
Number 
Clone 
frequency 
(10-5) 
# of Colonies 
analyzed 
Homeologous 
recombinants 
Homeologous 
recombination 
frequency (10-6) 
pBWW16-2 1 0.56 12 1 0.47 
 2 0.63 9 1 0.70 
 3 0.7 9 0 0.00 
 4 1.91 5 2 7.64 
 5 1.81 6 0 0.00 
      
  Avg.=1.12   Avg.=1.76 
pBWW16-6 1 2.57 14 5 9.18 
 2 1.92 14 3 4.11 
 3 1.3 16 4 3.25 
      
  Avg.=1.93   Avg.=5.51 
pBWW25-13 1 0.23 6 2 0.77 
 2 0.25 6 3 1.25 
 3 0.35 7 2 1.00 
      
  Avg.=0.28   Avg.=1.01 
pBWW25-16 1 6.49 16 1 4.06 
 2 4.45 14 1 3.18 
 3 4.97 15 1 3.31 
      
  Avg.=5.30   Avg.=3.52 
pBWW33-48 1 5.78 15 1 3.85 
 2 8.15 15 4 21.73 
 3 12.2 16 0 0.00 
      
  Avg.=8.71   Avg.=8.53 
pBWW33-67 1 0.92 16 4 2.30 
 2 2.51 11 1 2.28 
 3 2.35 12 5 9.79 
      
  Avg.=1.93    Avg.=4.79 
 
Electroporation of pSce was carried out at least 3 times on these pBWW cell lines. The 
table shows clone frequency, analyzed clones, HeR recombinants and HeR frequency of 
each experiment. For each experiment, the clone frequency was calculated by dividing 
the number of HAT resistant clones by the product of 5 million cells and plating 
efficiency. Then, all the clone frequencies were averaged to generate the clone frequency 
of the cell line. Similarly, for each experiment, the HeR frequency was calculated by 
multiplying clone frequency with the proportion of HeR clones in analyzed clones, and 
then they were averaged to generate HeR frequency of the cell line.  
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Table 2.8 Clone frequencies and HR frequencies of pHR99 during DSB repair. 
 
Cell line 
Expt. 
Number 
Clone 
frequency 
(10-5) 
Colonies 
analyzed 
Homologous 
recombinants 
Homologous 
recombination frequency 
(10-6) 
pHR99 1 3.31 5* 3 19.86 
 2 3.31 0 NA NA 
 3 3.43 5* 0 0.00 
      
  Avg.=3.53   Avg.=9.93 
  
Electroporation of pSce was repeated 3 times on pHR99-4 cell lines. The table shows 
clone frequency, analyzed clones, HR recombinants and recombination frequency of each 
experiment.  
The clone frequency of pHR99 was calculated as in Table 2.7. Moreover, the HR 
frequency was calculated by multiplying clone frequency of the subclone with the 
proportion of HR clone, and then they were averaged for the cell line. Since there are 
non-recombinants collected during DSB repair, the HR frequency would be much 
different from the clone frequency.  
* pHR99-4 has some HAT resistant clones carrying unchanged recipient, which indicate 
events other than DSB repair (further investigated in Chapter 3). The recombination 
frequency of pHR99-4 was corrected to the product of raw clone frequency and the 
proportion of DSB repair recombinants. 
NA, identity of colonies in experiment 2 are not clear since they were lost during cell 
culture. Therefore, the homologous recombination frequency is not available.  
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recombination frequencies and used synonymous with recombination frequency. As 
shown in Table 2.7, longer homeologous sequence between donor and recipient does not 
reduce the clone frequency of the host cell lines. For each cell line, clone frequency of 
DSB repair is 9 times or more than that of spontaneous recombination (see Table 2.1 to 
2.5), which agrees well with the fact that DSB boosts the DNA recombination between 
tandem repeats. Therefore, the vast majority of the collected recombinants are product of 
DSB repair rather than spontaneous recombination. The clone frequencies of pBWW cell 
lines with hybrid donors are equivalent or higher than that of pHR99-4 with pure 
homologous donor, however, their spontaneous recombination frequencies could be ten 
times lower than that of pHR99-4. 
 Categorization of DSB repair recombinants: Recovered clones in DSB repair 
experiments were categorized based on their recipient sequences. These recombination 
events, which restored I-SceI disrupted region of recipient to original HSV-1 TK 
sequence, were further divided according to the number of converted mismatched 
nucleotides: recipient with all mismatches, with mismatches (fewer than all) and with no 
mismatch. Those events that failed in restoring a continuous TK sequence were listed as 
other events, and they are most likely NHEJ events. In Table 2.9, these clones in column 
“recipient with all mismatches” and column “recipient with mismatches (fewer than all)” 
are HeR recombinants. 
 Conversion tract in homeologous recombinants: In HeR events, all or part of 
the mismatched nucleotides between homeologous sequences were transferred from 
donor to recipient, and Table 2.10 lists those mismatched nucleotides that were 
transferred in each HeR clone.  
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Table 2.9 Recovered recombination clones and conversion tracts from DSB repair. 
 
Cell Lines 
Analyzed 
clones 
Recipient with 
all mismatches 
Recipient with 
mismatches 
(fewer than all) 
Recipient 
with no 
mismatch 
Other 
events 
Fraction 
of HeR 
pBWW16-2 40 4 0 34 2 10% 
pBWW16-6 44 11 1 32 0 27% 
pBWW25-13 19 6 1 11 1 37% 
pBWW25-16 42 0 3 36 3 7% 
pBWW33-48 47 4 1 42 0 11% 
pBWW33-67 42 5 5 31 1 24% 
       
Total 
or 
Average 
234 30 11 186 7 19% 
 
 65 
Table 2.10 Conversion tracts in HeR recombinants from DSB repair.  
 
Cell line 
Total 
Mismatched 
Nucleotides 
Converted 
Mismatched 
Nucleotides 
Clone 
pBWW16-2 
 
16 
 
M1 to M16 
 
pBWW16-2-1-7, pBWW16-2-2-2, 
pBWW16-2-5-3, pBWW16-2-5-9 
pBWW16-6 
 
 
 
 
 
16 
 
 
 
 
 
M1 to M16 
 
 
 
 
 
pBWW16-6-1-5, pBWW16-6-1-7, 
pBWW16-6-1-8, pBWW16-6-1-14, 
pBWW16-6-1-16, pBWW16-6-2-1, 
pBWW16-6-2-12, pBWW16-6-2-15, 
pBWW16-6-3-1, pBWW16-6-3-11, 
pBWW16-6-3-13 
  M1 to M12 
 
pBWW16-6-3-16 
 
pBWW25-13 25 M1 to M14 pBWW25-16-1-B2 
  
M1 to M25 
 
 
pBWW25-16-1-C1, pBWW25-16-2-A1, 
pBWW25-16-2-C2, pBWW25-16-2-C3, 
pBWW25-16-3-B1, pBWW25-16-3-C2 
    
pBWW25-16 25 M3 to M14 pBWW25-16-1-11 
  M1 to M7 pBWW25-16-2-1 
  M1 to M2 pBWW25-16-3-15 
     
pBWW33-48 
 
33 
 
M1 to M33 
 
pBWW33-48-2-16, pBWW33-48-1-5, 
pBWW33-48-2-2, pBWW33-48-2-6 
  M1 to M2 pBWW33-48-2-14 
    
pBWW33-67 
 
 
33 
 
 
M1 to M33 
 
 
pBWW33-67-1-1, pBWW33-67-2-10, 
pBWW33-67-1-18, pBWW33-67-3-3, 
pBWW33-67-3-12 
  M1 to M5 pBWW33-67-1-5 
  M1 to M16 pBWW33-67-1-19, pBWW33-67-3-13 
  M1 to M10 pBWW33-67-3-4 
  M1 to M2 pBWW33-67-3-11 
For convenience, these mismatched nucleotides were numbered in an order, moving 
away from the I-SceI site, as follows: the mismatched nucleotide closest to I-SceI 
recognition site is named as mismatched nucleotide 1 (M1), while the farthest one is 
named as mismatched nucleotide 33 (M33). The name of each recombinant in this table 
is a combination of cell line, experiment and clone number, linked by dashes.  
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 These HeR recombinants restored the broken recipient back to continuous TK 
sequence, and also had HSV-1 TK sequence converted to HSV-2 TK sequence. In 
substrate pBWW16, pBWW25 and pBWW33, the homeologous region between donor 
and recipient has 16, 25 and 33 mismatched nucleotides respectively, and the details of 
these mismatched nucleotides are drawn in Figure 2.5.  
 HeR recombinants of six pBWW cell lines are listed in Table 2.10, and their 
recipient had mismatched nucleotides changed from HSV-1 TK sequence to HSV-2 TK 
sequences. Among recovered HeR events, the conversion tract almost always starts from 
the M1, and extends continuously toward M33. This rule applies to 40 HeR events except 
for pBWW25-16-1-11, which failed to convert the two mismatched nucleotides closest to 
the I-SceI site. HeR events in five pBWW cell lines have conversion tract containing all 
mismatched nucleotides as well as fewer mismatched nucleotides, while HeR events in 
cell line pBWW16-2 only have conversion tract including all mismatched nucleotides. 
 Comparison of spontaneous recombinants and DSB repair recombinants: 
For each examined cell line, 19 to 46 DSB induced recombinants were analyzed and gene 
conversion of mismatched nucleotides are common across these pBWW cell lines. The 
proportion of the HeR events in these cell lines ranges from 7% to 37%, however, cell 
lines with the least mismatched nucleotides in substrate do not show the highest 
proportion of HeR events. Comparing spontaneous recombination and DSB induced 
recombination, there are two major trends regarding the proportion of HeR events. First, 
in the same cell line, the proportion of HeR recombinants in spontaneous recombination 
is always higher than that in DSB induced recombination. Take cell line pBWW33-67 for 
example: the proportion of HeR recombinants in spontaneous recombination is 80%, 
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which is much more than the 24% in DSB induced recombination. Second, a cell line 
with higher HeR proportion in spontaneous recombination tends to have higher HeR 
proportion in DSB induced recombination, too. For example, the proportion of HeR 
recombinants in pBWW33-67 is 80% in spontaneous recombination and 24% in DSB 
induced recombination, and they are higher than those 41% and 11% HeR events in 
pBWW33-48. 
 In DSB induced recombination, the restored recipient almost always acquires the 
mismatched nucleotide closest to I-SceI site (M1), and from there, the conversion tract 
extends continuously to the distal end no matter where it ends. Totally 40 recovered HeR 
events have continuous conversion tract beginning at M1, while the conversion tract in 
one event started after M1. The HeR events are categorized into “recipient with all 
mismatches” if all the mismatched nucleotides were transferred to recipient, or “recipient 
with mismatches fewer than all” if not. As summarized earlier in the chapter, 53 out of 54 
spontaneous recombinants have “all mismatches” transferred to recipient, while in DSB 
induced recombination, 30 out of 41 recombinants have “all mismatches” transferred into 
recipient. After reviewing the data, apparently more HeR events with “fewer than all” 
mismatches appeared in DSB induced recombination compared with spontaneous 
recombination. The Fisher’s exact test comparing HeR clones in these two sub-categories 
between spontaneous recombination and DSBR generates a p-value of 3X10-4, which 
shows a significant difference in HeR subtypes between these two events.  
 Duplication of substrate in cell line pBWW33-67: Sequencing results of 9 
recombinants in cell line pBWW33-67 were confusing because almost all nucleotides 
after position 1215 have two readings: double peaks suddenly show up in the sequencing 
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chromatogram around the I-SceI site. A closer look of the chromatogram suggested these 
recombinants appears to have one original recipient and one altered recipient by DSB 
repair. Thus, these recombinants may arise from cells with duplication of the integrated 
substrate, and DSB repair only happened to one of the two copies. To learn the origin of 
the duplication, subcloning of cell line pBWW33-67 was carried out to obtain discrete 
subclones that only contain descendants from a single cell. All subclones are named by 
their parental cell line, initial of “subclone” and clone number. For example, subclone 
number 1 is called pBWW33-67S1. Copy number of substrate in these subclones was 
checked by Southern blot.  
 Southern blot was carried out to check substrate’s copy number in 24 subclones of 
pBWW33-67. Figure 2.18 examined the substrate's copy number in the first 12 subclones 
of pBWW33-67. As exemplified in this figure, pBWW33-67S11 shows darker bands of 
donor and recipient, which indicates duplication of the substrate in this subclone. Among 
the remaining 12 subclones, another subclone, pBWW33-67S20, shows the same 
duplication of the substrate (data not shown here). To learn more about the duplication, 
HindIII digestion was used to cut the integrated plasmid into a 0.87 Kb donor fragment 
and a junction fragment composed of plasmid sequence, 2.5Kb recipient and nearby 
genomic sequence at integration site. Figure 2.19 demonstrates that after HindIII 
digestion, the bands in normal subclones (lane 2 and lane 4) are the same as those in 
subclones with duplicated substrate. Since junction fragments of these subclones are the 
same as other cell lines, two copies of substrate in pBWW33-67S11 and pBWW33-
67S20 are most likely due to a DNA duplication event involving the integrated substrate, 
rather than two separate substrate integration events. The duplication of substrate exists   
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Figure 2.18 Duplication of the substrate happened in some subclones from cell line 
pBWW33-67. 
Lane P, HindIII and BamHI digested plasmid pBWW33; Lanes 1 to 12, HindIII and 
BamHI digested genomic DNA from cell line pBWW33-67S1 to pBWW33-67S12.  
  
 70 
 
Figure 2.19 Junction fragments in cell line pBWW33-67S11 and pBWW33-67S20 
remain the same after duplication of the substrate. 
Lane 1, HindIII digested pBWW33-67S11; Lane 2, HindIII digested pBWW33-67S12; 
Lane 3, HindIII digested pBWW33-67S20; Lane 4, HindIII digested pBWW33-67S21. 
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in a small portion of the cell population, independent of electroporation, so it is probably 
a product of a duplication event several generations after the integration of substrate. 
Other examined cell lines did not show the duplication of substrate. 
 In the current analysis, these 9 unexpected recombinants from pBWW33-67 were 
not listed in tables because they are a relatively small portion of the DSB induced 
recombinants, and the duplication confounds analysis.  
Discussion:  
 Type of spontaneous recombinants: In current work, the majority of 
spontaneous recombination events are categorized into two groups: HR event and HeR 
event. In addition to recombination events, other type of events did happen in fluctuation 
tests: recipient in clone pBWW16-6-4-15 shows no sequence change, and the same thing 
happened in cell line pBWW33-67. These events are most likely reactivation of mouse 
thymidine kinase, and they were further investigated in Chapter 3.   
 Type of DSB-induced recombinants: DNA double-strand breaks in mammalian 
cells are usually repaired through non-homologous end joining (NHEJ), homologous 
recombination (HR) and single strand annealing (SSA) (30, 34, 78). Since the donor has 
truncation at both 5’ and 3’ end, the SSA or crossover events between donor and recipient 
cannot produce functional thymidine kinase. In the current experiments, recombinants 
only came from gene conversion events between donor and recipient, as well as minor 
NHEJ events (53, 55).  
 All collected recombinants are divided into 3 groups for clarity. HR and HeR 
events are separated from NHEJ events based on whether repair of DSB restored the 
broken DNA sequence back to a continuous tk sequence. HR events only restore the I-
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SceI disrupted region of recipient using HSV-1 TK sequence from the donor, therefore 
the restored recipient loses the 30bp oligonucleotide insertion previously engineered into 
its HSV-1 TK sequence. If the restored recipient sequence has mismatched nucleotides 
converted to HSV-2 TK sequence besides losing the 30 bp insertion, the event is 
recognized as HeR. In comparison, recipient sequences in NHEJ events lose base pairs at 
DSB site, however, it is not precise excision of the 30 bp oligonucleotide insertion that 
happened in HR events. Though NHEJ events may have chance to remove the 30 bp 
insertion precisely like HR events, the probability and impact on current analysis are 
minor: previous experiments show the pure NHEJ events happened at dramatically low 
clone frequency, without providing a homologous donor for DSB repair.  
High frequencies of HeR events were observed in pBWW substrates during 
spontaneous recombination: Previously, we demonstrated that HR barely happens 
between highly diverged sequences. Spontaneous recombination between HSV-1 TK 
recipient and HSV-2 TK donor sequences was never recovered from previous 
experiments using pHOME (55, 73). Use of a HSV-1 TK and HSV-2 TK hybrid sequence 
as donor allowed recombination to happen between a tandem repeat, however, only 1 of 
81 recombinants from pHYB21A and pHYB12-8 had conversion of HSV-1 TK recipient 
to HSV2 TK sequence, far less than NHEJ or homologous recombination events that 
occurred within HSV-1 TK sequence (53). Using a hybrid donor composed of HSV-1 TK, 
HSV2 TK and HSV-1 TK sequences, the pHYB121 has recombination frequency 
equivalent to previous substrates. However, in 11 out of 39 recombinants converted the 
HSV-1 TK sequence of recipient to HSV-2 TK sequence, and the mismatched nucleotides 
were transferred all at once (53). These events clearly show HR restored the HSV-1 TK 
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recipient using the hybrid donor, and incorporated donor’s HSV-2 TK sequence into 
recipient frequently if HSV1-TK sequences are on both sides of HSV2-TK sequence. 
Recombination events from these previous substrates allow us to postulate that as long as 
perfect homology is available on both sides, the homeologous region could be processed 
by HR, and leave conversion tract on the recipient sequence. 
 In current work, the potential surveillance against exchange between 
homeologous sequences was scrutinized extensively. Three new substrates have hybrid 
donor composed of HSV-1 TK, HSV-2 TK and HSV-1 TK sequences, and their donors 
differ in the length of HSV-2 TK sequences. Ranging from 60 bp to 199 bp, these HSV-2 
TK sequences have 16, 25 or 33 mismatched nucleotides compared with HSV-1 TK 
sequence. Two cell lines of each substrate were examined in fluctuation test (summarized 
in Table 2.11): recombination frequencies of these substrates are around 10-8 and 10-7, 
and they have HeR frequencies at 10-8 except pBWW25-16 is at 1.83X 10-7. Compared 
with the HeR events between HSV-1 TK recipient and hybrid donor composed of HSV-1 
TK and HSV-2 TK sequence (pHYB21A or pHYB12-8), HeR events happened within 
these new substrates are substantial, and their clone frequency and proportion of HeR 
events are similar to previous substrate pHYB121. The results confirmed that homology 
on both sides of the homeology ensures the removal of the I-SceI insertion through HR as 
well as facilitates HeR events.  
Recombination and HeR events are not affected by length of homeologous 
region in both types of recombination: Cell lines of substrate pBWW25 have average 
recombination frequency at 4.38X10-7, close to 5.72X10-7 from cell line of pHR99, at 
least 5 times more than other cell lines; while their average HeR frequency is  
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Table 2.11 Comparison of clone frequencies, HeR frequencies and fractions between 
spontaneous recombination and DSB-induced recombination. 
 
Cell line 
Spontaneous Recombination DSB-induced Recombination 
Recombination 
frequency  
(10-8) 
HeR 
frequency 
(10-8) 
HeR 
fraction 
Recombination 
frequency  
(10-5) 
HeR 
frequency 
 (10-6) 
HeR 
Fraction 
pBWW33-48 6.66 2.66 41% 8.71 8.53 11% 
pBWW33-67 3.09 2.35 80% 1.93 4.79 24% 
pBWW25-13 35.11 2.72 40% 0.28 1.01 37% 
pBWW25-16 52.44 18.3 23% 5.3 3.52 7% 
pBWW16-2 8.29 1.54 22% 1.12 1.76 10% 
pBWW16-6 8.61 6.56 77% 1.93 5.51 27% 
pHR99-4 57.72 NA NA 0.99 NA NA 
 
Cell line pHR99-4 has homologous donor and recipient, therefore, HeR frequency and 
HeR fraction are not applicable to this cell line. Moreover, recombination frequencies of 
pHR99-4 are dramatically different from its clone frequency since many HAT resistant 
clones from it are not recombinants.  
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1.05X10-7, at least 2 times more than that of other substrates. Cell lines of pBWW16 only 
have slightly higher average clone frequency and HeR frequency than those in cell lines 
of pBWW33. Spontaneous recombination frequencies of these 6 cell lines suggest 
homeologous region does not necessarily bring down the clone frequency and HeR 
frequency. Apparently, the scrutiny and abortion against the exchange between 
homeologous sequences in examined cell lines are minor, compared with tens of folds 
fastidious rejection against evenly distributed homeology (79). If the rejection is effective 
within current substrates during spontaneous recombination, longer homeologous region 
would incur stronger rejection and should be harder to penetrate than a shorter one.  
To sum up, the data of spontaneous recombination does not support substantial 
rejection against exchange between homeologous sequences, since no correlation was 
found between HeR clone frequencies and the length of homeologous region neighboring 
the I-SceI site. In contrast, mismatched hDNA in initiation stage faces vigorous scrutiny 
and rejection shown by both in vitro and in vivo assays (56, 79).  
In examined substrates, the homeology does not impede the spontaneous 
recombination process upon successful initiation on either side. Spontaneous 
recombination events in substrate with even longer homeologous region could be 
explored in future, however, for examined substrates, no measurable impediment was 
observed in genetic exchange between homeologous region at least up to 200 bp.  
During DSB repair, the clone frequency and HeR frequency of the two cell lines 
with the same substrate are not dramatically different from that of other cell lines. One-
way ANOVA comparing HeR clone frequencies in 3 substrates during DSB repair give a 
p-value equals 0.2954, while the same test comparing clone frequencies in 3 substrates 
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give a p-value equals 0.0624. The performed ANOVA tests failed to find significant 
difference in frequencies between 3 examined substrates. Interestingly, the two cell lines 
carrying the 33 mismatched nucleotides have the highest average clone frequency and 
HeR frequency. In summary, during DSB repair, longer mismatched sequence does not 
decrease HeR frequency or fraction of HeR events across examined cell lines. Data in the 
current chapter failed to show fastidious rejection against genetic exchange between 
homeologous sequences during DSB repair. 
Higher spontaneous clone frequency and HeR frequency in pBWW25 cell lines 
are likely due to its longer homology than the other two substrates. The donor of 
pBWW25 has the same 300 bp downstream HSV-1 TK sequence as the other two 
substrates, while it has 400 bp upstream HSV-1 TK sequence, about 100 bp longer than 
the other two substrates. As demonstrated by Huang and other researchers (26, 71), 
efficient recombination depends on availability of continuous uninterrupted homology, 
and the recombination frequency is in linear relation with the length of homology once 
the homology exceeds the MEPS. In these pBWW substrates, the homeologous sequence 
inside donor reduced the continuous homology for HR, thus they have lower clone 
frequency compared with substrate pHR99. The substantially longer homology of 
substrate pBWW25 likely brought clone frequency higher than other pBWW substrates, 
though the position of substrate integration may contribute to these higher frequencies as 
well. 
 HeR events are common in both spontaneous recombination and DSB repair: 
In Table 2.11, the proportion of spontaneous HeR recombinants ranges from 22% to 80%, 
showing the mismatched nucleotides are easily transferred from donor to recipient.  
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Similar to the observation in spontaneous recombination, analysis of DSB repair 
recombinants supports that DSB provoked recombination frequently proceeds from the 
homologous region into a homeologous region. When a DSB was introduced into HSV-1 
TK recipient, 41 out of 227 recombination events have homeologous conversion tracts, 
indicating frequent use of homeologous sequence during DSB repair. Among the 
examined cell lines, 7% to 37% HeR events were found after DSB repair, so the genetic 
exchange between homeologous sequences is a common phenomenon during DSB repair.  
 HeR events are not affected by length of homeologous region in both types of 
recombination: In spontaneous recombination, recombination between sequences with 
33 mismatched nucleotides has even higher proportion of HeR events, which contradicts 
with the idea that cluster of mismatches triggers rejection and destruction. Otherwise, 
longer homeologous sequence in pBWW33 would incur more rejection, and cause lower 
proportion of HeR events compared with shorter ones. 
Similar to the finding in spontaneous recombination, there is no obvious rejection 
against homeologous exchange during DSB repair. For example, cell lines pBWW16-2 
and pBWW16-6 have a substrate harboring the shortest homeologous region, but their 
fractions of HeR events are not the highest among examined cell lines. 
 Trends in proportion of HeR events: Two trends in the proportion of HeR 
events were described in results. First, the proportion of HeR events during DSB repair 
has positive correlation with that in spontaneous recombination. A cell line with more 
HeR events in spontaneous recombination is likely to have more HeR events during DSB 
repair. So, the proportions of HeR events are probably determined by a combination of 
multiple factors, including origin of recombination, genetic background, substrate’s 
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integrated site and other unknown factors. Second, within the same cell line, the 
proportion of HeR events in spontaneous recombination is always higher than that in 
DSB repair. With the same genetic background, higher proportion of HeR in spontaneous 
recombination does suggest different underlying mechanism from DSB induced 
recombination. Examination of the substrates’ structure reveals that DSB provoked 
recombination is most likely initiated in downstream HSV-1 TK sequence of donor, while 
spontaneous recombination has another continuous homology, the upstream HSV-1 TK 
sequence of donor, to start recombination events efficiently. The recombination events 
initiated in upstream HSV-1 TK sequence and resolved in downstream HSV-1 TK 
sequence only produce HeR recombinants, therefore, with these HeR events added to the 
pool of HR and HeR events initiated in downstream HSV-1 TK sequence, the fraction of 
HeR events in spontaneous recombination would surely be higher than in DSB repair. 
 Different homology preference of DSB repair: As postulated before, in 
spontaneous recombination events, conversion tract rarely ends in homeologous region, 
converting some of the mismatched nucleotides: out of 53 clones, only 1 clone has 
conversion tract terminated in middle of homeologous region (Table 2.12). In the study 
of DSB repair events, out of 41 identified HeR clones, 11 clones have conversion tract 
ended in homeology, only converting part of these mismatched nucleotides between 
donor and recipient. Comparing the location where conversion ends in two situations, the 
Fisher’s exact test generates a p-value of 3X10-4, showing a dramatic difference between 
spontaneous recombination and DSB induced recombination. Current data clearly 
demonstrates that spontaneous recombination tends to resolve in the homologous region,  
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Table 2.12 Transfer of mismatched nucleotides between donor and recipient differs in 
spontaneous recombination and DSB-induced recombination. 
 
 
 
Number of 
Mismatches 
 
 
Cell line 
Spontaneous Recombination DSB-induced Recombination 
Fewer than all 
mismatches 
All 
mismatches 
Fewer than all 
mismatches 
All 
mismatches 
33 pBWW33-48 0 7 1 4 
 pBWW33-67 0 12 5 5 
      
25 pBWW25-13 0 8 1 6 
 pBWW25-16 1 4 3 0 
      
16 pBWW16-2 0 5 0 4 
 pBWW16-6 0 17 1 11 
      
Total 1 53 11 30 
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while DSB provoked recombination frequently resolves in middle of homeologous 
region.  
 In a fluctuation test, a recombination event may generate many clones with the 
same conversion tract, so to get an estimation of discrete events, these identical clones 
arising from the same subclone are counted as one event. And the discrete events counted 
in this way are named as minimal spontaneous recombination events, a conservative 
estimation of real recombination events. If one counts the minimal spontaneous 
recombination events, the number of these spontaneous events converting all mismatched 
nucleotides is 21 while the number of spontaneous events converting part of mismatched 
nucleotides is only 1. If minimal spontaneous recombination events are used instead of 
actual recombinants number, a Fisher’s exact test comparing HeR events changing partial 
or all mismatched nucleotides between spontaneous recombination and DSB repair 
generates p-value of 0.0433. The new test is more stringent than previous one using 
recombinants number. However, it still supports a significant difference between 
spontaneous recombination and DSB induced recombination. 
 Probable mechanistic differences behind the two types of recombination and 
their homology preference: Variances in mechanisms may cause the difference between 
spontaneous recombination and DSB provoked HR in choosing the resolution site. DSBR 
and SDSA models (Figure 1.1) provide satisfactory explanation of how cells repair DSB 
in mitotic cells (7). SDSA is considered as a major and preferable pathway to generate 
gene conversion events during mitosis (19). Different from DSBR, after strand invasion 
and DNA synthesis, the newly synthesized strand anneals back to the other resected 
broken end for ligation, which abrogates the second strand capture and double strand HJs 
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steps. SDSA tends to generate recombinants with unidirectional conversion tracts 
although occasionally it does allow two strand invasion and bidirectional conversion 
tracts (69). Moreover, without forming HJs, SDSA won not mediate crossover events 
between donor and recipient, which are only achieved by HJs resolution in DSBR model 
(7). Crossovers are not collected or discussed in the current experiments since crossover 
within pBWW substrates only produces recombinants carrying a truncated tk gene, and 
thus is unable to survive the HAT selection. 
 Spontaneous recombination may be due to repair of spontaneous occurring DSBs, 
through either SDSA or DSBR pathway, as described above. Spontaneous recombination 
may also start to restore the collapsed or stalled replication forks when the replication 
machinery meet DNA lesions on parental strands (Figure 1.2). Moreover, template 
switching or replication slippage may explain these obtained recombinants as well.  
 What remains to be explored is the underlying mechanism of relaxed homology 
requirement during DSB repair. Probably, DSB repair experiments collected 
recombinants repairing the homeologous sequence near a DSB, while the genetic 
exchange in collected spontaneous recombinants likely started from an unknown site 
some distance away. Or, the difference lies in how HR resolves the exchange between 
participating molecules: HJs need to be resolved during DNA recombination restoring 
replication forks while as a predominant pathway in DSB repair, SDSA does not employ 
HJ intermediate. More discussion and efforts to investigate the difference in homology 
requirement between spontaneous recombination and DSB-induced recombination are 
continued in Chapter 4. 
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CHAPTER 3 DNA MISMATCH REPAIR’S ROLE IN SPONTANEOUS 
AND DSB-INDUCED RECOMBINATION 
 DNA mismatch repair (MMR) is a critical pathway to maintain the genome’s 
fidelity during cell proliferation (58). When cells produce descendants through 
continuous divisions, their genomes need to be replicated timely and correctly. The major 
DNA polymerase employed in DNA replication is faithful due to a proofreading 
mechanism, and the errors occur at 1 in every 100,000,000 nucleotides (80). Though the 
risk is low, it cannot be neglected considering size of the genome and repetitive cell 
divisions. Moreover, when cells are threatened by endogenous or exogenous stresses, 
normal replication could be stalled by altered DNA structures.  In these situations, other 
error-prone translesion polymerases may replace the high-fidelity polymerase, and carry 
on DNA synthesis with a dramatically high error rate. Sometimes, the translesion 
polymerases may even synthesize random DNA sequence to overcome temporary lesions 
(81, 82). If not fixed properly, these mutations which arise from DNA replication will 
accumulate and cause gradual deterioration of the genome. MMR is the major strategy 
cells adopt to combat replicative errors. MMR deficiency in bacteria, as demonstrated by 
many mutants, will cause high mutation rates in these strains, and deficiency of MMR 
elevates spontaneous mutations in human cells as well (83). MMR deficiency associates 
with vast majority of the human cancers and actually leads to cancer directly as shown in 
certain hereditary nonpolyposis colorectal cancer (HNPCC) (60). 
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 MMR recognizes the DNA mismatches introduced by replicative errors, makes 
incision on one of the mismatched DNA strands, degrades and re-synthesizes the excised 
strand under the guidance of the complementary strand (84, 85). During MMR, the newly 
synthesized strand is always chosen for degradation, therefore, cells restore the 
mismatched DNA sequence back to the original parental sequence (86). In gram-negative 
bacteria, transient hemimethylation allows MMR to recognize and destroy newly 
synthesized strand and keep the methylated strand as template. In other bacteria and 
eukaryotes, further investigation is needed to reveal how MMR targets the newly 
synthesized DNA strand for degradation. Some reports suggest that temporary nicks 
occurring on newly synthesized strands will signal the MMR for destruction while others 
show the asymmetric orientation of replicative machinery may assist MMR to find the 
newly synthesized target strand. 
 In bacteria, MMR has three major components working cooperatively to 
recognize and repair mismatched nucleotides. MutS family members perform their 
function as a dimer: they detect the distortion in DNA double helix caused by 
mismatched nucleotides, and signal for downstream effectors (57). MutLs and MutHs 
will form complex with the MutS dimer and recruit endonuclease, DNA helicase, and 
exonuclease for strand degradation. In eukaryotes, there are two types of MutS complex: 
Msh2/Msh6 detects base substitution and small loops while Msh2/Msh3 screens for small 
loops or larger loops. 
 MMR has been proposed to play more than one roles in HR (54). MMR may 
target and repair nucleotide mismatches in heteroduplex DNA (hDNA) left by HR events. 
At several steps of HR, the hDNA intermediates are formed through annealing DNA 
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strands from two homologous sequences. After HR resolved these two DNA sequences, a 
stretch of foreign strand might be left in one DNA molecule as hDNA.  These 
mismatched nucleotides within hDNA would be the obvious target of MMR. Repair of 
the hDNA by MMR either restores the original DNA sequence or converts it to the 
template sequence. Second, MMR scrutinizes the strand paring between HR substrates 
and prevents recombination between diverged sequences as discussed in Chapter 3. In 
yeast, without functional MMR, the frequency of HeR events between diverged 
sequences will raise 100 times to that between identical sequences (66). Although the 
mechanism and protein components involved in rejection are still in debate, the rejection 
occurs as early as strand invasion and D-loop formation (57, 87). 
 As shown in the previous chapter, in either spontaneous recombination or DSB 
induced recombination, it is common to see nucleotide mismatches transferred from 
hybrid donor sequence to HSV1-TK recipient sequences. However, the generation of 
these HeR events is not clear. First, the homeologous sequence may be lost during the 
earlier steps in breakage, end resection and degradation before the strand invasion. So the 
restored recipients with HSV2-TK sequence are solely products of DNA gap repair, 
which re-synthesized the lost DNA according to its homologous template. Second, as 
described in Chapter 1, the hDNA annealing homeologous sequences could form during 
initial strand invasion or HJs migration, so after HJ resolution, MMR may repair 
nucleotide mismatches either toward HSV2-TK sequence (HeR events) or HSV1-TK 
sequence (HR). Third, in SDSA pathway, resected HSV-1 TK DNA strand and newly 
synthesized HSV2-TK strand may anneal and ligate with each other with help from 
nearby homologous sequences, while MMR fixes the mismatched nucleotides afterward.  
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 Abrogation of MMR was achieved in selected cell line pBWW33-67 by stably 
transfection of MSH2 shRNA. Through analysis of the recombinants in absence of 
MMR, it is possible to reveal the molecular intermediate of HeR events and help to piece 
together the process for previously observed HeR events. At the same time, comparing 
the HeR frequency before and after MSH2 knockdown, it is possible to see whether 
MMR prevents HeR events from happening within pBWW substrates. Moreover, it is 
also possible to see whether MMR affects the resolution site of DNA recombination. 
Materials and Methods: 
 Stable knockdown of MSH2 in cell lines pBWW33-67: To make experimental 
and control cell lines for the MSH2 knockdown experiment, cell line pBWW33-67 was 
transfected with MSH2 shRNA#3 (target sequence is 5’ CCG GCC CGG CAA TCT TTC 
TCA GTT TCT CGA GAA ACT GAG AAA GAT TGC CGG GTT TTT G 3’ for mouse 
Msh2 gene) or Control shRNA#1 (non human or mouse shRNA, target sequence is 5’ 
CCG GCA ACA AGA TGA AGA GCA CCA ACT CGA GTT GGT GCT CTT CAT 
CTT GTT GTT TTT 3’). MSH2 shRNA #3, TRCN0000042493, was obtained from the 
MISSION TRC shRNA bacterial glycerol stock library (Sigma), while Control shRNA 
#1, SHC002, is one of the MISSION shRNA Control Vectors from Sigma. pBWW33-67 
cells were plated in 35 mm dishes, and one day later, 0.8 ug shRNA plasmid was 
prepared and transfected into cells using Qiagen Effectene as instructed by the supplier. 
Two days after the transfection, the cells were trypsinized and about 2 million cells were 
plated in one T75 flask for puromycin selection at 5 ug/mL. Two weeks later, puromycin 
resistant colonies from the shRNA transfections were picked, cultured and stored 
separately.  
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 6-Thioguanine (6-TG) resistance test: To check 6-TG's effect on obtained cell 
lines, 100 cells were plated in each T25 flask. The flasks were refilled with media 
containing different concentrations of 6-TG on the second day and then changed back to 
regular media on the third day. After 14 days, viable colonies were stained with 
Methylene blue and counted as described before. The colonies number in 6-TG treated 
flask was divided by that in control flask to give survival rate for each cell line. To screen 
the obtained cell lines, 4 uM 6-TG was used in the first round of tests. Selected cell lines 
were subjected to a second round of tests to estimate of their resistance, and the 6-TG 
concentrations include 0.5 uM, 2 uM, 4 uM and 8 uM. 
 Preparation of protein sample: To exact soluble protein samples, cells were 
trypsinized and suspended in 5 mL culture media. The cell suspension in a 15 mL conical 
tube was centrifuged at 300 x g for 3 minutes, and then the pelleted cells were washed 
with 1.5 mL ice cold PBS and transferred into a 1.5 mL Eppendorf tube. After the second 
centrifugation at 1,500 x g for 3 minutes, the newly pelleted cells were mixed with 30 uL 
lysis buffer (RIPA buffer: 50 nM Tris-HCl, 150 nM NaCl, 1 mM EDTA, 0.1% SDS, 1% 
deoxycholate and 1% Triton x-100, PH 7.4, mixed 1/10 v/v proteinase inhibitor cocktail, 
Sigma Cat. P8340). The cell clumps were broken up through repetitive pipetting, and the 
cell lysis was incubated on ice for 30 minutes. All obtained protein samples were stored 
at -80˚C until use. Before western blotting, the thawed cell lysis was centrifuged at 
10,000 x g for 10 minutes at 4˚C, and the supernatant was transferred into a new tube. 
 Protein electrophoresis and transferring: Protein samples were freshly 
prepared before electrophoresis: 30 ug protein sample was mixed with 6 X SDS sample 
buffer (300 mM Tris-HCl, 600 mM DTT, 12% SDS, 30% Glycerol and 0.06% 
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Bromophenol blue, pH 6.8) and additional lysis buffer to reach the same final volume 
across samples. The sample mixture was incubated at 95˚C for 5 minutes, and then 
briefly spun down. 
 All protein samples were separated on 8% polyacrylamide gels in 1 X SDS 
running buffer (25 mM Tris base, 192 mM Glycine and 0.1% SDS). For one gel, the 
current was set at 15 mA while samples moved in the 4% stacking gel and then switched 
to 19 mA after samples entered the 8% separating gel. The electrophoresis was stopped 
once the 37 KD protein marker approached the end of the separating gel. 
 The 1 x transfer buffer (25 mM Tris base, 192 mM Glycine, 0.1% SDS and 20% 
methanol) was prepared in advance and cooled at 4˚C before use. After the 
electrophoresis ended, the gel was disassembled from the cassette and the stacking gel 
was cut off from the separating gel. The separating gel was soaked in 1 x transfer buffer 
and shaken slowly for 15 minutes. During the time, the nitrocellulose membrane 
Amersham Hybond ECL from GE was wet with deionized water as instructed by the 
supplier, and then soaked in 1 x transfer buffer together with filter paper, and the foam 
filter pad.  
 The transfer “sandwich” was assembled in following order: black plate, filter pad, 
filter paper, gel, membrane, filter paper, filter pad and white plate. Bubbles between 
layers were gently driven out by a rolling test tube across the “sandwich”. The transfer 
“sandwich” was put into the electrode assembly and then inserted into the tank with 1 x 
transfer buffer. The protein transferring was carried out at 100 volts for 90 minutes unless 
specified separately. During the transferring, the tank was incubated in an ice water bath, 
and an ice cooling pad was kept in the tank as well. 
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 Western blot: After transferring, the membrane was washed briefly in 1 X Tris-
buffered saline (TBS), and incubated in blocking buffer (5% non-fat milk and 0.1% 
Tween-20 in TBS) for 1 hour at room temperature. Primary antibody was diluted 
empirically in 10 mL blocking buffer, and the overnight incubation of the membrane was 
carried out in a suitable petri dish with slow agitation at 4˚C. On the second day, the 
membrane was rinsed briefly in wash buffer before three consecutive washing steps. The 
membrane was washed with slow agitation for 5 minutes each time in 100 mL wash 
buffer and the washing buffer is TBS with 0.1% Tween-20 (0.1% TBST) unless 
otherwise specified.  
 Secondary antibody was diluted empirically in 10 mL blocking buffer, and the 
incubation was set at room temperature for 1 hour with slow agitation. After incubation 
with the antibody, three washing steps were carried out as described before except the 
last wash took 10 minutes. 
 The detection was performed using Amersham’s ECL Select as instructed by the 
supplier. Equal volume of solution A and solution B were mixed, and then the 
membranes were immersed in the mixture for 5 minutes in the dark. The membrane was 
drained of excessive liquid and wrapped in Saran wrap for chemiluminescent detection. 
 Western blot detecting MSH2 expression: expression of MSH2 in selected cell 
lines was examined through western blot using MSH2 antibody from NOVUS (Cat# NB 
100-621). The western blot process was described above and the differences in loading 
and blotting were listed below. For electrophoresis, 30 ug Protein sample of selected cell 
lines was separated on 8% polyacrylamide gel, and then transferred onto Amersham 
Hybond ECL nitrocellulose at 400 mA for 90 minutes. The membrane was cut through 
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75KD to separate MSH2 and β-tubulin for subsequent immune-blotting. MSH2 primary 
antibody was applied at 1:15,000 in Tris buffered saline (TBS) with 3% non fat milk 
(NFM), and the secondary antibody (Goat polyclonal antibody to Rabbit IgG, HRP 
conjugated from NOVUS, Cat# NB 730-H) was added at 1: 100,000 in TBS with 3% 
NFM. For β-tubulin, the primary antibody (mouse monoclonal antibody from SANTA 
CRUZ, Cat# sc-5274) was applied at 1: 10,000 in 0.1% TBST with 5% NFM and the 
secondary antibody (goat anti-mouse IgG-HRP, Cat# sc-2005) was applied at 1: 10,000 
in 0.1% TBST with 5% NFM as well. For both proteins, the primary antibody was 
incubated overnight at 4°C, and secondary antibody was incubated at room temperature 
for 45 minutes. The washing buffer for MSH2 was TBS with 0.05% Tween-20 (0.05% 
TBST), while 0.1% TBST was used for tubulin. Three washes were performed after each 
incubation for 5 minutes. Finally, the membranes were developed using Amersham ECL 
Select Western Blotting Detection Reagent (GE). 
 Collection and analysis of spontaneous recombination through fluctuation 
test: To collect spontaneous recombinants in pBWW33-67 derivative cell lines, 10 
subclones were cultured from 100 cells up to 40 million cells before HAT selection, as 
described in Chapter 2.   
 Collection and analysis of spontaneous recombination through modified 
fluctuation test: A modified fluctuation test was attempted on pBWW33-67 to collect 
the recombination clones containing all descendants of a spontaneous recombination 
event. Each subclone was cultured from 100 cells up to 4 million cells in the modified 
test, and then these 4 million cells were separated into 4 T175 flasks. The cells in each 
T175 flask were grown for another 3 days before subjected to HAT selection without 
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counting and re-plating. Recombinant clones were collected and analyzed as described 
before.   
 Collect and analyze DSB repair recombinants: To collect DSB provoked 
recombinants of pBWW33-67 derivative cell lines, the electroporation and HAT 
selection were done as described in Chapter 3. 
 PCR amplification and sequencing: The PCR and sequencing procedures were 
described in Chapter 2. Moreover, nucleotide callings at every mismatched postilion (M1 
to M33) were checked manually on the chromatograms when conversion occurred to 
recipient, in order to see whether nucleotides of donor and recipient both appear at each 
mismatched position.   
 Subcloning: To separate different cell populations within a DSB repair 
recombinant, subclones of existing cell lines were obtained as described in Chapter 2. 
The recipient sequences in newly established subclones were amplified, sequenced and 
compared with their parental recombinant. 
 Drug resistance tests on tk function: To check the function of tk in selected cell 
lines, the cells were tested with Trifluorothymidine (TFT) and Gancyclovir (GCV). 
100,000 cells were plated into each T25 flask, and 4 hours later, these flasks were refed 
with media containing 5 ug/uL TFT or 10 uM/uL GCV. After 3 days, the cells in these 
flasks were examined under the microscope at day 3 and day 6. 
 RNA extraction: RNA from selected cell lines was extracted using Qiagen 
Rneasy Mini Kit as instructed by the supplier. About 3 million cells in a T25 flask were 
trypsinized, collected and lysed with supplied buffer. The cell lysate was homogenized by 
passing through a blunt 20-gauge needle at least 5 times.  
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 RT-PCR and sequencing: qScripts XLT One-Step RT-PCR Kit was used with 
primer pair AW109 (5’ TAA TAC GAC TCA CTA TAG GGA AGT AGC ACA GGC 
GGC ACA C 3’, downstream primer matches the seventh exon of mouse TK sequence) 
and AW100 (5’ GAT TTA GGT GAC ACT ATA GGC TGC CAT GAG CTA CAT 
CAA TC 3’, upstream primer matches the first exon of mouse TK sequence) to amplify 
the mRNA transcripts of mouse thymidine kinase. The RT-PCR was carried out in a final 
volume of 25 uL with 500 ng sample RNA and 400 nM each primer. The RT-PCR begins 
with cDNA synthesis at 48ºC for 20 minutes, and then the initial denaturation at 94ºC 
takes 3 minutes. The subsequent 32 PCR cycles include 20 seconds denaturation at 94ºC, 
1 minute annealing at 55ºC and 90 seconds elongation at 72ºC. The final elongation step 
is done at 72ºC for 10 minutes.  
 These RT-PCR products were separated on 0.8% agarose gel and the 612 bp 
target band in these samples was cut out for PCR amplification. The excised gel piece 
was frozen overnight, and then centrifuged at 16,100 x g for 3 minutes to pellet the 
agarose gel. The second PCR with AW109 and AW110 was carried out as described in 
Chapter 2 using 1 uL of the resulting supernatant.  
 PCR amplification of mouse thymidine kinase pseudogene: The mouse 
thymidine kinase pseudogene in selected cell lines was amplified using AW109 and 
AW100 as described in Chapter 2. Their sequences were aligned to the reference mouse 
tk sequence to check for any nucleotide change. 
Results: 
 Establishing cell lines used in MSH2 knockdown experiments: Twelve stably 
transfected cell lines were obtained from control shRNA transfections performed on 
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pBWW33-67, while another 12 stably transfected cell lines were obtained from MSH2 
shRNA transfections. These cell lines were named for their parent cell line, initial of 
experiment group and clone numbers. The cell lines with integration of control shRNA 
were named from pBWW33-67C1 to pBWW33-67C12, while the cell lines carrying 
MSH2 shRNA were named from pBWW33-67M2 to pBWW33-67M13.  
 Selecting cell lines for recombination assays: To initially screen for MMR-
deficient cell lines and control cell lines, all established cell lines were subjected to 
survival test in 4uM 6-TG, whose genotoxicity is mediated by MMR (88). As listed in 
Table 3.1, half of the stable cell lines from MSH2 shRNA transfections have 21% or 
higher survival rate, showing substantial resistance to 6-TG. In contrast, almost all cell 
lines from control shRNA transfections were sensitive to 6-TG just like the parental cell 
line pBWW33-67. Only one clone pBWW33-67C2 has a 14% survival rate, but this is 
still lower than aforementioned 6-TG resistant clones from MSH2 shRNA transfection. 
pBWW33-67M13 and pBWW33-67M11 have the highest survival rates, so they were 
selected for western blot analysis together with control cell lines pBWW33-67C6 and 
pBWW33-67C8, which were sensitive to 6-TG just like the parental cell line. These four 
cell lines were subjected to a second round of 6-TG testing at different concentrations to 
better estimate their MMR functionality, and the results are listed in Table 3.2. 
 Western blot in Figure 3.1 shows expression of MSH2 in selected cell lines, and 
about 6 to 10-fold reductions were observed in MSH2 knockdown cell lines, compared 
with parental cell line or control cell lines. The MSH2 expression in pBWW33-67M5, 
pBWW33-67M11 and pBWW33-67M13 reduced dramatically while its expression in 
pBWW33-67C6 and pBWW33-67C8 did not. Interestingly, the MSH2 expression in 
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Table 3.1 Preliminary 6-TG resistance test on 22 stable cell lines carrying control shRNA 
or MSH2 shRNA . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of colonies in 4 uM 6-TG was divided by number of colonies in 0 uM 6-TG to 
generate the survival rate for each cell line in last column. 
NA: Two cell lines were lost during cell culture, not available for 6-TG test.  
Experimental 
groups 
Cell Lines 
# of colonies 
in 0uM 6-TG 
# of colonies 
in 4uM 6-TG 
Survival Rate 
           
Parental pBWW33-67  89   1   1%  
           
Control shRNA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pBWW33-67C1 NA   NA   NA  
pBWW33-67C2 81   11   14%  
pBWW33-67C3 NA   NA   NA  
pBWW33-67C4 80   1   1%  
pBWW33-67C5 82   0   0%  
pBWW33-67C6 74   1   1%  
pBWW33-67C7 63   0   0%  
pBWW33-67C8 32   0   0%  
pBWW33-67C9 55   1   2%  
pBWW33-67C10 41   1   2%  
pBWW33-67C11 41   0   0%  
pBWW33-67C12 71   0   0%  
          
MSH2 shRNA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pBWW33-67M2 63   0   0%  
pBWW33-67M3 67   0   0%  
pBWW33-67M4 55   2   4%  
pBWW33-67M5 52   30   58%  
pBWW33-67M6 61   0   0%  
pBWW33-67M7 103   22   21%  
pBWW33-67M8 49   1   2%  
pBWW33-67M9 65   5   8%  
pBWW33-67M10 70   28   40%  
pBWW33-67M11 75   96   128%  
pBWW33-67M12 66   31   47%  
pBWW33-67M13 75   61   81%  
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Figure 3.1 Expression of MSH2 in cell line pBWW33-67 and its derivative cell lines 
from control or experimental group.  
Lane 1, pBWW33-67C2; Lane 2, pBWW33-67C6; Lane 3, pBWW33-67C8; Lane 4, 
pBWW33-67M2; Lane 5, pBWW33-67M3; Lane 6, pBWW33-67M5; Lane 7, 
pBWW33-67M11; Lane 8, pBWW33-67M13 and Lane 9, pBWW33-67C2.  
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Table 3.2 Detailed 6-TG resistance test on 5 selected cell lines. 
 
Experiment Cell Lines 
0.5uM 6-
TG 
2uM 6-
TG 
4uM 6-
TG 
8uM 6-
TG 
          
1 pBWW33-67 84%  2%  3%  10%            
 pBWW33-67C6 61%  3%  4%  15%  
 pBWW33-67C8 54%  4%  2%  7%  
          
 pBWW33-67M11 101%  99%  55%  25%  
 pBWW33-67M13 141%  138%  117%  79%  
          
           
2 pBWW33-67 54%  2%  4%  2%  
          
 pBWW33-67M13 99%  81%  96%  58%  
 
Two replicates were carried out for each 6-TG concentration in the second test, and their 
average colony number was divided by that in media only to generate survival rate. Cell 
line pBWW33-67M13 had survival rates over 100% in the first trial, so it was tested 
again together with parental cell line.   
 96 
these cell lines has negative correlation with their resistance to 6-TG: the higher MSH2 
expression in a cell line, the more sensitive it is to 6-TG. pBWW33-67M13 has lowest 
expression of MSH2 on the western blot but has highest survival rate in 6-TG media. 
Combining the 6-TG test and Western blot results, the cell lines pBWW33-67M11, 
pBWW33-67M13, pBWW33-67C6 and pbww33-67C8 are good candidates for 
recombination experiments. Finally, pBWW33-67M13 and two other two control cell 
lines, pBWW33-67C6 and pBWW33-67C8 were chosen for further recombination 
experiments. 
Collection and analysis of spontaneous recombination and DSB induced 
recombination: Fluctuation tests were carried out on selected cell lines pBWW33-67M13, 
pBWW33-67C6 and pBWW33-67C8, and their clone frequency, analyzed clones and HeR 
frequency are listed in Table 3.3. DSB repair experiments were carried out on selected cell 
lines 3 to 5 times to collect recombinants of DSB repair, and their clone frequency, 
analyzed clones and HeR frequency are listed in Table 3.4. 
 Equivalent recombination frequency in MSH2 knockdown cells: For each 
pBWW33-67 derivative cell line, 12 to 22 clones from spontaneous recombination 
experiment were examined, and 20 to 63 clones from DSB repair were examined. 
pBWW33-67 and its derivative cell lines have similar spontaneous recombination 
frequencies at 10-8 and HeR events around 10-8. pBWW33-67M13 has a spontaneous clone 
frequency of 5.71X10-8 and HeR frequency of 3.37X10-8, pBWW33-67C6 has spontaneous 
clone frequency of 5.95X10-8 and HeR frequency of 0.82X10-8, and pBWW33-67C8 has a 
spontaneous clone frequency of 3.22X10-8 and HeR frequency of 3.22X10-8.  
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Table 3.3 Spontaneous recombination frequencies of cell lines in MSH2 knockdown 
experiment. 
 
Cell line Subclone 
Clone 
frequency 
(10
-8
) 
# of 
Colonies 
analyzed 
# of 
Homeologous 
recombinants 
Homeologous 
recombination 
frequency  
(10
-8
) 
pBWW33-67M13 1 4.17 2* 0 0 
 2 0 0 0 0 
 3 3.64 0 0 0 
 4 0 0 0 0 
 5 12.30 3 1 4.10 
 6 19.84 9* 8 19.84 
 7 0 0 0 0 
 8 2.50 3* 0 0 
 9 0 0 0 0 
 10 14.63 8* 4 9.76 
 Total  25 13  
  Avg.=5.71   Avg.=3.37       
pBWW33-67C6 1 0 0 0 0 
 2 13.97 4 0 0 
 3 0 0 0 0 
 4 0 0 0 0 
 5 5.09 2 1 2.54 
 6 25.82 11 0 0 
 7 6.60 2 0 0 
 8 0 0 0 0 
 9 4.67 2 1 2.34 
 10 3.33 1 1 3.33 
 Total  22 3  
  Avg.=5.95   Avg.=0.82       
pBWW33-67C8 1 5.26 2 2 5.26 
 2 0 0 0 0 
 3 0 0 0 0 
 4 0 0 0 0 
 5 0 0 0 0 
 6 26.94 1 1 26.94 
 7 0 0 0 0 
 8 0 0 0 0 
 9 0 0 0 0 
 10 0 0 0 0 
 Total  3 3  
  Avg.=3.22   Avg.=3.22 
 
*Some HAT resistant clones of pBWW33-67M13 survived selection because of 
reactivated mouse tk pseudogene rather than recombination between HSV TK sequences, 
so the recombination frequency was adjusted as the product of raw clone frequency and 
proportion of recombination events. 
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Table 3.4 DSB-induced recombination frequencies of cell lines in MSH2 knockdown 
experiment. 
 
Cell line 
Expt 
# 
Expt. 
Number  
Clone 
frequency 
(10-5) 
# of 
colonies 
analyzed 
# of 
homeologous 
recombinants 
Homeologous 
recombination 
frequency (10-5) 
pBWW33-67M13 1 1 4.77 18 9 2.39 
  2 6.14 5 2 2.46 
  3 5.18 15 4 1.38  
       
 2 1 2.7 14 4 0.77  
  2 4.24 14 6 1.82 
       
   Avg.=4.61   Avg.=1.76 
       
pBWW33-67C6 1 1 0 0 0 0 
  2 0.91 4 1 0.23 
  3 0.53 6 2 0.18 
       
 2 1 0.29 5 0 0 
  2 0.29 6 1 0.05 
       
   Avg.=0.40   Avg.=0.10 
       
pBWW33-67C8 1 1 9.26 6 0 0 
  2 6.6 6 2 2.20 
  3 5.38 8 3 2.02 
       
   Avg.=7.08   Avg.=1.41 
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 Clone frequencies of DSB repair in these cell lines are around 10-5 except for cell 
line pBWW33-67C6 in the control group, which has an especially low clone frequency of 
4X10-6. pBWW33-67M13 has a clone frequency of 4.61X10-5 and HeR frequency of 
1.73X10-5, pBWW33-67C6 has a clone frequency of 0.4X10-5 and HeR frequency of 
0.1X10-5. 
 Similar conversion tract of spontaneous recombinants in MSH2 Knockdown 
cells: The spontaneous HeR events in parental, control and MSH2 knockdown cell lines 
have these 33 mismatched nucleotides in HSV-1 TK recipient converted to HSV2-TK 
sequence all at once. In contrast, many DSB repair events only converted fewer than the 
33 mismatched nucleotides to HSV2-TK sequence. The detail of conversion tract in DSB 
repair is listed in Table 3.6. 
 Elevated proportion of HeR events in MSH2 knockdown cells during DSB 
repair: The proportion of HeR events increased in MSH2 knockdown cell lines: the 39% 
HeR events in pBWW33-67M13 cell lines is close to two times of that in parental cell line 
and control cell lines (Table 3.5). However, clone frequency and HeR frequency of 
pBWW33-67M13 are not different from that in parental or control cell lines (Table 3.4). 
 Unchanged proportion of HeR events in spontaneous recombination: For 
spontaneous recombination, the proportion of HeR events in pBWW33-67M13 is 68%, 
close to pBWW33-67 and pBWW33-67C8, but different from pBWW33-67C6, which has 
the lowest proportion of HeR events in the 4 examined cell lines. The proportion of HeR 
events in pBWW33-67C6 is about 4 times lower than other cell lines in spontaneous 
recombination. The details of HeR events in experimental cell lines are listed in Table 3.5. 
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Table 3.5 HeR events of spontaneous recombination and DSB repair in MSH2 
knockdown experiment. 
 
Recombination 
events 
Cell 
Line 
Analyzed 
clones 
Recipient 
with all 
mismatches 
Recipient 
with 
mismatches 
(fewer than 
all) 
Recipient 
with no 
mismatch 
Other 
events 
HeR 
Fraction 
Spontaneous 
recombination 
P 15 12 0 3 0 80% 
C6 22 3 0 19 0 14% 
 C8 3 3 0 0 0 100% 
 M13 19 13 0 6 0 68% 
        
DSB repair P 42 5 5 31 1 24% 
 C6 21 2 2 16 1 19% 
 C8 20 3 2 14 1 25% 
 M13 64 12 13 39 0 39% 
 
Cell lines’ names are abbreviated in Table 3.5. P = parental cell line pBWW33-67, C6 = 
control cell line pBWW33-67C6, C8 = control cell line pBWW33-67C8 and M13 = 
MSH2 deficient cell line pBWW33-67M13.   
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Table 3.6 Converted mismatched nucleotides in HeR recombinants from DSB repair. 
 
Cell line Clone 
Converted 
Mismatched 
Nucleotides  
Coexistence of mismatched 
nucleotides 
pBWW33-67M13 pBWW33-67M13-1-1 M1 to M17 M1 to M2 
 pBWW33-67M13-1-2 M1 to M33  
 pBWW33-67M13-1-6 M1 to M7 M1 to M7 
 pBWW33-67M13-1-7 M1 to M12 M1 to M12 
 pBWW33-67M13-1-8 M1 to M17 M1 to M17 
 pBWW33-67M13-1-9 M1 to M33 M1 to M33 
 pBWW33-67M13-1-11 M1 to M33 M17 to M33 
 pBWW33-67M13-1-13 M1 to M16 M1 to M16 
 pBWW33-67M13-1-16 M1 to M16 M6 to M16 
 pBWW33-67M13-2-7 M1 to M33 M1 to M33 
 pBWW33-67M13-2-9 M1 to M33  
 pBWW33-67M13-3-3 
 
M6 to M14 & 
 M17 &M20 
M6 to M14 & M20 
 pBWW33-67M13-3-6 M1 to M33 M1 to M16, M21 to M33 
 pBWW33-67M13-3-9 M1 to M16 M1 to M16 
 pBWW33-67M13-3-13 M1 to M33 M1 to M33 
 pBWW33-67M13-7-6 M6 to M17 M6 to M12 
 pBWW33-67M13-7-7 M1 to M33  
 pBWW33-67M13-7-10 M1 to M33 M29 to M33 
 pBWW33-67M13-7-16 M1 to M33 M1 to M33 
 pBWW33-67M13-8-4 M1 to M30  
 pBWW33-67M13-8-7 M1 to M12  
 pBWW33-67M13-8-9 M1 to M5 M1 to M5 
 pBWW33-67M13-8-11 M1 to M33 M1 to M5, M21 to M33 
 pBWW33-67M13-8-14 M1 to M33 M1 to M33 
 pBWW33-67M13-8-15 M1 to M12 M1 to M12 
pBWW33-67C6 pBWW33-67C6-2-12 M1 to M33   
 pBWW33-67C6-3-5 M1 to M12  
 pBWW33-67C6-3-7 M1 to M33  
 pBWW33-67C6-5-10 
M1 to M5 & M13 to 
M17 
 
pBWW33-67C8 pBWW33-67C6-2-3 M1 to M33   
 pBWW33-67C6-2-5 M1 to M5  
 pBWW33-67C6-3-1 M1 to M33  
 pBWW33-67C6-3-3 M1 to M22  
 pBWW33-67C6-3-6 M6 to M33  
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 Evidence of hDNA intermediates appeared after MSH2 knockdown: When 
analyze DSB repair recombinants of pBWW33-67M13 cell line, the alignments show 
discontinuous conversion tracts in recipient sequences where the identity of mismatched 
nucleotides changed between HSV-1 TK and HSV-2 TK sequences repetitively. In the 
chromatograms, almost all HeR events show double peaks at the positions of mismatched 
nucleotides, and each peak represents a nucleotide of either donor or recipient. As a 
result, coexistence of mismatched nucleotides causes the shifting of nucleotide calling 
between donor and recipient in sequencing data. The coexistence of mismatched 
nucleotides at each position demonstrates that the cell lines carry two set of sequence 
information, conceivably from both donor strand and recipient strand of a hDNA 
intermediate. 
 The chromatograms of previous recombinants were reviewed at this time and no 
DSB repair recombinant shows double peaks like these from pBWW33-67M13. Only one 
DSB repair recombinant, pBWW25-16-3-10, has mismatched nucleotides at M16 with 
unknown reason. Another exception is one spontaneous HeR recombinant, pBWW16-2-
5-9, which has double peaks for all mismatched nucleotides.  
 Table 3.6 lists the conversion of mismatched nucleotide in HeR recombinants 
from cell line pBWW33-67M13, pBWW33-67C6 and pBWW33-67C8 during DSB 
repair. Spontaneous HeR events are not listed in a table because they have all 
mismatched nucleotides converted to HSV-2 TK sequence and they have no double peaks 
at mismatched position in the sequencing chromatogram. 
In addition to gene conversion details, coexistence of mismatched nucleotides is 
labeled in a separate column. Conversion of mismatched nucleotide describes the 
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nucleotide positions where the donor’s nucleotide is visible, while coexistence of 
mismatched nucleotide demands the donor’s nucleotide as well as recipient’s nucleotide. 
If the mismatched nucleotides are all from donor, they would be recorded in “converted 
mismatched nucleotide” column, but not marked in “coexistence of mismatched 
nucleotide” column.  
 Coexistence of mismatched nucleotides in DSB repair recombinant are 
separated by subcloning: To learn more about the coexistence of mismatched 
nucleotides in collected recombinants, 5 recombinants from pBWW33-67M13 were 
subcloned to separate cell populations that may carry different set of nucleotides at the 
mismatched positions. Sequencing results of their subclones are listed in Table 3.7. 
 pBWW33-67M13-1-13 and pBWW33-67M13-3-13 have continuous conversion 
tract starting from M1, and the nucleotides of donor and recipient coexist at each 
converted mismatched nucleotide position. They represent 12 out of the 20 HeR events 
showing evidence of hDNA. Sequencing data of subclones from these two cell lines 
shows that these recombinants are actually composed of two cell populations, which 
carry either the donor’s HSV-2 TK sequence or recipient’s HSV-1 TK sequence in their 
recipients.  
 Two cell lines have continuous conversion tracts starting from M1. However, 
mismatched nucleotides of donor and recipient only coexist at some of the converted 
mismatched nucleotide position. All 12 subclones of pBWW33-67M13-3-6 show donor’s 
HSV-2 TK sequence, while all 6 subclones of pBWW33-67M13-1-16 show only HSV-1 
TK sequence. Recovering one of the two cell populations is not satisfactory, however, it 
does not contradict with current conclusion.  
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Table 3.7 Separation of coexisted mismatched nucleotides was observed after subcloning 
recombinants from pBWW33-67M13. 
 
 
Clone 
Converted 
Mismatched 
Nucleotides 
Coexistence of 
mismatched nucleotides 
Mismatched nucleotides  
in 
Subclone 
type A 
Subclone 
type B 
pBWW33-67M13-1-13 M1 to M16 M1 to M16 D1 to D16 R1 to R33 
pBWW33-67M13-3-13 M1 to M33 M1 to M33 D1 to D33 R1 to R33 
pBWW33-67M13-1-16 M1 to M16 M6 to M16 NA R1 to R33 
pBWW33-67M13-3-3 
 
M6 to M14 & 
M17 &M20 
M6 to M14 & M20 
 
D17 to D20 
 
NA 
 
pBWW33-67M13-3-6 M1 to M33 M1 to M16, M21 to M33 D1 to D33 NA 
 
The details of gene conversion tracts are listed after the recombinants, and the identities 
of mismatched nucleotides in their subclones followed afterward. The mismatched 
nucleotides of donor are labeled as D1 to D33, and the mismatched nucleotides of 
recipient are labeled as R1 to R33. 
  
 105 
The last cell line pBWW33-67M13-3-3 has discontinuous conversion tract, and 
nucleotides of donor and recipient only coexist at some of the converted nucleotide 
positions. Surprisingly, all 7 recovered subclones carry the same partial HSV-2 TK 
sequence and the conversion of nucleotides is different from DNA sequence of their 
parental cell lines. It is not clear how this event with confusing sequence data happened 
during DSB repair. 
Collection of spontaneous recombinants containing all cells from one 
recombination event: No spontaneous recombinant of pBWW33-67M13 was found 
with double peaks in chromatograms. To find evidence for hDNA in spontaneous 
recombination, further attempts were made to harvest a spontaneous recombination clone 
representing a single recombination event.   
 A modified fluctuation test was carried out on pBWW33-67M13 twice, and all 
recovered clones are listed in Table 3.8. Different from the previous fluctuation test, HAT 
selection was carried out on approximate 40 million cells of each subclone without re-
plating, and conceivably, all descendant cells from a recombination event form a discrete 
clone. However, in modified fluctuation test, there was still no evidence of hDNA. 
Recombinants recovered in a subclone tend to have the same type of events: 3 subclones 
have all HR recombinants and 7 subclones have all HeR recombinants. Only subclone 9 
in experiment 1 have both HR recombinant and HeR recombinant.  
 Reactivated mouse thymidine kinase pseudogene in non-recombinant clones:  
HAT resistant clones with unaltered recipient had been found sporadically in Chapter 2, 
but it was common for pBWW33-67M13 in spontaneous recombination. Non-
recombinant clones with a reactivated mouse thymidine kinase pseudogene were 
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Table 3.8 Spontaneous recombinants collected from modified fluctuation test.  
 
Experiment 
 
Subclone 
 
Recombinants 
analyzed 
Homeologous 
Recombinants 
1 1 to 6 0 0 
 7 2 0 
 8 2 2 
 9 3 1 
 10 0 0 
    
2 1 0 0 
 2 2 2 
 3 0 0 
 4 1 0 
 5 0 0 
 6 2 2 
 7 0 0 
 8 1 0 
 9 1 1 
 10 0 0 
 11 1 1 
 12 to 17 0 0 
 18 1 1 
 19 1 1 
 20 to 24 0 0 
    
 Total 17 11 
 
All recombinants from any subclone were harvested and examined. All HeR 
recombinants in this chart have all 33 mismatched nucleotides converted to HSV-2 TK 
sequence.  
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observed in our laboratory before (first characterized by Jessica Burr Lea in her Master  
 Thesis titled “Influence of the DNA Long Inverted Repeat on Recombination in 
Mammalian Cells”). Therefore, two drug resistant tests and RT-PCR were carried out to 
confirm the identities of current non-recombinant clones (89, 90). 
 Trifluorothymidine (TFT) is toxic to all cells with functional thymidine kinase 
while Ganciclovir (GCV) specifically targets cells with thymidine kinase of herpes 
simplex virus. The non-recombinant clone, pBWW33-67M13-4-11, reached confluence 
in GCV containing media but died out in TFT containing media, while control cell line 
grew well in either TFT or GCV containing media. Figure 3.2 shows that the mouse TK 
transcript was efficiently amplified in non-recombinant clones, but not from parental cell 
lines. 
 RT-PCR targeting mouse TK gene as well as pseudogene was carried out on non-
recombinant clone pBWW33-67M13-4-11, parental cell line pBWW33-67M13 and 
previous cell lines classified in Jessica Burr Lea’s master thesis. Lane 1 to 6 show RT-
PCR products of non-recombinant clones in presence or absence of reverse transcriptase, 
while lane 7 to 9 show RT-PCR products of parental cell lines. Mouse TK sequence or 
pseudogene sequence was successfully amplified from pBWW33-67M13-4-11 in 
presence of reverse transcriptase while minor amplification happened in parental cell line 
pBWW33-67M13. Similarly, previously classified non-recombinant clones, pJAVA3 5c- 
SS-1a and pJAVA1 26E-O have the same 612 bp TK sequence amplified through RT-
PCR, while the parental cell lines JAVA1 26E and pJAVA3 5c do not. 
 Finally, the RT-PCR products of recombinant clone pBWW33-67M13-4-5, non-
recombinant clone pBWW33-67M13-4-11 and parental cell line pBWW33-67M13 in   
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Figure 3.2 Mouse TK gene or pseudogene were successfully amplified through RT-PCR 
from selected non-recombinant cell lines and parental cell lines. 
Lane 1, pJAVA3 5c-SS-1a; Lane 2, pJAVA3 5c-SS-1a without reverse transcriptase; lane 
3, pBWW33-67M13-4-11; lane 4, pBWW33-67M13-4-11 without reverse transcriptase; 
lane 5, pJAVA1 26E-O; lane 6, pJAVA1 26E-O without reverse transcriptase; lane 7, 
pJAVA1 26E; lane 8, pJAVA3 5c; lane 9, pBWW33-67M13; lane 10, pJAVA1 5c-VV-2a.  
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pBWW33-67M13 experiment were excised, re-amplified and sequenced. These transcript 
sequences were aligned to the mouse TK gene and its pseudogene to examine their 
identity. 
 As shown in Figure 3.3, the 612 bp transcript sequences amplified from these cell 
lines are mouse TK pseudogene because they carry all the 8 unique nucleotides from 
mouse TK pseudogene. Meanwhile, these three transcripts have 14 additional mismatches 
across the sequence compared with either reference mouse TK sequence. PCR and 
sequencing the pseudogene’s genomic sequence in examined cell lines shows that most 
new found mutations on transcript sequence are not found on the genome. Reviewing the 
chromatogram of the transcripts’ sequences reveals that mixed reading occurs at these 14 
mutation sites. These “mutations” in transcripts’ sequence is probably an artifact from 
prolonged RT-PCR process. 
Discussion: 
 Generation of homeologous conversion tract: To address the mechanism of 
observed HeR events, experiments in the current chapter were designed to learn how 
these mismatched nucleotides were incorporated into the recipient sequence during 
recombination. In SDSA, newly synthesized recipient strand may take donor’s 
mismatched nucleotides, anneal to the other resected recipient strand and form hDNA. In 
DSBR model, hDNA may form during strand invasion, second strand capture, or HJs 
migration that mediates strand exchange between donor and recipient. In both situations, 
if MMR repair the hDNA toward the foreign sequence, the recipient would receive 
homeologous conversion tract. Without MMR, the hDNA would be separated after DNA 
replication, and one of the daughter cells gains homeologous conversion tract afterward.   
  
1
1
0
 
 
Figure 3.3 Amplified transcript sequences in selected cell lines were aligned to mouse TK gene and pseudogene. 
M13, M13-4-11 and M13-4-5 are parental cell line, non-recombinant and recombinant respectively. Totally 8 mismatches exist 
between mouse TK gene and its pseudogene within the sequencing area, and these mismatched nucleotides are marked with 
“V”. Perfectly matching sequences were highlighted in the figure for clarity. 
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Therefore, mismatched hDNA formed during HR could be repaired or separated to 
generate homeologous conversion tract. 
 Alternatively, excessive end resection and degradation may chew out the 
homeologous sequence on the recipient, and the broken recipient gets converted through 
DNA synthesis along the template strand. Thus, no mismatched hDNA is formed through 
annealing diverged sequences during the process.   
 Experiments in the current chapter specifically ask whether these HeR events 
possibly went through hDNA intermediate annealing homeologous sequences. If the 
hDNA intermediates do exist, whether they always include the whole homeologous 
region? Is it possible that the shorter conversion tracts are repair product of hDNA 
intermediates annealing the whole homeologous region? 
 Establishment of MMR impaired cell line: To answer these questions above, 
MSH2 in cell line pBWW33-67 was stably knockdown using shRNA. Then, spontaneous 
recombination and DSB induced recombination in MMR deficient background were 
examined and compared. Cell line pBWW33-67 was chosen for MSH2 knockdown 
experiment since it has higher fraction of HeR events during DSB repair, and half of the 
HeR events have few than all mismatched nucleotides converted. Alterations in 
conversion tract would be easy to see if they occur. 
 Obtained cell lines were screened by Western blot and 6-TG experiments. The 
chosen cell line of MSH2 knockdown group, pBWW33-67M13, has the lowest MSH2 
expression, and highest survival rate in 6-TG experiments, indicating functional 
deficiency in MMR. In contrast, the control cell lines pBWW33-67C6 and pBWW33-
67C8, with control shRNA integrated, have regular MSH2 expression, and they are 
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sensitive to 6-TG like the parental cell line. Data from these two experiments also shows 
the MSH2 expression in examined cell lines has negative correlation with their resistance 
to 6-TG, which agreed with the core role of MSH2 in MMR.  
 HeR recombinants of DSB repair in MSH2 deficient cells: Out of 25 HeR 
recombinants of pBWW33-67M13 obtained from DSB repair experiments, 20 
recombinants show double peaks at mismatched nucleotide position in sequencing 
chromatogram. Coexistence of mismatched nucleotides in these HeR events implies that 
hDNA intermediates formed between homeologous region segregates into two daughter 
cells in MMR deficient cell, so these clones have mixed genetic information from both 
donor and recipient.  
 To learn whether these 20 recombinants are mixed cell populations from hDNA 
segregation events, subcloning was attempted on 5 selected cell lines. Two cell lines, 
pBWW33-67M13-1-13 and pBWW33-67M13-3-13, have continuous conversion tract 
and mixed nucleotides at every mismatched position. Subcloning of these two cell lines 
successfully separates two cell populations: one have all the donor’s nucleotides at each 
converted position while the other have all the recipient’s nucleotides. The result here 
suggested these recombinants are likely products of hDNA intermediates, which are 
separated into daughter cells instead of repaired by MMR. These two cell lines represent 
12 out 20 HeR carrying mixed nucleotides. 
  pBWW33-67M13-3-6 and pBWW33-67M13-1-16 have continuous conversion 
tracts and mixed nucleotides at some mismatched positions, representing 7 out of 20 HeR 
carrying mixed nucleotides. Every examined subclones from these two cell lines have 
sequence from one side, donor or recipient. The results agree with segregation of two 
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strands with different identities, however, information of the other strand is not 
visualized. It is not clear why the information of one strand was lost during subcloning. 
 Only for clone pBWW33-67M13-3-3, the result of subcloning is not compatible 
with the sequencing data of its parental cell line. The recovered subclones have converted 
nucleotides different from parental cell, new converted nucleotides appear while some 
converted nucleotides from parental cell line disappears. The mystery of this particular 
recombinant could not be explained by simple HR models, and remains unsolved.       
 Again, 20 out of 25 recombinants show double peaks in sequencing 
chromatograms, suggesting segregation of hDNA intermediates encompassing 
homeologous sequences. Therefore, the vast majority of HeR events involves formation 
of hDNA intermediate. And the doubled percentage of HeR events after MSH2 
knockdown implies that while hDNA intermediates in normal cells are repaired by MMR 
toward either strand, the foreign strands in hDNA intermediates are always preserved and 
visible in MMR deficient cells. 
No change in clone frequencies after MSH2 knockdown while increase in 
HeR frequency: After MSH2 knockdown, clone frequencies are not dramatically 
different from that in parental and control cell lines. One-way ANOVA comparing 
frequencies in parental, control and knockdown cell lines give a p-value equals 0.3942. 
HeR frequencies look higher after MSH2 knockdown, while the same test give a p-value 
equals 0.0508. Neither frequencies are statistically significant between tested groups.  
 No change in conversion tracts after MSH2 knockdown: 12 out of 25 HeR 
events in pBWW33-67M13 have 33 mismatched nucleotides converted to HSV-2 TK 
sequence, close to the 50% seen in parental cell line pBWW33-67. Unchanged ratio 
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between partial and whole conversion tract after MSH2 knockdown suggested that MMR 
does affect the length of conversion tract. Therefore, partial conversion tract is repair 
product of hDNA intermediates annealing short homeologous sequences, while whole 
conversion tract is product of hDNA intermediate annealing the complete homeologous 
sequences.  
 Gene conversion tracts in MMR deficient cells support previous assumption that 
HeR events with fewer converted mismatched nucleotides do resolve in middle of the 
homeologous region. The alternative explanation that HeR events with fewer converted 
mismatched nucleotides came from incomplete repair of 33 mismatched nucleotides, is 
also barely feasible due to the mechanism of MMR: MMR always degrades hundreds or 
thousands of nucleotides on one strand and re-synthesize it based on the other intact DNA 
strand. It is unlikely that MMR switched the choice of strand within this 200 bp short 
sequence. Also, if hDNA intermediates always include the entire homeologous sequence 
but they are repaired differently, depletion of MSH2 will abrogate MMR and keep this 
intermediate with all 33 mismatched nucleotides for later segregation. Thus, it was 
predicted that in pBWW33-67M13, fraction of recombinants converting all mismatched 
nucleotides would rise due to deficiency of MMR. However, we observed a slightly 
decrease of these recombinants. To sum up, available evidences confirmed the existence 
of hDNA intermediates that anneal the partial homeologous region proximal to I-SceI site 
as well as that anneal the whole homeologous sequence. 
 The results in current chapter and previous two chapters clearly show the role 
MMR plays in collected HeR events. For examined three substrates, HeR events are 
common phenomenon in both spontaneous recombination and DSB-induced 
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recombination, and increase of homeologous sequence does not dramatically decrease 
either HeR frequency or proportion of HeR events. Moreover, MSH2 knockdown failed 
to bring dramatic boost in HeR frequency, though it increased fraction of HeR events up 
to 2-fold during DSB repair. Apparently, there is no vigorous rejection or destruction 
toward the genetic exchange between homeologous sequences by MMR in examined cell 
lines. It is possible that as long as nearby homology is available to initiate recombination, 
homeologous sequence could participate in genetic exchange without noticeable 
discrimination. Taken together, MMR does not target and eliminate genetic exchange 
between homeologous sequences in these substrates, while it rather repairs the hDNA to 
generate homeologous conversion tract, most likely half of the time. These results allow 
us to say MMR does not impede recombination between homeologous sequences but 
actually facilitates it between diverged sequences by converting hDNA leftover to 
template sequence. Though against the intuition and current scheme for MMR, it is 
reasonable for cells to allocate energy to reject improper recombination at the initiation 
stage, rather than destroy any ongoing genetic exchange between diverged sequences. 
 No detection of hDNA during spontaneous recombination:  In pBWW33-
67M13, 13 out of 19 spontaneous recombinants were products of HeR event. However, 
none of them show double peaks at the position of mismatched nucleotides in 
chromatography, which provided the evidence of hDNA intermediate during DSB repair. 
In fluctuation test, cells were trypsinized and plated right before the HAT selection, so if 
one recombination event generates two daughter cells carrying either strand of the hDNA 
intermediate, they are probably separated by trypsinization and form discrete colonies in 
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these flasks. Therefore, the fluctuation test was modified to collect clone that contains all 
descendant cells of a recombination event. 
 Fluctuation test of pBWW33-67M13 has no more than 8 clones in one subclone. 
If these clones were from a recombinant cell containing hDNA remnant, the recombinant 
cell went through divisions up to three times before HAT selection. Since most subclones 
grew up to about 40 million cells before HAT selection, the recombinant DNA product of 
a recombination event most likely still resided in a single cell when the subclone had 4 
million cells, if the recombination event already happened. Therefore, in modified 
fluctuation test, each subclone was cultured up to 4 million cells. Then these 4 million 
cell were plated sparsely, cultured for another 3 days before fed with HAT media for 
selection. Ideally, offspring of the same recombinant cell will form a single recombinant 
clone with mixed cell populations. In new experiments, 8 subclones generated HeR 
events, but none shows direct evidence of hDNA segregation: double peaks in 
sequencing chromatography. Only one subclone has both HeR and HR recombinants, a 
sign of possible hDNA segregation, while the other 7 subclones only have HeR 
recombinants. The percentile of hDNA segregation events is dramatically lower than that 
in DSB repair. Fisher exact test comparing the ratio of hDNA segregation event versus 
non-segregation events in spontaneous recombination and DSBR gives p-value equal 
0.0012. Therefore, hDNA segregation dominates the HeR events of DSBR while it is 
minor in spontaneous recombination. Currently, no direct evidence shows that 
spontaneous recombinants go through hDNA intermediates annealing homeologous 
sequences. 
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 Two possibilities remain for further exploration. First, as described in Chapter 3, 
the hDNA intermediates actually formed between homeologous sequences, and they 
included I-SceI site as well. Therefore, segregation of hDNA in subsequent cell division 
produced one daughter cell carrying donor’s continuous TK strand and the other daughter 
cell carrying I-SceI disrupted recipient strand. Since the latter daughter cell would perish 
in HAT selection, only the first one was able to form pure HeR recombinant in 
fluctuation test. Though in agreement with the mechanism of MMR and HR, the 
speculation still need further investigation to see whether hDNA intermediates annealing 
all the mismatches and I-SceI site are actually the precursors of collected HeR 
recombinants. It is still possible that the spontaneous recombinants in current experiments 
simply went through successive template switching during replication rather than hDNA 
intermediate formed by strand exchange. 
 Reactivation of mouse thymidine kinase pseudogene in collected clones: 
Many non-recombinant clones, mostly in fluctuation test of pBWW33-67M13, survived 
HAT selection without nucleotide sequence change in HSV-1 TK recipient. It was 
initially described in Jessica Burr Lea’s Master thesis that once a processed pseudogene 
of mouse TK gene (91)  is transcribed in high quantity, its expression can supply these 
Ltk- cells with functional thymidine kinase. Data from two drug tests shows these newly 
discovered non-recombinant clones did not grow in media with TFT, but reached 
confluence in presence of GCV. These drug tests indicate active thymidine kinase in 
these cells, but not of Herpes simplex virus origin (89, 90). The RT-PCR amplifying the 
transcript of mouse TK gene as well as pseudogene shows successful amplification in 
non-recombinant clones, but not in recombinant or parental cell lines. The transcript’s 
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sequence in aforementioned clones have 8 nucleotides identical to mouse TK pseudogene 
but not mouse TK gene. Meanwhile, all these three transcripts possess many mutations 
different from either mouse TK gene or pseudogene. However, genomic sequence of the 
mouse pseudogene in aforementioned three clones are almost the same as the reference 
pseudogene sequence. The large amount of mutations in RT-PCR products are probably 
artifact after prolonged amplification steps, or less likely, vigorous RNA editing of the 
transcripts.  
 All these results suggested that the expression of mouse tk pseudogene arises 
dramatically in non-recombinant clones, which supplied tk function in these cells rather 
than the tk of herpes simplex virus in recombination substrates.
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CHAPTER 4 INVESTIGATION OF THE RELAXED HOMOLOGY 
REQUIREMENT FOR RESOLUTION DURING DSB REPAIR 
 Holliday junction (HJ) refers to the cross-shaped, four-stranded DNA structure 
after two DNA molecules swap one strand with each other during recombination (Figure 
1.1). HJ was initially introduced to describe the exchange between homologous 
chromosome: the HJ formed between two DNA molecules migrate to conduct strand 
exchange between them until its resolution (20). This hypothesis captures the nature of 
genetic exchange between homologous partners, and it is later on adopted in multiple 
theoretical models to explain DNA recombination in various circumstances, such as 
Meselson-Radding model, DSBR model and restoration of replication fork (7, 92). To 
date, the existence and dynamic of HJ during recombination have been illustrated by 
many genetic, cytological and molecular evidences in meiosis as well as mitosis (20, 44, 
93, 94). The gene conversion events are most time unidirectional, either through gap 
repair or by repair of asymmetric hDNA. Sometimes in meiosis, when sequence 
divergence exists between the homologous partners, the HJ mediated strand exchange 
may leave hDNA intermediate on both molecules with mismatched nucleotides, which 
are repaired by MMR to produce reciprocal conversion tract (7). Without the MMR 
responsible for the latter process, information from both strands will be visible after post 
meiosis segregation of the hDNA (54, 95). Though HJs were found in mitosis at much 
low frequency, it is conceivable that it can mediate similar strand exchange in mitotic 
cells (93).
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 While HJs are adopted in various models explaining usually rare mutual exchange 
between homologous DNA sequences, SDSA serves as a prominent and simple way in 
which the broken DNA utilize homologous partner for repair without altering the HR 
template (Figure 1.1) (17, 18). Considering the recombination frequency and homology 
requirement in these two types of recombination, strict homology requirement appears to 
be required in resolution of HJ: it is likely that the resolution of HJs need significant 
amount of homology to properly anneal the four strands for recognition and procession. 
In contrast, the SDSA in mitosis may anneal strands with mismatched nucleotides, 
showing sloppy choice in resolution site.  
 Alternatively, chromatin structure around DSB site is modified due to DNA 
damage response (DDR), for example, the local phosphorylation of H2AX on chromatin 
or other potential structural changes brought by DDR factors (1, 96). Therefore, the 
homology requirement could be dramatically different from that proximal to a DSB 
lesion. In another word, the homology requirement for resolution may be relaxed by 
nearby DSB.  
 To validate aforementioned possibilities, it is critical to collect and analyze the 
recombinant clones solely from HJs resolution. Analyzing existing recombination events 
in prior chapters does not lead to an unequivocal answer. The cause of spontaneous 
recombination is still debatable and it might be achieved through rescuing replication 
fork or a two ends DSB; while DSB repair could take either SDSA or DSBR pathway. 
After scrutinizing all possible pathways of HR, it is found that when dHJs resolution 
occurs, the sequence of homologous template (donor) could be altered and converted to 
recipient sequence. As demonstrated in Dr. Szostak’s DSBR model and his supportive 
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data studying HR between gapped plasmid and chromosomal gene, this particular type of 
events has been detected at low frequency in yeast mitotic cells (7, 97).  
 As shown in Chapter 2 and 3, when HR event started near a homeologous 
sequence, the broken DNA received homeologous conversion tract through either gap 
repair or repair of hDNA. Conversely, the HR template may gain mismatched hDNA by 
taking recipient strand during HJs migration. If aforementioned HJ branch migration and 
resolution in DSBR model do generate desired recombinant clones with altered donor, 
the conversion tract on donor would present the footprint of branch migration between 
initiation site and resolution site of HJ. If the HJs need adequate homology to resolve, the 
conversion tract should always contain the whole homeologous region, the same as 
observed in spontaneous recombination, while if DSB reduce the homology requirement 
in resolution, the conversion tract on donor will have conversion tract contain partial 
homeologous region as well as whole homeologous region.  
 In order to obtain recombinant clones from HJs resolution, and compare them 
with previous results from pBWW substrates, new substrate was designed to recreate the 
same condition for potential HR events (Figure 4.1). In previous chapters, the full length 
HSV1-TK sequence was broken at the I-SceI site (nucleotide 1215), and the invasion was 
primed by its broken ends toward a 0.8 Kb hybrid donor, which has HSV2-TK 
homeologous sequence about 50 bp away from the invasion site (nucleotide 1215). In the 
new design, though a 2.5 Kb full length tk gene serves as hybrid donor, and the I-SceI 
site resides in the 0.8 Kb HSV1-TK recipient, after breakage, it is the same HSV1-TK 
DNA ends invading a similar template with homeologous sequence about 50 bp from the 
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invasion site. And most importantly, the HR events are driven by the same amount of 
homology: nucleotide 623 to 1459 of HSV1-TK.   
 To demonstrate the similarity in HR events happening in pBWW33 and new 
pLS4 substrate, their HSV-1 TK recipients are aligned to their hybrid donors respectively 
(Figure 4.1): the I-SceI site in recipient is always aligned against the downstream HSV-1 
TK sequence in hybrid donor, about 50 bp away from the border of HSV2-TK sequence. 
In both substrates, HR events rely on the 0.8 Kb homology shared by donor and recipient.  
 The original 2.5 Kb HSV1-TK fragment was modified extensively to make the 
hybrid donor for substrate pLS4. The donor would have mismatched nucleotides M33-
M8 of pBWW33 substrate, and then 5 point mutations afterward introducing a BamHI 
recognition site and two stop codons. As a result, the hybrid donor has a cluster of 31 
mismatched nucleotides about 50 bp upstream of the I-SceI insertion site (nucleotide 
1215), compared with HSV1-TK recipient. In this arrangement, the invasion and repair 
events would be almost the same as in substrate pBWW33, where the broken HSV1-TK 
strands invade a 0.84 kb hybrid donor at a site 50 bp away from a cluster of 33 
mismatched nucleotides.  
 For the new substrate pLS4, HR or NHEJ events ligating the broken recipient 
would not necessarily bring HAT resistance to the host cells. Recombinant clone from 
DSB repair will grow up only when the HR restore the broken recipient through dHJs 
resolution, and the HSV2-TK sequences together with stop codons in 2.5 Kb hybrid 
donor are converted to HSV1-TK recipient after repair of hDNA intermediate. 
Sequencing the HR donors in this type of recombination events will reveal the conversion 
tracts on participating HR donor, which in turn tells the range of HJs migration.  
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Figure 4.1 Alignment of donor and recipient in substrate pBWW33 or pLS4. 
Donor and recipient in pBWW33 and pLS4 are placed side by side to show the similarity 
in recombination events happened between these two substrates. 
The white rectangles represent HSV-1 TK sequences and the striped rectangles represent 
HSV-2 TK sequences. The recombination events happened within pBWW33 and pLS4 
are similar because they have hybrid donor and HSV1-TK recipient sharing the same 
length of homology. The HSV2-TK sequence in donor of pLS4 starts from the same 
position as in hybrid donor of pBWW33, and it possesses the same mismatched 
nucleotides M33 to M8 in donor of pBWW33. The 5 additional mismatched nucleotides 
introduced a BamHI site and 2 stop codons right after HSV2-TK sequence. 
  
 124 
Materials and Methods: 
 Structure of substrates: The new substrate pLS4 has a 2.5 Kb hybrid tk donor in 
tandem with a truncated HSV1-TK recipient. The hybrid donor is full length HSV1-TK 
sequence carrying a patch of HSV-2 TK sequence, an engineered BamHI recognition site 
and two engineered stop codons in middle of its coding sequence (CDS); and expression 
of donor’s encoded thymidine kinase is aborted by these two stop codons. The new 
truncated recipient is made of 837 bp HSV-1 TK sequence (nucleotide 623-1459, the 
same length and location as the hybrid donor of pBWW33), and it has 30 bp I-SceI 
recognition site at the position 1215 (the same I-SceI insertion site as in recipient of 
pBWW33). The positions of these nucleotides are all numbered the same as in the 
Wagner’s paper, as described in Chapter 2 (74). 
 Substrate pLS4 was linearized by endonuclease ClaI before transfection, and the 
restriction map of the linearized substrate is show in Figure 4.3. To check the 
completeness of these tandem repeats after genome integration, endonuclease BamHI or 
HindIII are used to digest genomic DNA for Southern blot. 
 Construction of substrate pLS4: The backbone of pLS4 is from pBWW16, and 
HSV1-TK recipient and donor were amplified either from pTK1 (carry complete HSV-1 
TK gene sequence), pBWW16, or previously obtained recombinants pBWW33-67-1-1 
(nucleotide sequence 968-1167 in its HSV-1 TK recipient was substituted by HSV-2 TK 
sequence). The cloning protocols were the same as described in Chapter 2 and the work 
flow was described in following paragraphs. 
 At the beginning, pBWW16 was cut by HindIII, and its 8.2 Kb backbone was 
purified and ligated to generate pLS2. To make pLS1, 0.87 Kb HSV1-TK recipient   
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Figure 4.2 Mismatched nucleotides between recipient and donor of substrate pLS4. 
Compared with donor, the recipient (top sequences) has 30 bp oligonucleotide insertion 
including 18 bp I-SceI recognition site (underlined). Totally 31 mismatched nucleotides 
exist between donor and recipient (marked with * in the alignment), and they are 
numbered from m1 to m31 depending on their closeness to the I-SceI insertion site, the 
same as they were labeled in pBWW33. The mismatched nucleotides m31 to m6 in pLS4 
are correspondingly M33 to M8 in pBWW33. And 5 more different nucleotides, m1 to 
m5, introduce BamHI site and two stop codons (all in bold, between nucleotide 1127 and 
nucleotide 1155). Nucleotide positions are marked below the sequence with “^”, and 
annotated in parentheses if they are corresponding to a mismatched nucleotide in 
pBWW33 or pLS4.  
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Figure 4.3 Structure and restriction map of substrate pLS4. 
The linearized substrate is 9.1 Kb, and it has a 0.9 Kb HSV1-TK recipient flanked by 
HindIII recognition site as well as a 2.5 Kb hybrid donor carrying two BamHI site. The 
Neo cassette between the two repeats is for selection purposes in both prokaryotic cells 
and eukaryotic cells. 
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 (623-1459) containing I-SceI insertion at position 1215 was amplified from pBWW16 
using AW130 and AW93, and then the PCR product was cut by HindIII and purified for 
ligation. Substrate pLS2 was cut by HindIII, treated by bacterial alkaline phosphatase 
(BAP), gel purified and ligated with aforementioned 0.87 Kb recipient fragment to 
generate pLS1. In subsequent cloning steps, the plasmid backbones were always treated 
by SAP and gel purified for ligation with insertion fragment. 
 The 2.5kb full length hybrid donor was cloned into pLS plasmids through two 
steps of PCR and ligation, during which HSV2-TK sequence, BamHI recognition site and 
2 stop codons were introduced by PCR primers and selected templates.    
 First, 1.1Kb HSV1-TK sequence was amplified from pTK1 using AW146 (5’ 
CAG CCA GGA TCC TTC CGT AGG CCT GAC ACA TCG ACC G 3’, matches HSV1-
TK nucleotides 1132-1162) and AW147 (5’ AAG TAG GGA TCC AGA TCT CGA GCT 
TGG CCG TGG TG 3’, matches the 3’ end of the 2.5Kb, BamHI flanked HSV1-TK 
fragment). This fragment contains partial coding sequence of HSV1-TK and downstream 
non-coding sequence. BamHI site and 2 stop codons were introduced at the 5’ end of the 
fragment by primer AW146, while BglII was introduced at the 3’ end by primer 147. The 
amplified PCR product was cut sequentially by BglII and BamHI, and then purified for 
ligation with 6.6 Kb plasmid backbone from BamHI digested pLS1. The ligated pLS3 has 
a 0.87 Kb I-SceI disrupted recipient and a 1.1 Kb HSV1-TK donor tail with 2 stop codons 
in coding sequence.  After ligation, the intact BamHI site at the 5’ end of the insertion is 
followed by 2 stop codons while the BamHI site at the 3’ end was destroyed through the 
re- ligation with BglII digested sticky end.  
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Figure 4.4 Work flow to construct substrates pLS2. 
Plasmids, primers and restriction sites in use are drawn and labeled accordingly in the 
figure: the white bars in donors and recipient are HSV-1 TK sequences, while the solid 
bars in these donors are HSV-2 TK sequences. Donor fragment in pBWW16 was excised 
and the remaining plasmid was ligated to produce pLS2. pLS2 was then used to build 
plasmid pLS1.  
 129 
 
Figure 4.5 Work flow to construct substrates pLS1. 
A 0.9 Kb, PCR amplified recipient was inserted into the unique HindIII site of pLS2 to 
produce plasmid pLS1, which was used to build plasmid pLS3.    
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Figure 4.6 Work flow to construct substrates pLS3. 
The plasmids were labeled the same way as in Figure 4.5. The 2.5 Kb TK fragment was 
excised from pLS1 by BamHI, and a 1.1 Kb, PCR amplified donor’s downstream 
fragment was inserted into the open BamHI site to produce plasmid pLS3, which was 
used to build plasmid pLS4.  
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Figure 4.7 Work flow to construct substrates pLS4. 
The plasmids were labeled the same way as in Figure 4.5. A 1.4 Kb, PCR amplified 
donor’s upstream fragment was inserted into the unique BamHI site of pLS3 to produce 
plasmid pLS4. pLS4 is the recombination substrate used in subsequent DSB repair 
experiments.  
 132 
 Second, 1.4Kb HSV1-TK sequence containing promoter and partial coding 
sequence was amplified from clone pBWW33-67-1-1 using AW52 (matches plasmid 
backbone upstream of BamHI site) and AW148 (5’ CCG GAA GGA TCC CCA GGA 
CCA GGT TCG TGC CGG 3’, matches HSV1-TK nucleotides 1131-1111). The PCR 
product was cut by BamHI and purified for ligation with 7.7 Kb backbone from BamHI 
digested pLS3. Therefore, the pLS4 has a 2.5 Kb hybrid donor with a stretch of HSV2-
TK sequence followed by 2 stop codons. 
 Cell culture: Mouse Ltk- cell line and its derivative cell lines are cultured as 
described in Chapter 2.  
  Cell line establishment: Mouse Ltk- cells were transfected with pLS4 through 
electroporation and the cells with stable substrate integration were selected using G418. 
The electroporation, selection and screening process were the same as described in 
Chapter 2. Cell lines were chosen for further experiments if they have intact tandem 
repeats and the signal indicates a single copy integration of the substrate. 
 Collection of DSB repair recombinant clones: To collect DSB repair 
recombinants, electroporation of selected cell lines with pSce plasmid and subsequent 
HAT selection were carried out as described in Chapter 3. HAT resistant clones were 
ready to pick after 2 -3 weeks in selection, and the clone frequencies or HeR clone 
frequencies were calculated the same as in Chapter 3.  These clones were picked and 
cultured for sequence analysis as described in Chapter 2. 
 PCR amplification and sequencing: The PCR and sequencing procedures were 
described in Chapter 2.  
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 Analysis of DSB repair recombinants: All alignments were carried out in 
SciEdCentral to compare recombinant sequence with reference sequences (engineered 
hybrid donor sequence and HSV-1 TK recipient sequence). Through alignment, 
conversion of mismatched nucleotide from HSV2-TK to HSV1-TK sequence on donor 
would be revealed. Moreover, nucleotide callings at every mismatched postilion (m1 to 
m30) were checked manually in chromatography. 
Results: 
 Construction of substrates: the HindIII flanked donor was removed from 
pBWW16 to generate pLS2. Compared with pBWW16, new pLS2 is linearized by 
HindIII without releasing 0.7 kb fragment. pLS2 was confirmed through HindIII 
digestion in Figure 4.8. 
 After 0.9 kb I-SceI disrupted HSV1-TK recipient was amplified from pBWW16’s 
recipient, it was then ligated into the unique HindIII site of pLS2. Figure 4.9 confirmed 
successful insertions of 0.9 Kb HSV1-TK recipient in 4 pLS1 plasmid: successful 
insertion was observed in pLS1-7 to pLS1-10 (Lane 3 to Lane 6). Recipient in pLS1-8 
has the correct sequence and direction according to DNA sequencing data, therefore, the 
plasmid was renamed as pLS1 and used in following experiments.  
 The downstream 1.1 kb HSV1-TK sequence was amplified from pTK1 and 
inserted into the BamHI site of pLS1. If the PCR product was corrected inserted, new 
plasmid will show a longer vector fragment, and a 1 kb plasmid fragment after ClaI and 
BamHI double digestion, as shown in Lane 3 of Figure 4.10. Double digestion by ClaI 
and BamHI revealed pLS3-16 clone has 1.1 Kb HSV1-TK insertion with right direction 
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(see Figure 4.10). plasmid pLS3-16 was confirmed by sequencing and renamed as pLS3 
for subsequent experiments.  
 At the last step, 1.4 kb upstream HSV1-TK sequence was amplified from a 
recombinant clone carrying 33 mismatched nucleotides, and then inserted into the unique 
BamHI site of pLS3. BamHI digestion was used to revealed pLS4 clones with correct 1.4 
Kb HSV1-TK insertion (see Figure 5.11). Successful insertions were found in pLS4-5B, 
pLS4-6B and pLS4-8B. After sequencing, plasmid pLS4-6B has the insertion with 
correct sequence and direction and finally renamed as pLS4.  
 Establishing cell lines pLS4: pLS4 was linearized at the unique ClaI site before 
transfection and the substrates was transfected into mouse Ltk- cells through 
electroporation as described before. Totally 29 G418 resistant clone (pLS4-1 to pLS4-29) 
were picked, cultured and screened on Southern blots for single copy integration of the 
substrate.  
 Screening cell lines with single copy integration of substrate: Genomic DNA 
from each clone was digested using HindIII or BamHI for Southern blot. In HindIII 
digestion, the cell line with intact substrate should show a DNA fragment lining up with 
the 0.9 Kb recipient, and a junction fragment larger than 6.9 Kb, the size of remaining 
non-recipient fragment. Similarly, in BamHI digestion, the cell line should have a DNA 
fragment lining up with a 1.4Kb donor fragment, and a junction fragment larger than 6.3 
Kb. All cell lines in use were checked by both digestion to make sure they have intact 
donor and recipient.  
 Selected Southern blot images of pLS4 stably transfected cell lines are shown in 
Figure 4.12 and Figure 4.13. The HSV-1 TK probe recognizes the HSV-1 TK recipient as   
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Figure 4.8 Identification of plasmid pLS2 through HindIII digestion. 
Lane 1, HindIII digested pBWW16. Lane 2, HindIII digested pLS2. The 8.3 Kb and 0.7 
Kb labels point to the backbone fragment and donor fragment of digested pBWW16. 
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Figure 4.9 Plasmids pLS1 were confirmed with 0.9 Kb recipient insertion through 
HindIII digestion. 
Lane 1 to 7, HindIII digestion of plasmid from clone pLS1-5 to pLS1-11.   
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Figure 4.10 Plasmid pLS3 with 1.1 Kb donor insertion was confirmed by BamHI and 
ClaI double digestion. 
Lane 1 to 8, double digested plasmid from clone pLS3-14 to pLS1-21.  
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Figure 4.11 Plasmids pLS4 with 1.4 Kb donor insertion were confirmed by BamHI 
digestion. 
Lane 1 to 8, BamHI digestion of plasmid from clone pLS4-1B to pLS4-8B.  
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Figure 4.12 Identification of pLS4 cell lines with correct substrate integration by HindIII 
digestion. 
The size of recipient was examined as described above. Lane 1 to 15, HindIII digested 
genomic DNA of pLS4 stably integrated cell lines: pLS4-2 to pLS4-11, pLS18, pLS4-20, 
plS4-21, pLS4-23 and pLS4-26. Cell lines pLS4-5 (lane 4), pLS4-7 (lane6) and pLS4-23 
(lane 14) were chosen for following experiments. 
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Figure 4.13 Identification of pLS4 cell lines with correct substrate integration by BamHI 
digestion. 
The size of donor fragment was screened as described above. Lane 1 to 14, BamHI 
digested genomic DNA of pLS4 stably integrated cell lines: pLS4-3 to pLS4-11, pLS18, 
pLS4-20, plS4-21, pLS4-23 and pLS4-26. Cell lines pLS4-5 (lane 3), pLS4-7 (lane5) and 
pLS4-23 (lane 13) were chosen for following experiments. 
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well as the hybrid donors. Cell lines were chosen for future experiments only when they 
have intact donor and recipient fragments.  
  The Southern blot results of selected cell lines pLS4-5, pLS4-7, pLS4-23 were 
labeled in these figures (Figure 4.12 and Figure 4.13). The plasmid digestions on these 
blots were not as expected, and failed to indicate the correct molecular weight. Therefore, 
the 6.6 kb MW maker was used to estimate the size of junction fragment. Junction 
fragments in chosen cell lines were much larger than 6.6 kb, supposedly having intact 
donor and recipient. 
 Collection of DSB repair recombination events: for each selected cell line, 4 
electroporation experiments were initially attempted to collect DSBR recombinants. All 
three cell lines have similar plating efficiency (around 30%) after electroporation, while 
only pLS4-7 generated HAT resistant clones within 4 attempts. Totally, 23 resistant 
clones were selected from roughly 20 million cells of pLS4-7 after I-SceI expression. 
 When electroporation was carried out on cell lines pLS4-5 and pLS4-23, 5 million 
untreated cells were plated in HAT selection to check potential existed spontaneous 
recombinant. No recombinant grew up in these selections either. Four mock 
electroporation experiments were carried out later on for pLS4-7 cell line using 1 X TE 
instead of pSce, while surprisingly, 83 resistant clones grew up in HAT selection from 20 
million cells.  
 The hybrid donor sequences in pLS4-7 cell line, and 4 resistant clones from pSce 
transfection were amplified and sequenced as before. The results show that they all carry 
the original hybrid donor sequence with stop codons. So far, no induction of DSBR 
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recombinants was observed in examined cell lines and no desired DSBR recombinants 
were recovered in performed experiments.  
Discussion:  
 Designed substrate to collect recombinants from dHJs resolution:  As 
proposed in introduction, current recombination substrate was designed to collect only 
recombinant clones from dHJs resolution. Analysis of this type of recombinant could tell 
whether HJs resolution requires proper homology to resolve, and whether DSB affects 
homology requirement of HJ resolution.   
 Ideally, if DSB-induced recombination have HJs established in nearby homology, 
the HJ may anneal the homeologous sequences into mismatched hDNA. Upon 
establishment, as long as HJs need proper homology to resolve, they have to resolve 
outside the homeologous region and include the whole homeologous sequences in the 
conversion tract.  
 Failure in recovery of desired DSBR recombinants: Because induction of DSB 
induced recombinant clones was not observed across examined cell lines, the attempts 
failed to collect recombinants solely from dHJs resolution during DSB repair.  
 Without obtaining conversion tracts on donor through Holliday junction 
resolution, it remains unclear what relaxed homology requirement during DSB repair, the 
nearby DSB or the pathway choice of SDSA.  
Explanation and future direction: In meiosis, reciprocal conversion of two 
participating DNA molecules were occasionally recovered after HR, while there are not 
many reports studying the possible change in HR template in mitosis. In Dr. Orr-weaver 
and Dr. Szostak’s original study on DSB-induced recombination between gapped plasmid 
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and chromosome, 3 out of 72 recombination events possibly changed the chromosomal 
donor after they repaired the gapped plasmid through gene conversion (98). However, 
this phenomenon was barely reported in mitotic cells afterward even if periodically 
observed. 
The desired gene conversion events changing donor as well as the recipient DNA 
are expected to occur at low frequency during mitosis. First, the predominant HR 
pathway in DSB repair is assumed to be SDSA, and only a small fraction of HR would 
progress into HJs intermediate (19). Second, Holliday junction dissolution could resolve 
dHJs without altering donor (21), and then the rest events may diverge into crossover or 
gene conversion events with even smaller probability.  
 MMR may reduce the chance to collect desired gene conversion events. Even HJ 
migration and resolution do leave recipient’s DNA strand in donor, in the form of hDNA 
intermediate, it may be restored back to original donor sequence. If the MMR prefers to 
repair the hDNA intermediate toward the original sequence, it is even harder to recover 
the gene conversion events on donor without intervention in MMR. Since it is 
demonstrated that the deficiency of MMR does not alter the resolution site in 
spontaneous recombination or DSB-induced recombination (Chapter 3), depleting MSH2 
could be attempted next to preserve information from both strands of the hDNA 
intermediate after HR. Ideally, after HJ resolution, hDNA intermediates left on donor are 
not corrected by MMR, and their exogenous recipient strand would be preserved and 
segregated to produce viable recombinants with conversion tract on donor sequence. 
 As discussed in introduction, the desired recombinants from HJ resolution are 
probably too low to be detected in current experimental condition, and multiple rounds of 
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electroporation may be needed to collect the expected recombinants. Second, if the MMR 
prefers restoring donor’s hDNA toward its original sequences, the desired recombinants 
are not recoverable in current condition. Depleting MSH2 may be attempted next to 
reveal potential sequence change in donor brought by recipient through dHJs resolution.
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CHAPTER 5 RECQ4 AFFECTS THE PATHWAY CHOICE IN 
HOMOLOGOUS RECOMBINATION DURING DSB REPAIR 
 RecQ4 helicase belongs to a conservative DNA helicase family which shares 
homology with RecQ of bacteria (39, 99). There are five human RecQ like helicase, 
while three of them, WRN, BLM and RecQ4 are directly linked to genetic diseases 
characterized by genome instability, premature aging or cancer predisposition. 
Deficiencies in RecQ helicases have such great impacts on genome maintenance that they 
have been postulated to play roles in DNA replication, DSB-induced recombination and 
telomeric maintenance. Current research and opinions on their functions are illustrated in 
following paragraphs.  
 Werner syndrome arises from deficiency in RecQ helicase WRN, and the patients 
show premature aging and cancer predisposition (39). WRN has multiple catalytic 
activities on DNA, including 3’ to 5’ DNA helicase, DNA dependent ATPase, 5’ to 3’ 
exonuclease, and strand annealing. In vitro experiments show that WRN interacts with 
DNA-PKcs and inhibits its function unless assembled with DNA and Ku70, while 
conversely, DNA-PKcs also phosphorylates WRN in vitro and in vivo, though the impact 
is not fully understood yet (65). Besides these direct interactions with NHEJ core 
components, WRN has been proven critical in NHEJ events: WRN’s deficiency brings 
more repair events with large deletions, indicating delayed NHEJ and a shift to A-NHEJ 
(31, 100). A recent report revealed more details of WRN’s function and its effect on 
NHEJ: study of NHEJ and A-NHEJ events in WRN deficient cells suggests that WRN 
 146 
promotes NHEJ, reduces A-NHEJ, and decreases the use of microhomology in end 
joining. WRN’s catalytic activities, exonuclease and helicase are critical to NHEJ while 
its solely presence inhibits A-NHEJ. Moreover, WRN significantly reduces CtIP’s 
recruitment to DSB site, and inhibits progressive resection needed for HR and A-NHEJ 
(41). Without WRN, the repair shifts toward A-NHEJ pathway, which promote telomere 
fusion and chromosomal translocation. Consistent with existing reports, nearly half of 
NHEJ events in WRN deficient cells collected in our laboratory have chromosomal 
rearrangements, which were confirmed by Southern blot and cytological analysis 
(unpublished data). 
 Bloom syndrome arises from mutations in BLM helicase, and BLM syndrome 
patients have cancer predisposition in multiple tissues, while their cells have obvious 
cytogenetic abnormality showing high frequency of SCE during mitosis (12, 13, 70). 
Without proper function of BLM, crossover becomes preferred outcome of HR in BLM 
deficient cells (70). As described before, crossover events in meiosis promote genetic 
diversity and ensure correct separation of homologous chromosomes, however, when 
somatic cells are forced to repair lethal DSB lesions, crossover is neither necessary nor 
optimal outcome. In BLM deficient cells, elevated crossover between homologous 
chromosome is conceivable, which may facilitate LOH and contribute to the development 
of a wide spectrum of cancer (9, 101).  
 The similar roles BLM plays at two HR steps explain the bias toward crossover in 
BLM deficient cells. First, BLM could unwind newly synthesized DNA strand from its 
template, allowing it to anneal back to the other resected DNA strand for ligation (102, 
103). Therefore, BLM directs HR events toward the SDSA pathway instead of a dHJs 
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intermediate, which has great potency to generate crossover (16, 19). Similar to 
aforementioned function, BLM may cooperate with MMR to prevent homeologous 
invasion at this earlier step of HR. Sgs1 (yeast homolog of BLM) interacts with MMR’s 
components, recognizes and efficiently unwinds strand annealing with mismatched 
nucleotides during SSA (68),  so at strand invasion step, similar mismatched hDNA 
within D-loop intermediate is likely unwound the same way. Although helicase UvrD of 
E.coli interacts with MutS-MutL and unwinds the hDNA containing nucleotide 
mismatches in vitro (87), the choice of helicase in mammalian cells could be different 
and still need further investigation.  
 Secondly, BLM propels convergent movement of dHJs to hemicatenated DNA, 
with two DNA duplexes conjoining through a single-strand interlock, and then the 
hemicatenated linkage gets resolved by decatenation instead of HJs resolution (21, 99). 
Hemicatenated or catenated structure frequently arises in DNA replication or DNA 
recombination, and it needs prompt unlocking for subsequent segregation (104). In yeast, 
epistatic effect was observed between sgs1, topoisomerase IIIα and RIM1 in resolving 
this particular replicative lesion, which confirmed sgs1’s participation in DNA 
decatenation (105–107). In following up biochemical assays, the complex was 
reconstituted to drive convergent branch migration of HJs along DNA substrates and 
detach DNA molecules in catenation (104, 108, 109). Similarly in mammalian cells, 
BLM mediates the convergent branch migration of dHJs to a single-strand interlock, 
which is readily resolved by associated topoisomerase IIIa and RMI1-RIM2 (22), 
therefore, BLM manages to reduce crossover events during HR. 
 148 
 RecQ4 deficiency causes Rothmund-Thomson syndrome, and the patients have 
skeletal abnormalities and predisposition to malignant tumors (110). Cytological 
evidences show RecQ4 deficient cells have issues in genome stability and proper 
segregation of chromosome (111). RecQ4 participates in telomeric maintenance, and 
protects chromosomes from telomere erosion. RecQ4 is also assembled in initiation 
complex for replication (112). Overexpression of RecQ4 has been found in prostate 
cancer, and its expression level correlates with the tumor grade, while depletion in RecQ4 
reduces the tumor growth and invasiveness (113).  
 Moreover, RecQ4 participates in DSB repair. RecQ4 moves to the repair loci 
earlier than other RecQ helicase members (BLM or WRN) (110) and the recruitment 
depends on MRE11 (15). RecQ4’s unwinding activity is vital for the 5’ end resection and 
it also helps to recruit CtIP to the repair site (15). RecQ4 also shows high affinity to 
branched DNA substrate, especially HJs structure, therefore, it could help to resolve 
DNA intermediates during replication or recombination (114).  In Arabidopsis, RecQ4 is 
reported with anti-crossover activity in meiosis similar to Top3a or FANCM (115). 
 Though suggested with multiple functions, RecQ4’s role during DSB repair still 
lack systematic studies. Limited studies on RecQ4 in DNA repair were conducted in 
mammalian cells, especially possible impact on DSB repair outcome. A recent published 
paper described the interaction and potential cooperation between BLM and RecQ4 
supported by cytological evidence (116), In their paper, SCE events in control cells and 
patient’s BLM deficient cells were briefly compared before and after RecQ4 knockdown. 
Due to the chronic stress BLM deficient cells went through, potential genetic changes 
make them not optional experimental system for further manipulation. The comparison of 
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recombination events immediately after the protein depletion, as conducted in current 
chapter, would be better to avoid potential distortion from genetic background. Moreover, 
the use of substrate pLB4-11 could present changes in multiple pathways for DSB repair, 
and also subtle details of HR. If RecQ4 plays roles in DSB repair and affects the repair 
outcome, different composition of DNA recombination events would be expected in 
RecQ4 deficient cells. 
 pLB4-11 cell line has a chromosomal integrated recombination substrate pLB4, 
which was designed to collect all types of DSB repair events.  As shown in Figure 6.1, 
pLB4 has a 2.5 kb full length tk gene and a 3.9 kb tk-neo fusion gene in tandem, and they 
serve as donor and recipient in a HR events. The 2 kb DNA sequence separating tandem 
repeats contains hygromycin resistance gene, which was used in substrate integration. An 
I-SceI recognition site was engineered into the tk-neo fusion gene, and these 22 bp 
oligonucleotide insertion shift the reading frame, so the tk-neo gene only produces a 
truncated thymidine kinase protein. Initially the downstream neo gene is not expressed 
due to the shifted reading frame of tk gene, until a recombination event restores the 
correct reading frame for the fusion gene.  
 When I-SceI introduce a DSB into the tk-neo fusion gene, cells have chance to 
rejoin the two broken ends and sometimes, regain the original reading frame for the 
fusion gene. Therefore, DSB repair events may allow host cells to survive G418 
selection, and form clones for sequence analysis. Reading frame could be restored in 
several ways. First, HR could direct the resected DNA overhang to the nearby 
homologous template, the tk gene sequence of donor, and the broken recipient sequence 
would get restored to a continuous HSV-1 TK sequence, allowing translation of tk-neo 
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fusion gene. The crossover events between donor and recipient would be recovered as 
well because the upstream donor has full length tk gene carrying intact promoter. Second, 
some NHEJ events may restore the reading frame to correctly translate neo gene. When 
the number of deleted nucleotides happens to be 3N+1 bp, the rejoined DNA sequence 
will resume the original reading frame, and the produced tk-neo fusion protein still render 
host cells G418 resistance even with polypeptide loss in tk region. Third, SSA may rejoin 
the broken DNA molecule through long stretch of homology shared by the two tandem 
repeats. These events cause fusion of the two tk sequences and loss of DNA sequence in-
between. For substrate pLB4, SSA events cause 2.4 Kb deletion and generate a 3.9 Kb 
fusion fragment. Technically, the recombinant clones from SSA events are 
indistinguishable from crossover events, since they both fuse the donor and recipient.  
 Restriction map in Figure 5.1 demonstrates the expected bands from endonuclease 
digested pLB4, and changes brought by different recombination events. If digested by 
BamHI, the original substrate or gene conversion product will show a 3.9 Kb recipient 
fragment and a 4.5 Kb junction fragment containing donor and hygromycin resistance 
gene. The NHEJ product have the same 4.5 kb junction fragment as original pLB4, while 
the recipient fragment would be smaller than 3.9 kb due to sequence deletion (not 
obvious with short deletion). The crossover or SSA events would fuse aforementioned 
two fragments into a 3.9 Kb “recipient” fragment, the only visible band on the blot. 
 To unveil the details of recombination events, thymidine kinase gene sequences 
from two different strains of type 1 herpes simplex virus were placed in pLB4.  Totally 
13 nucleotide polymorphisms exist between the tk genes in donor and recipient (see 
Figure 5.2). These 13 nucleotides were numerated by their position along the tk sequence.   
 151 
 
Figure 5.1 Restriction map of substrate pLB4 and possible recombinants. 
Recombination substrate pLB4 has two tandem repeats: the 3.9 Kb recipient of tk-neo 
fusion gene and the 2.5 Kb donor of tk gene. Recognition site of I-SceI was inserted into 
the tk sequence of the recipient. The 22 bp oligonucleotide insertion shifts the original 
reading frame and aborts the function of downstream neo gene. The restriction map of the 
gene conversion and crossover products is shown below. Adapted from Wang et al. 2016 
(70). 
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There are 4 mismatched nucleotides upstream of the I-SceI site: the first 3 mismatches 
cluster together about 400 bp away from the I-SceI site while the last one located within 
20 bp. The fifth nucleotide is 2 bp after the I-SceI site, and the rest 8 mismatches start 
200 bp downstream of the I-SceI site, spanning around 400 bp. The nucleotide 
polymorphism within tk-neo recipient helps to delineate NHEJ and HR events, because 
HR may convert recipient’s nucleotide to donor at these positions.  
Materials and Methods: 
 Transient knockdown of RecQ4, BLM or both in human fibroblast cell line 
pLB4-11: Transfections of RecQ4 siRNA were carried out using Qiagen HiPerfect 
Transfection Reagent following the supplier’s instructions. On the first day, 1.5 x105 cells 
were plated in 35 mm dish with 2.3 mL culture media (а-MEM supplied with 10% FBS). 
On the second day, 12 uL of 10 uM siRNA solution was mixed gently with 88 uL а-
MEM in 1.5 mL Eppendorf tube, and then with 12 uL HiPerfect Transfection Reagent. 
The mixture was gently vortexed and kept at room temperature for 10 minutes to allow 
formation of transfection complex. Afterward, the siRNA mixture was added drop-wisely 
onto the cells, and the dish was gently swirled back and forth to ensure even distribution. 
On the third day, the dish was refilled with fresh media 2-3 hours before the second 
siRNA transfection. The transfection procedure was the same as performed a day before. 
The calculated siRNA concentration is always 50 nM in RecQ4 knockdown experiments.  
 The double knockdown experiments employed the same procedure as described 
for RecQ4 knockdown experiments, while the amount of siRNA was adjusted 
accordingly. Control siRNA, BLM siRNA and RecQ4 siRNA were added at a final 
concentration of 75 nM, 25 nM and 50 nM in corresponding experimental groups, while   
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Figure 5.2 Mismatched nucleotides between donor and recipient in pLB4. 
Totally 13 nucleotide mismatches were highlighted and numbered in the sequence 
alignment. Bold font was used to show the 22 bp insertion with I-SceI recognition site 
capitalized. Adapted from Wang et al. 2016 (70). 
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in BLM and RecQ4 double knockdown group, two siRNA were added at the same 
concentrations as in their own knockdown groups. 
 All mentioned siRNAs targeting RecQ4 or BLM with commercial name 
FlexiTube siRNA, were bought from Qiagen. RecQ siRNA#2 (Cat. No SI00061852) and 
RecQ siRNA#3 (Cat. No SI00061859) target RecQ4 transcript in human cells. BLM 
siRNA#3 (Cat. No SI00000952) targets BLM transcript in human cells. A negative 
control siRNA not targeting human transcripts was also purchased from Qiagen (Cat. No 
1027310).  
 Recovery of DSB repair recombinant clones: To collect recombinant clones 
from DSB repair, pSce was electroporated into cells 24 hours after the second siRNA 
transfection. The cells were trypsinized from 35 mm dish, suspended in culture media 
and then counted on a hemocytometer. For each experimental group, 2.5 x105 cells were 
transferred into a 15 mL conical tube for electroporation while all the rest cells, 
approximately 3.5-4.5 x105 cells, were cultured in T25 for another day before lyzed to 
extract protein sample.   
  For transfection, the conical tubes containing 2.5 x105 cells were centrifuged at 
300 X g for 3 minutes. After removing the supernatant, the pelleted cells were suspended 
in 3 mL phosphate buffered saline (PBS), and then centrifuged as described above. The 
newly pelleted cells were suspended in 300 uL PBS before electroporation. To start the 
electroporation, 2.4 uL DNA solution containing 7.5 ug pSce plasmid, and then the 300 
uL cells suspension were added into a cuvette with 0.4 mm gap width. The DNA and 
cells were mixed together by pipetting 3 to 4 times. All electroporation experiments were 
carried out using Bio-Rad Gene Pulser set to 700 volts and 25 uF. Immediately after 
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electroporation, cells were transferred into a T25 with 5 mL culture medium, and they 
were incubated for two days before G418 selection. 
 The G418 selections were carried out at 1000 ug/mL from previous experience, 
and for an appropriate colony density, no more than 5 x104 cells were plated per T75 
flask. Discrete colonies usually formed within 14 days and they were randomly picked 
and cultured for further analysis.   
 Preparation of protein sample: The procedure to exact soluble protein samples 
was the same as described in Chapter 4. 
 Protein electrophoresis and transferring: The procedure has been carried out 
the same as described in Chapter 3. The transferring condition for BLM was described in 
previous paragraph but the transferring was set at 450 mA for 90 minutes. The 
transferring buffer for RecQ4 does not contain 0.1% SDS and the transferring was set 
100 volts for 90 minutes. 
 RecQ4 deficient lymphocyte cell lines AG18465 from Coriell Institute for 
Medical Research was used as negative control in western blotting, while BLM deficient 
human fibroblast cells GM08505 was obtained from NIGMS. 
 Western blot: The Western blot procedure was described in details in Chapter 4. 
The primary and secondary antibodies were both diluted at 1: 10, 000 to detect tubulin, 
while they were diluted at 1: 500 and 1: 25, 000 for RecQ4, or diluted at 1: 8, 000 and 25, 
000 for BLM. As instructed by the supplier, the blocking and incubation of RecQ4 
primary antibody were carried out in TBS solution with 5% BSA instead of 0.1% TBST  
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  Calculation of clone frequency: After clone picking, all T75 flasks were stained 
and the remaining clones were counted. For each experimental group, the total clone 
number was divided by the cells number in G418 selection to obtain the clone frequency. 
 PCR amplification: The PCR procedures was described in Chapter 2. AW85 and 
AW133 were used to amplify tk-neo sequence including the 13 nucleotide mismatches 
between donor and recipient, so any nucleotide change within the area would be revealed 
by DNA sequencing.  
 Sequencing and alignment: The sequencing procedure was described in Chapter 
3. Nucleotide sequences from these recombinant clones were aligned to recipient 
sequence and donor sequences for any nucleotide change using SciEdCentral. 
 Southern blot: The genomic DNA of these recombinant clones was digested by 
BamHI, and then separated on 0.8% agarose gel for Southern blot. The procedure was the 
same as described in Chapter 2. 
Results: 
 Knockdown of RecQ4 in human fibroblast cell line pLB4-11: Successful 
knockdown of RecQ4 was achieved in pLB4-11 cell line after two consecutive siRNA 
transfections. Figure 5.3 shows the RecQ4 expression in the RecQ4 knockdown 
experiment 1. Cellular RecQ4 expression in Mock (only treated with transfection reagent 
but without siRNA) and control siRNA group is high while its expression is barely 
detectable in RecQ4 siRNA #2 group and RecQ4 siRNA #3 group.      
  Figure 5.4 demonstrated that RecQ4 knockdown was performed successfully in 
second experiment. Moreover, the lane 6 was loaded with 15 ug protein sample from 
RecQ4 deficient cells and 15 ug protein sample from mock to mimic 50% RecQ4   
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Figure 5.3 Knockdown of RecQ4 was achieved in RecQ4 knockdown experiment 1. 
Protein extract (30ug) from following cells are shown in western blot: Lane 1, RecQ4 
deficient cells; lane 2, control siRNA group; lane 3, Mock; lane 4, RecQ4 siRNA #2 
group; lane 5, RecQ4 siRNA #3 group.  
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Figure 5.4 Knockdown of RecQ4 was achieved in RecQ4 knockdown experiment 2. 
Protein extract (30ug) from following cells are shown in western blot: Lane 1, RecQ4 
deficient cells; lane 2, control siRNA group; lane 3, Mock; lane 4, RecQ4 siRNA #2 
group; lane 5, RecQ4 siRNA #3 group; lane 6, mixture of 15ug protein sample from 
RecQ4 deficient cell and Mock. 
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expression. RecQ4 expression in both RecQ4 siRNA groups is obviously lower than the 
last lane, and it is estimated that 75% knockdown efficiency was achieved in both RecQ4 
knockdown groups. 
 Knockdown of RecQ4, BLM or Both in human fibroblast cell line pLB4-11: 
Knockdown of RecQ4, BLM or both was achieved in pLB4-11 cell line before transient 
expression of I-SceI. In first double knockdown experiment, as shown in Figure 5.5, 
knockdown of RecQ4, BLM and both in pLB4-11 were achieved in corresponding 
experimental groups. BLM and RecQ4 expression in parental cell line, untreated group 
and control siRNA group are equivalent; expression of BLM is dramatically lower in 
BLM siRNA group or RecQ4 and BLM double siRNA groups; and minor RecQ4 
expression is seen in RecQ4 siRNA groups or RecQ4 and BLM double siRNA groups. 
Tubulin served as internal control across these samples, and its image in Figure 5.5 came 
from the blot of RecQ4. Detection of Tubulin was not stable after protein transferring 
optimized for BLM (400 mA, 90 minutes with 0.1% SDS), however, stained acrylamide 
gel or stained nitrocellulose membrane after transferring showed that protein loadings 
were equal across samples (data not shown). RecQ4 and BLM expression in double 
knockdown experiment 2 are shown in Figure 5.6. BLM and RecQ4 expression were 
dramatically reduced in corresponding groups before induction of DNA DSB. 
 Collection of DSB-induced recombinant clones: To collect DSB-induced 
recombinant clones from these experimental groups, I-SceI was transiently expressed in 
cells through electroporation of pSce. After I-SceI introduced a DSB within the recipient, 
the broken DNA sequence may be repaired through HR, SSA or NHEJ events. If the  
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Figure 5.5 Knockdown of BLM and RecQ4 was confirmed in RecQ4 and BLM double 
knockdown experiment 1. 
Protein extract (30ug) from the following cells are shown in Western blot: Lane 1, cell 
line pLB4-11; lane 2, untreated group; lane 3, control siRNA group; lane 4, BLM siRNA 
group; lane 5, RecQ4 siRNA group; lane 6, RecQ4 and BLM double siRNA group; lane 
7, BLM deficient cells in top panel while RecQ4 deficient cells in middle and low panel 
The minor bands in RecQ4 panel are likely artifact due to intense signal of main bands.  
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Figure 5.6 Knockdown of BLM and RecQ4 was confirmed in RecQ4 and BLM double 
knockdown experiment 2. 
Protein extract (30ug) from the following cells are shown in western blot: Lane 1, 
untreated group; lane 2, control siRNA group; lane 3, RecQ4 siRNA group; lane 4, BLM 
siRNA group; lane 5, RecQ4 and BLM double siRNA group; lane 6, BLM deficient cells 
in top panel while RecQ4 deficient cells in middle and low panel. The minor bands in 
RecQ4 panel are likely artifact during film exposure due to intense signal.  
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DNA repair restores the correct reading frame for the tk-neo gene in recipient, the host 
cell will become G418 resistant and form recombinant clone. 
 DSB-induced recombinant clones from different experimental groups were 
recovered from two times of RecQ4 knockdown experiment and two times of RecQ 4 and 
BLM knockdown experiments. The clone frequencies and clones analyzed for each 
experimental group in each experiment are all listed in Table 5.1. Clone frequencies 
observed in these experimental groups range from 1.74X10-3 to 1.10X10-2. In each 
experiment, the clone frequencies across the experimental groups are close though cells 
may have different genetic background. The clone frequencies after RecQ4 knockdown 
are not different from those in control groups, with a p-value equals 0.413 from student’s 
test, while BLM knockdown brings slightly higher clone frequencies than the rest groups. 
 Categorization of DSB repair recombinant clones: Recombinant clones from 
DSB repair are categorized based on their recipient sequences. If the recipients are 
restored to continuous HSV-1 TK sequence, losing the 22 bp oligonucleotide insertion, 
these events are classified as HR. HR events also convert some of the 13 nucleotide 
mismatches to donor, and left a conversion tract in recipient for each HR event. The HR 
events are further separated into gene conversion and crossover events: crossover results 
in the fusion of donor and recipient, in addition to aforementioned 22 bp deletion and 
conversion of nucleotide. 
 If the recipient lost a stretch of nucleotide around the break site after end 
rejoining, they are categorized as NHEJ events. NHEJ events do not have any nucleotide 
mismatches converted to donor, and almost all NHEJ events have sequence deletions 
other than the loss of 22 bp oligonucleotide in HR. Occasionally, there might be NHEJ   
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Table 5.1 Clone frequencies and analyzed clones in knockdown experiments. 
 
Experiment Expt # Experimental group 
Clone 
frequency 
(10-3) 
Colonies 
analyzed 
RecQ4 knockdown 1 Control siRNA 1.74 58 
  Mock 3.73 55 
  RecQ4 siRNA #2 4.38 58 
  RecQ4 siRNA #3 2.76 51 
     
 2 Control siRNA 4.90 28 
  Mock 6.00 25 
  RecQ4 siRNA #2 4.38 27 
  RecQ4 siRNA #3 4.76 27 
          
RecQ4 and BLM  1 Untreated 6.19 28 
double knockdown  Control siRNA 4.15 26 
  BLM siRNA 6.60 27 
  RecQ4 siRNA 4.30 30 
  RecQ4&BLM siRNA 5.11 25 
     
 2 Untreated 8.38 16 
  Control siRNA 7.89 14 
  BLM siRNA 10.97 19 
  RecQ4 siRNA 6.55 19 
  RecQ4&BLM siRNA 9.54 18 
 
The clone frequencies were calculated as described in Materials and Methods.  
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events precisely removing the 22 bp oligonucleotide insertion without conversion of 
mismatches 5, which should be always converted in HR events due to its extremely 
closeness to the DSB site. 
 There are also complicated events which could not be simply assigned to either 
HR or NHEJ. Some sporadic events were found to be combinations of HR and NHEJ 
repair. They converted nucleotide mismatches to donor, and they also lost oligonucleotide 
other than the 22 bp engineered insertion.   
 Changes in DSB repair recombinant clones after RecQ4 knockdown: As 
shown on top in Table 5.2, the majority of DSB repair recombinant clones in RecQ4 
knockdown experiments are product of HR events, with nucleotide mismatches converted 
to donor. NHEJ events compose about one third of all DSB repair events, either in control 
cells or in RecQ4 knockdown cells: there are totally 118 HR events and 41 NHEJ events 
recovered in control cells, while 102 HR events and 45 NHEJ events in RecQ4 
knockdown cells. 
 The proportion of gene conversion in HR events changed after RecQ4 
knockdown. With reduced RecQ4 expression, more recombinant clones of gene 
conversion event appeared as the result. Polling data from two RecQ4 knockdown 
experiments, the control groups have 53 gene conversion recombinant clones and 65 
crossover recombinant clones, while RecQ4 knockdown cells have 60 gene conversion 
recombinant clones and 43 crossover recombinant clones. After RecQ4 knockdown, the 
increase of gene conversion events is substantial, however, the Fisher’s exact test 
comparing the ratio between HR subtypes in control and RecQ4 knockdown cells gives  
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Table 5.2 DSB repair recombinants in knockdown experiments. 
 
 
GC: gene conversion; CO: crossover; NHEJ: non-homologous end joining 
Recombinant clones were grouped into NHEJ, HR or complex events based on their 
recipient sequence as described before. If the events are combinations of NHEJ and HR, 
or have other rare alterations of sequence, they are grouped as complex events. 
  
Experiment 
Expt 
# 
Experimental group 
Clone 
analyzed 
GC CO NHEJ COMPLEX 
RecQ4  1 Control siRNA 58 19 25 11 3 
knockdown  Mock 55 14 19 19 3 
  RecQ4 siRNA #2 58 19 15 16 8 
  RecQ4 siRNA #3 51 20 16 11 4 
        
 2 Control siRNA 28 10 8 9 1 
  Mock 25 10 13 2 0 
  RecQ4 siRNA #2 27 9 6 9 3 
  RecQ4 siRNA #3 27 12 6 9 0 
             
RecQ4 and  1 Untreated 28 8 12 6 2 
BLM  Control siRNA 26 14 8 3 1 
knockdown  BLM siRNA 27 7 15 4 1 
  RecQ4 siRNA 30 13 10 7 0 
  RecQ4&BLM siRNA 25 12 9 3 1 
        
 2 Untreated 16 6 7 2 1 
  Control siRNA 14 7 4 2 1 
  BLM siRNA 19 5 14 0 0 
  RecQ4 siRNA 19 5 9 4 1 
  RecQ4&BLM siRNA 18 4 9 5 0 
 166 
p=0.0590, which states the difference is probably close to, however, not statistically 
significant. 
 Changes in DSB repair recombinant clones after BLM knockdown: in double 
knockdown experiments, DSB repair recombinant clones were collected from untreated, 
control, BLM knockdown, RecQ4 knockdown or BLM and RecQ4 double knockdown 
cells. In BLM knockdown groups, vast majority of HR events are crossover. Fisher exact 
test comparing HR subtypes before or after BLM knockdown gives p=0.0177, while the 
same test comparing HR subtypes before or after BLM and RecQ4 double knockdown 
gives p=0.6867. 
 Conversion tracts in gene conversion events: During gene conversion, all or 
part of the 13 nucleotide mismatches were transferred from donor to recipient. Table 5.3 
and 6.4 lists the transferring of donor’s nucleotides to recipient in these gene conversion 
events. Short conversion tracts dominate in all experimental groups, and most of them 
just converted mismatches 4 and 5, these two closest to I-SceI site. Some short 
conversion tracts only converted mismatches 5. All short conversion tracts described 
above are shorter than 600 bp (distance between mismatches 3 and 6). For each 
experimental group, recombinant clones with the same conversion tract are listed in one 
cell at the end of the chart.  
 The gene conversion tracts in RecQ4 and BLM double knockdown experiments 
are listed in Table 5.4 and they were labeled the same way as in Table 5.3. 
 Donor’s mismatched nucleotides left in fusion sequence after crossover 
events: In crossover events, fusion sequences always possess donor’s nucleotides before 
the I-SceI, and beyond that, they may have more donor’s nucleotides until crossover   
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Table 5.3 Gene conversion tracts in RecQ4 knockdown experiments. 
 
 
Expt. 
# 
 
Experimental 
group 
 
Converted 
nucleotides in GC 
events 
 
Clone 
number 
 
 
Clone name 
1 Control siRNA 4, 5 18 RC1J, RC1K, RC1O, RC1R, RC1S, RC1T, 
RC1U, RC1BA, RC1BN, RC1BP, RC1BQ, 
RC1BR, RC1BS, RC1BW, RC1CA, 
RC1CC, RC1CD, RC1CI 
4 to 11 1 RC1M 
Mock 5 2 RM1BG, RM1BY 
4, 5 12 RM1D, RM1F, RM1I, RM1J, RM1O, 
RM1Q, RM1BC, RM1BD, RM1BL, 
RM1BQ, RM1BV, RM1CI 
RecQ4 5 2 RR21T, RR21CD 
 siRNA #2 4, 5 15 RR21E, RR21F, RR21G, RR21Q, RR21U, 
RR21W, RR21BA, RR21BC, RR21BE, 
RR21BT, RR21BV, RR21BW, RR21BX, 
RR21CA, RR21CE  
1 to 5 1 RR21BI 
 
1 to 12 1 RR21O 
RecQ4 5 2 RR31V, RR31BA 
 siRNA #3 4, 5 14 RR31E, RR31I, RR31L, RR31N, RR31R, 
RR31T, RR31U, RR31W, RR31BE, 
RR31BG, RR31BM, RR31BT, RR31CA, 
RR31H  
1 to 5 2 RR31Q, RR31BY  
4 to 8 1 RR31A  
1 to 12 1 RR31M 
2 Control siRNA 4, 5 10 RC3W, RC3U, RC3T, RC3O, RC3J, RC3I, 
RC3H, RC3BD, RC3B, RC3A 
 
Mock 5 2 RM3M, RM3BC 
4, 5 6 RM3X, RM3Z, RM3V, RM3S, RM3J, 
RM3E 
4 to 11 1 RM3D 
4 to 12 1 RM3H 
RecQ4 5 3 R23Z, R23J, R23BC 
 siRNA #2 4, 5 5 R23S, R23P, R23L, R23G, R23C  
1 to 5 1 R23V 
RecQ4 5 2 R33Q, R33C 
 siRNA #3 4, 5 9 R33N, R33M, R33L, R33K, R33J, R33I, 
R33G, R33E, R33D  
1 to 5 1 R33T 
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Table 5.4 Gene conversion tracts of DSB repair recombinants in RecQ4 and BLM double 
knockdown experiments. 
 
Expt 
# 
Experimental 
group 
Converted 
nucleotides in 
GC events 
Clone 
number 
 
Clone name 
1 Untreated 4, 5 8 RBU1Y, RBU1R, RBU1Q, RBU1O, 
RBU1N, RBU1F, RBU1D, RBU1A 
Control siRNA 5 1 RBC1O 
4, 5 11 RBC1C, RBC1D, RBC1H, RBC1I, RBC1N, 
RBC1P, RBC1S, RBC1T, RBC1X, RBC1Y, 
RBC1BD 
4 to 10 2 RBC1BB, RBC1E 
BLM siRNA 4 5 4 RBB1K, RBB1L, RBB1P, RBB1Z,   
1 to 10 1 RBB1X 
1 to 11 1 RBB1I 
4 to 12 1 RBB1G 
RecQ4 siRNA 4, 5 11 RBR1BB, RBR1BC, RBR1BD, RBR1E, 
RBR1J, RBR1K, RBR1L, RBR1Q, RBR1R, 
RBR1S, RBR1X 
1 to 5 1 RBR1O 
4 to 12 1 RBR1W 
BLM&RecQ4 5 3 RBRB1B, RBRB1BC, RBRB1D 
 siRNA 4, 5 8 RBRB1A, RBRB1BD, RBRB1H, RBRB1I, 
RBRB1O, RBRB1R, RBRB1S, RBRB1Y  
4 to 12 1 RBRB1C 
2 Untreated 4, 5 6 RBU3B, RBU3F, RBU3H, RBU3L, RBU3P, 
RBU3T  
Control siRNA 4, 5 6 RBC3B, RBC3F, RBC3K, RBC3M, 
RBC3N, RBC3T 
4 to 7 1 RBC3C 
BLM siRNA 5 1 RBB3K,  
4, 5 4 RBB3F, RBB3G, RBB3O, RBB3Q 
RecQ4 siRNA 5 1 RBR3J,  
4, 5 3 RBR3C, RBR3I, RBR3N 
3 to 10 1 RBR3G 
BLM&RecQ4 5 2 RBRB3I, RBRB3Q 
 siRNA 4, 5 2 RBRB3L, RBRB3R 
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occurs. The possession of donor’s mismatched nucleotides in crossover events is listed in 
Table 5.5 and Table 5.6. The crossover events are categorized into multiple groups with 
the same amount of donor’s mismatched nucleotide: for example, crossover events that 
have donor’s nucleotide 1 to nucleotide 5 (right after I-SceI), and other crossover events 
that have specific amount of donor’s nucleotides. The possession of donor’s mismatched 
nucleotides in crossover events are not that different across experimental groups, and no 
obvious correlation was found between the number of donor nucleotides and the genetic 
background.  
 NHEJ events: The NHEJ events and their clone information are listed in Table 
5.7 and Table 5.8. For each clone, deletion size and potential usage of microhomology 
are described. The sequence deletions in NHEJ events range from 1 bp to 1018 bp, and 
they are always 3N+1 bp in length, which restored the original reading frame for the tk-
neo fusion gene. Frequently, microhomology was utilized to rejoin the broken DNA ends 
during NHEJ: if the broken ends of DNA go through end resection, short complementary 
DNA sequences could be revealed on both side and they are able to anneal for end 
rejoining. NHEJ events in pLB4-11 cells are not different from that in RecQ4 knockdown 
conditions: they are minority in DSB repair events. NHEJ events in pLB4-11 cells tends 
to be lower after BLM knockdown, however, it is not statistically significant compared 
with that in control cells. 
Discussion: 
 Types of DSB-induced recombination: NHEJ and HR are two prominent 
pathways to repair DNA double-strand breaks in mammalian cells (30, 32, 34). In 
agreement with previous reports, these two types of events comprise the vast majority of 
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Table 5.5 Position of donor’s mismatched nucleotides in crossover events (RecQ4 
knockdown experiments). 
 
Expt # Group Donor's 
nucleotide 
Clone 
number 
Clone name 
1 Control 
siRNA 
1 to 5 13 RC1V, RC1Y, RC1BC, RC1BG, RC1BH, 
RC1BL, RC1BM, RC1BT, RC1BU, RC1BZ, 
RC1CB, RC1CF, RC1CH 
1 to 8 3 RC1BF, RC1BJ, RC1BK 
1 to 9 1 RC1BX 
1 to 10 1 RC1P 
1 to 11 2 RC1E, RC1BD 
1 to 12 3 RC1X, RC1CE, RC1Z 
1 to 13 2 RC1N, RC1BO 
Mock 1 to 5 3 RM1V, RM1Y, RM1CE 
1 to 8 1 RM1CD 
1 to 8 1 RM1BP 
1 to 9 2 RM1CC, RM1BN 
1 to 10 5 RM1E, RM1G, RM1S, RM1BF, RM1BX 
1 to 11 1 RM1W 
1 to 12 4 RM1X, RM1Z, RM1BM, RM1BT 
1 to 13 2 RM1BI, RM1CB 
RecQ4 
siRNA #2 
1 to 5 5 RR21V, RR21BH, RR21BR, RR21BS, 
RR21BY 
1 to 8 1 RR21R 
1 to 9 1 RR21BO 
1 to 10 3 RR21J, RR21BK, RR21H 
1 to 11 1 RR21L 
1 to 12 3 RR21N, RR21BG, RR21BQ 
1 to 13 1 RR21P 
RecQ4 
siRNA #3 
1 to 5 5 RR31J, RR31Y, RR31BR, RR31BS, 
RR31CH 
1 to 7 1 RR31BZ 
1 to 9 3 RR31B, RR31G, RR31BN 
1 to 10 3 RR31P, RR31BH, RR31BP 
1 to 12 3 RR31CD, RR31CI, RR31BO 
1 to 13 1 RR31BU 
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Table 5.5 continued 
 
Expt # Group Donor's 
nucleotide 
Clone 
number 
Clone name 
2 Control 1 to 5 3 RC3Y, RC3N, RC3E  
 siRNA 1 to 8 1 RC3C 
 
1 to 10 1 RC3P 
 
1 to 11 1 RC3D 
 
1 to 12 1 RC3S  
 
1 to 13 1 RC3BC 
Mock 1 to 5 3 RM3Q, RM3G, RM3B 
1 to 8 2 RM3P, RM3O 
1 to 9 1 RM3W 
1 to 10 1 RM3U 
1 to 11 2 RM3I, RM3A 
1 to 12 4 RM3BA, RM3Y, RM3N, RM3BB 
RecQ4 1 to 8 1 R23H 
 siRNA #2 1 to 10 1 R23N 
 
1 to 12 2 R23Q, R23BD 
 
1 to 13 2 R23F, R23A 
RecQ4 1 to 5 1 R33Z 
 siRNA #3 1 to 8 1 RR31O 
 
1 to 9 2 R33B, R33H,  
 
1 to 12 2 R33S, R33P 
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Table 5.6 Position of donor’s mismatched nucleotides in crossover events (RecQ4&BLM 
knockdown experiments). 
 
Expt # Group Donor's 
nucleotide 
Clone 
number 
Clone 
1 Untreated 1 to 5 3 RBU1Z, RBU1V, RBU1K 
1 to 9 1 RBU1B 
1 to 10 2 RBU1J, RBU1X 
1 to 11 1 RBU1T 
1 to 12 4 RBU1BD, RBU1M, RBU1G, RBU1BC,  
1 to 13 1 RBU1W 
Control 
siRNA 
1 to 5 1 RBC1A 
1 to 6 1 RBC1Q 
1 to 9 1 RBC1B 
1 to 10 3 RBC1F, RBC1G, RBC1K,  
1 to 12 2 RBC1V, RBC1BC 
BLM siRNA 1 to 5 3 RBB1BB, RBB1O, RBB1U 
1 to 9 2 RBB1S, RBB1BD 
1 to 10 4 RBB1E, RBB1Q, RBB1R, RBB1A 
1 to 11 1 RBB1B 
1 to 12 3 RBB1J, RBB1M, RBB1C 
1 to 13 2 RBB1BC, RBB1D 
RecQ4 
siRNA 
1 to 5 6 RBR1P, RBR1A, RBR1C, RBR1G, RBR1N, 
RBR1U  
  1 to 8 1 RBR1Y 
 
1 to 9 2 RBR1BA, RBR1M 
 
1 to 12 1 RBR1T 
BLM&RecQ4 1 to 5 1 RBRB1V 
 siRNA 1 to 8 1 RBRB1T 
 
1 to 10 2 RBRB1L, RBRB1U 
 
1 to 11 1 RBRB1F 
 
1 to 12 4 RBRB1X, RBRB1G, RBRB1J, RBRB1Q 
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Table 5.6 continued 
 
Expt # Group Donor's 
nucleotide 
Clone 
number 
Clone 
2 Untreated 1 to 5 3 RBU3A, RBU3K, RBU3M 
1 to 10 1 RBU3S 
1 to 12 2 RBU3G, RBU3J 
1 to 13 1 RBU3N 
Control 1 to 5 1 RBC3A,  
 siRNA 1 to 9 1 RBC3I 
 
1 to 10 1 RBC3D 
 
1 to 12 1 RBC3O 
BLM siRNA 1 to 5 2 RBB3E, RBB3N 
1 to 7 1 RBB3C 
1 to 8 2 RBB3D, RBB3P 
1 to 9 1  RBB3T 
1 to 10 3 RBB3I, RBB3B, RBB3H 
1 to 11 1 RBB3L 
1 to 12 4 RBB3A, RBB3M, RBB3R, RBB3S 
RecQ4 1 to 5 2 RBR3A, RBR3Q 
 siRNA 1 to 8 2 RBR3F, RBR3K 
 
1 to 9 1 RBR3R 
 
1 to 10 2 RBR3B, RBR3L 
 
1 to 12 1 RBR3O 
 
1 to 13 1 RBR3S 
BLM&RecQ4 
 siRNA 
1 to 5 6 RBRB3F, RBRB3G, RBRB3H, RBRB3M, 
RBRB3N, RBRB3S, 
 
1 to 10 1 RBRB3E 
 
1 to 12 2 RBRB3J, RBRB3O 
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Table 5.7 NHEJ events and clone information in RecQ4 knockdown experiments. 
 
Expt # Group Deletion 
size (bp) 
Microhomology Clone 
name 
1 Control siRNA 10 GG RC1I 
22 AGCT RC1A 
22 AGCT RC1G 
22 A RC1Q 
28 GGG RC1W 
133 CAGGGT RC1CG 
169 GCCGT RC1L 
241 GC RC1BE 
256 G RC1H 
295 TA RC1BI 
Mock 1 A RM1T 
1 A RM1CA 
4 A RM1CF 
7 A RM1BS 
7 G RM1BZ 
10 GG RM1C 
10 A RM1BK 
22 0 RM1H 
22 AGCT RM1R 
22 AGCT RM1BH 
22 AGCT RM1BJ 
43 GG RM1BW 
118 AGC RM1K 
145 AACA RM1L 
148 ACA RM1A 
307 C RM1BU 
343 GCCC RM1BR 
685 ACG RM1BA 
1018 C RM1CH 
 
  
 175 
Table 5.7 continued 
 
Expt # Group Deletion  
size (bp) 
Microhomology Clone 
name 
1 RecQ4 siRNA #2 1 A RR21A 
1 A RR21B 
1 G RR21BJ 
1 A RR21CC 
4 0 RR21CB 
10 GG RR21M 
10 GG RR21S 
22 AGCT RR21C 
22 AGCT RR21I 
22 AGCT RR21BD 
22 AGCT RR21CF 
25 G RR21BM 
133 A RR21CG 
157 C RR21BZ 
244 GC RR21D 
427 G RR21Z 
RecQ4 siRNA #3 1 A RR31Z 
1 0 RR31BF 
1 A RR31BQ 
1 G RR31CG 
4 0 RR31O 
7 G RR31F 
22 AGCT RR31D 
22 AGCT RR31S 
22 AGCT RR31BD 
22 AGCT RR31BL 
193 CAGG RR31BW 
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Table 5.7 continued 
 
Expt # Group Deletion 
size (bp) 
Microhomology Clone 
name 
2 Control siRNA 4 0 RC3X 
4 0 RC3BB 
10 GG RC3Q 
10 GG RC3M 
22 AGCT RC3Z 
76 GGG RC3V 
145 G RC3F 
271 GAT RC3L 
400 ATAGC RC3BA 
Mock 19 GG RM3BD 
286 ATCG RM3R 
RecQ4 siRNA #2 1 A R23T 
4 0 R23D 
4 0 R23BB 
22 AGCT R23E 
28 GGG R23U 
37 GC R23B 
64 GC R23I 
389 GCCG R23O 
607 GGGAT R23Y 
RecQ4 siRNA #3 7 A R33W 
10 GG R33U 
16 G R33BB 
22 AGG R33BC 
133 CAGGGT R33Y 
166 0 R33X 
166 GA R33V 
337 C R33BD 
430 G R33F 
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Table 5.8 NHEJ events and their clone information in RecQ4 and BLM double 
knockdown experiments. 
 
Expt # Groups Deletion 
size (bp)  
Microhomology Clone 
name 
1 Untreated 1 A RBU1C 
7 A RBU1S 
19 A RBU1U 
22 AGCT RBU1L 
25 G RBU1P 
25 G RBU1H 
Control siRNA 7 A RBC1L 
19 GG RBC1M 
22 0 RBC1U 
BLM siRNA 1 G RBB1W 
8 TAA RBB1Y 
10 GG RBB1BA 
118 0 RBB1V 
RecQ4 siRNA 1 A RBR1F 
22 AGCT RBR1B 
22 AGCT RBR1I 
76 GGG RBR1D 
133 A RBR1V 
133 CAGGGT RBR1Z 
310 AC RBR1H 
BLM&RecQ4 siRNA 1 G RBRB1M 
1 G RBRB1N 
22 A RBRB1BA 
2 Untreated 1 A RBU3O 
133 CAGGGT RBU3Q 
Control siRNA 16 0 RBC3J 
268 ATC RBC3E 
BLM siRNA NA NA  NA 
RecQ4 siRNA 1 G RBR3E 
4 0 RBR3H 
10 GG RBR3D 
445 CAT RBR3M 
BLM&RecQ4 siRNA 22 AGCT RBRB3A 
22 A RBRB3B 
22 AGCT RBRB3T 
394 TG RBRB3D 
430 TG RBRB3K 
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recovered DSB repair recombinant clones. As mentioned in introduction, SSA could 
produce recombinant during DSB repair, which is indistinguishable from that of 
crossover events. 
 In pLB4-11 cell line, NHEJ events survived G418 selection as long as they 
rejoined the broken recipient sequence with 3N+1 bp deletion, which restore the original 
reading frame for tk-neo fusion gene. According to the data presented here, NHEJ events 
are only a small proportion of the recovered recombinant clones, the actual NHEJ events 
are most likely 3 times higher. This estimation suggests that NHEJ events induced by the 
break are roughly as many as HR events. NHEJ events do not convert the aforementioned 
13 nucleotide mismatches, and the homologous donor does not serve the “template” role 
in NHEJ events. 
 Different from NHEJ events, HR events restore the disrupted recipient back to a 
continuous HSV-1 TK sequence through removing the 22 bp engineered insertion. 
Moreover, donor’s unique nucleotides would be transferred into recipient sequence: the 
mismatched nucleotide 5, 3 bp downstream the I-SceI, was always converted while the 
rest mismatched nucleotides were converted to donor as the conversion tract move 
further. The HR events were further divided into gene conversion events and crossover 
events. Crossover events had donor sequence spliced to recipient sequence, causing 4.5 
Kb fragment deletion between these two tandem repeats.  
 Crossover events fusing tandem repeats: Aforementioned crossover events 
could be achieved by SSA: if the broken ends went through extensive unwinding and 
resection, the donor strand would eventually have chance to anneal with recipient strand. 
After flaps cleavage and ligation, the rejoined DNA molecule would have a fusion of 
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donor and recipient, the same as crossover events generated by HR. It is unknown 
whether recovered fusion events arise primarily from crossover or SSA, however, we 
found an increase in crossover events after BLM knockdown, which agree well with 
BLM’s roles in Holliday junction dissolution or D-loop rejection to prevent crossover, 
but contradict with BLM’s roles in long-range resection (117) and strand annealing to 
promote SSA (118). 
 Clone frequency not affected by RecQ4 knockdown: The DSB repair clone 
frequencies are equivalent in control and RecQ4 knockdown groups in each experiment, 
while variations in clone frequency were observed across experiments. In BLM 
knockdown experiments, no obvious change in clone frequency was observed after BLM 
knockdown or BLM and RecQ4 double knockdown.   
 No dramatic change in NHEJ events after RecQ4 knockdown: NHEJ events 
comprise a small portion of recovered events, and their proportions in RecQ4 knockdown 
groups are not dramatically different from that in control groups. They have sequence 
deletion from several nucleotides to thousands of nucleotides, and the deletion sizes are 
similar across experimental groups. Most NHEJ events rejoin the broken ends with 
potential use of microhomology, while only 13 out of 122 NHEJ events rejoined the 
broken ends without using short complementary ends. 
 Microhomology used in these events is generally short, from 1 to 6 nucleotides. 
About half of the NHEJ events used microhomology with 2 or more nucleotides, about 
one third used microhomology with 1 nucleotide, while the rest one sixth did not use 
microhomology. No obvious difference in utilizing microhomology was observed across 
experimental groups, and if any difference did exist, it does not correlate with genetic 
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background of examined cells. Though knockdown of RecQ4 or BLM does not affect 
NHEJ events, current data confirmed that NHEJ prefer to use terminal microhomology to 
ligate two broken ends. 
 Ratio of gene conversion to crossover changed after RecQ4 knockdown: In 
control groups, more crossover events were recovered than gene conversion events after 
DSB repair (65 vs 53), while this trend was reversed after RecQ4 knockdown (43 vs 60). 
The substantial difference between control cells and knockdown cells suggests the HR 
outcome shift from crossover to gene conversion after RecQ4 knockdown. However, the 
fisher exact test comparing these two HR subtypes between control and knockdown 
groups does not support significant difference between these two conditions.   
 RecQ4 knockdown alleviate the effect of BLM deficiency on HR:  In RecQ4 
and BLM double knockdown experiments, the DSB repair in BLM knockdown cells 
were examined as well as in RecQ4 and BLM double knockdown cells. BLM knockdown 
increased the proportion of crossover events, supported by fisher exact test comparing 
HR subtypes between BLM knockdown groups and control groups (p=0.0499). The same 
observation has been reported in our recent publication (70). The ratio of HR subtypes 
between other groups are not dramatically different. In RecQ4 and BLM double 
knockdown cells, though RecQ4 deficiency failed to increase the gene conversion events, 
it does abrogate potential increase of crossover event in BLM deficient cells. Since 
RecQ4 depletion alleviates effect from BLM deficiency, RecQ4 likely acts against BLM 
in HJ dissolution or D-loop rejection steps, which need further investigation. 
 Resolution site of crossover events is away from DSB: Most recovered gene 
conversion events have mismatches 4 and 5 converted to donor, with maximal 700 bp 
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conversion tract surrounding the break site. Some gene conversion events only converted 
mismatch 5, which means maximal 200 bp conversion tract mostly downstream of the 
break site. 
 In contrast, crossover events have more donor’s unique nucleotide downstream of 
the I-SceI insertion site in their recombinant DNA sequences. Polling data from control 
cells, 50 out 54 gene conversion events in control cells have conversion tract ended 
between mismatches 5 and 6, only gaining one donor’s unique nucleotide after break site. 
However, in 43 out of 62 crossover events, their recombinant DNA sequences have two 
or more donor’s unique nucleotides after I-SceI site. Fisher exact test comparing the 
resolution sites in gene conversion events and crossover events comes out statistically 
significant (p=0.0001). The results suggest that the crossover events may went through 
extensive strand exchange and DNA synthesis, so the area of genetic exchange tends to 
be dramatically longer than that in gene conversion events. 
Complex recombination events encountered in current experiments: 
Sporadically, there are complex recombination events which cannot be simply grouped 
into either HR or NHEJ events. There are totally 30 such events out of 551 examined 
events across experiments and they are generally listed in Table 5.9. 
Many complex recombinants have additional modifications on their DNA sequences 
besides the repair at the DSB site. They might be a combination of NHEJ and HR event, 
a combination of NHEJ and a secondary deletion event, or a combination of HR and a 
secondary unknown sequence changing event. There are also other gross rearrangement 
events that could not be identified through sequencing and southern blotting. All these 
events demonstrated that during DSB repair, cells probably made multiple attempts to fix 
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the lesion and adopted more than one pathway to save them from stalled cell cycle and 
cell death.  
Concluding Remarks: 
HR protects genome stability by fixing severe DNA damage affecting both 
strands of a DNA molecule, while occasionally it brings detrimental mutation, deletion or 
duplication after recombining diverged DNA sequences. In the current dissertation, 
recombination between diverged sequences has been examined using a new set of 
recombination substrates, which have different lengths of homeologous sequences 
between donor and recipient surrounded by perfect homology. The frequency and the 
fraction of HeR events were compared among these substrates to reveal how the length of 
homeologous sequences affects the HeR events between donor and recipient, or 
conversely, how cells process these homeologous sequences during DNA recombination.  
The obtained results clearly demonstrate that when aided by surrounding 
homology, HeR events occur at significantly higher frequencies than that between purely 
homeologous sequences, and they are common regardless of the length of homeologous 
sequences. Additionally, recombinants’ DNA sequences after MSH2 knockdown 
suggested hDNA as the recombination intermediate in these HeR recombinants of DSB 
repair. Moreover, MMR depletion brought a minor boosting effect on HeR frequency in 
cell line pBWW33-67, in contrast with its dramatic boost on recombination between 
diverged sequences. Available data presented evidence supporting that cells carry out 
recombination ignoring the mismatched nucleotides between donor and recipient as long 
as enough homology is available on both side of the homeologous sequence to mediate 
the recombination.   
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Table 5.9 Complex recombination events collected in all experiments. 
 
Clone 
Number 
1st event Event Details 2nd event 
RBU1I NHEJ 37 bp deletion with no 
microhomology 
CO with conversion tract to 3 
RR21BF NHEJ 993 bp deletion with 
microhomology GCG 
CO at location beyond 13 mismatched 
nucleotides 
RC1D NHEJ 193 bp deletion with 
microhomology CAGG 
GC with conversion tract to 3 
RC1B NHEJ 22 bp deletion with 
microhomology AGG 
GC with conversion tract to 4 
RR31CC NHEJ 10 bp deletion with no 
microhomology 
a string of G to C mutation near NHEJ 
RR21BL NHEJ 8 bp deletion with 
microhomology TAA 
467 bp deletion with microhomology AC 
RC1C NHEJ 8 bp deletion with 
microhomology TAA 
13 bp insertion near NHEJ 
RR31BX NHEJ 23 bp deletion with no 
microhomology 
DEL&INS with 209 bp deletion and 207 
bp insertion near NHEJ, 0.9 kb deletion 
beyond 13 mismatched nucleotides in 
recipient. 
RR31BI CO  with donor's nucleotide 
from 1 to 11 
Possibly 0.3 kb insertion in recipient 
beyond 13 mismatched nucleotides 
RR31BK CO with donor's nucleotide 
from 1 to 12 
unknown sequence alteration at a second 
location 
RR21CH CO  with donor's nucleotide 
from 1 to 12 
Possibly 0.4 kb deletion in recipient 
beyond 13 mismatched nucleotides 
RM1U CO with donor's nucleotide 
from 1 to 5 
Possibly sequence alteration affecting the 
terminal enzyme sites 
RM1BO CO  with donor's nucleotide 
from 1 to 11 
Possibly 0.1 kb insertion in recipient 
beyond 13 mismatched nucleotides 
RBB1F DEL&INS 24 bp deletion with 5 bp 
insertion 
CO with conversion tract to 4 at an 
upstream location 
RR21BU DEL&INS 602 bp deletion with 266 
bp insertion 
Possibly CO at location beyond 13 
mismatched nucleotides 
R23W NHEJ 18 bp deletion 1 bp second deletion between mismatched 
nucleotides 4 and 5 
RBC3G INS 2 bp insertion NA 
RC3R INS 137 bp insertion NA 
RR21Y INS 11 bp insertion NA 
RBR3T DEL&INS 2 bp deletion and 1 bp 
insertion 
NA 
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Table 5.9 continued 
 
Clone 
Number 
1st event Event Details 2nd event 
RBU3I DEL&INS 21 bp deletion and 2 bp 
insertion 
NA 
RBC1Z DEL&INS 11 bp deletion and 13 bp 
insertion 
NA 
R23R DEL&INS 8 bp deletion and 1 bp 
insertion 
NA 
RR21K DEL&INS 13 bp deletion and 6 bp 
insertion 
NA 
RR21CI DEL&INS 41 bp deletion and 4 bp 
insertion 
NA 
RBRB1K UNKNOWN  gross rearrangement NA 
RBU1E UNKNOWN gross rearrangement 
affecting recipient 
NA 
RR21BN UNKNOWN  gross rearrangement 
affecting recipient 
NA 
RM1B UNKNOWN  gross rearrangement 
affecting recipient 
NA 
R23K DEL0 0 bp deletion in recipient NA 
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Existing data indicates that MMR vigorously inhibits recombination between 
homeologous sequences and that MSH2-MSH6 interacts with hDNA within D-loop in 
vitro. Data in this dissertation strongly suggested that MMR helps to terminate HeR 
events at initiation step, while once invasion and synthesis established along the DNA 
template, the strand exchange and recombination between nearby homeologous sequence 
seem not a problem to the cells. This further sketch of HeR rejection mechanism does 
have its own virtue since the rejection of homeologous recombination is better to be at an 
earlier stage considering the long lasting, complicated procedure to achieve 
recombination. Timely check and abortion of recombination between diverged sequences 
greatly benefit for cells to combat a deadly lesion without wasting unnecessary time and 
energy. To sum up, results and conclusion in this dissertation provide detailed genetic 
evidence supporting homeologous tolerance at later stages of HR.  
Our findings also have great significance in understanding HeR events 
documented in rare medical conditions. The recombination events within these artificial, 
chromosomally integrated substrates are conceivably similar to the recombination events 
between evolutionarily related, diverged sequences in vivo, such as recombination 
between Alu sequences or between members of a gene family. Our results highlighted the 
risk of recombination between these repeats since they still share a significant amount of 
homology. On the other side, from the evolution point of view, the results also showed 
the recombinational exchange between slightly diverged sequence could be very active in 
aforementioned favorable conditions, which probably contributes to the homogenization 
of a gene family, termed as concerted evolution.  
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Another important conclusion of the current research is that homology 
requirements of spontaneous and DSB-induced recombination are dramatically different, 
and DSB is sloppy in choosing resolution site. The results emphasize the high risk in 
DSB repair, where HeR events are easily obtained even without assistance of homology 
on both sides of the homeologous sequences. Currently, the mechanism underlying the 
different homology requirements, whether SDSA or nearby DSB, during DSB repair 
relaxed homology requirement, remains unknown; the desired HeR events resulting 
solely from Holliday junction resolution are not yet recovered. If the products of this sub-
pathway really exist and are able to be recovered in the future, they would provide 
invaluable help to clarify the cause of relaxed homology requirements during DSB repair. 
It remains necessary to conduct more DSB experiments or MSH2 depletion experiments 
in order to recover the aforementioned recombination events. And meanwhile, in vitro 
studies are also informative and valuable if they can determine whether Holliday 
junctions could be efficiently resolved in a region of homeologous sequences. 
Moreover, attempts have been carried out to see RecQ4’s function in DSB repair. 
The recombination substrate pLB4 allows us to collect a broad spectrum of DNA repair 
events, and check the details of sequence changes in recovered events. Agonistic roles of 
BLM and RecQ4 were found in generating crossover events. Since RecQ4 joins the 
replisome, unwinds DNA strands for DNA synthesis and has high affinity to Holliday 
junctions, it is postulated that RecQ4 counteracts BLM in D-loop rejection or convergent 
branch migration of Holliday junctions. There is a conflicting report stating RecQ4 and 
BLM cooperate to reduce crossover events in studies on BLM patients’ cells. Therefore, 
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more experiments, both in vitro and in vivo, are required to verify and pursue the current 
results.  
The work presented in this dissertation moves forward our understanding of the 
mechanism and regulation of HR, and warrants further investment to answer these yet-
resolved and newly emerging questions. Better understanding of HR will inevitably 
contribute to our knowledge about genome instability, carcinogenesis, and has potential 
applications to improve human health.  
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